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Abstract
The release and clearance of adenosine are reasonably well-documented in the
mature CNS but relatively little is known about how adenosine signalling changes
during postnatal development. The activation of presynaptic A1 receptors (A1R) at
cerebellar parallel fibre terminals is known to inhibit synaptic transmission and the
expression of A1R has been observed in mature rat cerebellar slices. However its
distribution during development or in relation to parallel fibre–Purkinje cell (PF-PC)
synapses has not previously been described. In the mature cerebellum blockade of
presynaptic A1R at PF-PC synapses enhances synaptic transmission suggesting an
inhibitory adenosine tone and an extracellular purine tone is detectable with
microelectrode biosensors under basal conditions. The active release of adenosine
can be stimulated with trains of activity in the molecular layer of mature slices
although this does not appear to be a source of the basal extracellular adenosine tone.
This study used immunohistochemistry to determine the distribution of A1R at PF-
PC synapses in cerebellar slices at postnatal day 3 prior to PF-PC synapse formation,
postnatal days 8-14 and postnatal days 21-28. This study also used cerebellar slices
from rats at postnatal days 9-14 to investigate the pharmacological profile of the
immature rat PF-PC synapse with electrophysiology and microelectrode biosensors.
The immunohistochemistry suggests that A1R are widely distributed across Purkinje
cell bodies and their dendrites and within the granule layer of the cerebellum and that
its expression does not change during development. The same staining patterns were
also observed prior to PF-PC synapse formation.
Application of adenosine resulted in a variable A1R-mediated inhibition at immature
PF-PC synapses. This did not appear to be gender-specific or correlated with age of
rat and the synapses otherwise appeared identical in their properties. The
comparison of log concentration-response curves generated for an A1R agonist
suggested that some A1R may have a lower efficacy at this stage of development.
Blockade of presynaptic A1R at immature PF-PC synapses suggested that an
inhibitory adenosine tone is low or absent at this stage of development and is not the
result of a low A1R expression or developmental differences in A1R efficacy.
Inhibition of adenosine clearance via adenosine deaminase, adenosine kinase and
equilibrative transporters had little effect on synaptic transmission suggesting that
little adenosine is moving between the intracellular and extracellular spaces under
basal conditions in immature slices. Active adenosine release measured by
electrophysiology and microelectrode biosensors could be stimulated with hypoxia in
immature slices but this was delayed and slower in comparison to the release
observed in mature slices. Adenosine could not be actively released at immature PF-
PC synapses in response to electrical stimulation in the molecular layer.
xiii
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1Chapter 1 Introduction
1.1 Purines and their receptors
1.1.1 Purines
The nitrogenous purine bases, adenine and guanine, and pyrimidine bases, cytosine,
thymine and uracil are the building blocks of nucleic acids that form
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Adenosine and
guanosine are purine nucleosides that contain a pentose sugar in addition to their
purine base. Purine nucleotides consist of a purine base, ribose sugar and additional
phosphate group(s) and include adenosine 5’ triphosphate (ATP), adenosine 5’
diphosphate (ADP), adenosine 5’ monophosphate (AMP), guanosine 5’ triphosphate
(GTP), guanosine 5’ diphosphate (GDP) and guanosine 5’ monophosphate (GMP).
Plant and animal cells contain an abundance of the purine nucleosides and
nucleotides in addition to the cyclic purine nucleotides, adenosine 3’5’- cyclic
monophosphate (cAMP) and guanosine 3’5’- cyclic monophosphate (cGMP).
Within the mammalian CNS extracellular purines act as important intercellular
signalling molecules that exert a number of effects via cellular uptake or cell-surface
purinergic receptors (Rathbone, Middlemiss et al. 1999).
21.1.2 Purinoceptors
The idea of neurotransmission by purines was first introduced in 1972 following
previous reports of the release of a substance from inhibitory nerves within the
guinea pig taenia coli (muscle bands of the large intestine) that was neither
cholinergic nor adrenergic. Subsequent elimination of potential transmitters
concluded this substance to be the purine nucleotide ATP that was possibly acting
via a specific receptor (Burnstock 1972).
In 1978, Burnstock suggested that a family of purinoceptors existed that could be
divided into two groups. These were classified based on agonist/antagonist potency,
resultant changes in cAMP levels and induction of prostaglandin synthesis.
Adenosine is the primary natural ligand at P1 purinoceptors and P2 purinoceptors
recognise ATP,ADP, uridine 5’ triphosphate (UTP), uridine 5’ diphosphate (UDP)
and UDP-glucose (Burnstock 1980). It is now understood that the family of P1 and
P2 purinoceptors are present in all types of mammalian cells and are likely to be the
most abundant receptor type in mammalian tissue (Abbracchio, Burnstock et al.
2009).
The P2 receptors are further divided into P2X receptors that recognise ATP and P2Y
receptors that are activated by ATP, ADP, UTP, UDP or UDP-glucose. P2X
receptors are ligand-gated ion channels with subunits encoded by seven genes (P2X1-
7) which assemble as either homomeric (P2X1-5, 7) or heteromeric trimers (P2X1/2, 1/4,
1/5, 2/3, 2/6, 4/6). All P2X channels are permeable to Na+, K+ and Ca2+ cations. P2Y
receptors are metabotropic G-protein coupled receptors (GPCR) composed of 8
3subtypes (P2Y1, 2, 4, 6, 11, 12, 13, 14). These can be further subdivided into a group that
are primarily coupled to Gq/11 to activate phospholipase C (PLC) (P2Y1, 2, 4, 6, 11) and
a group that are coupled to Gi/o to inhibit adenylate cyclase (P2Y12, 13, 14) (Abbracchio,
Burnstock et al. 2009). Adenosine is the focus of this study so only P1 receptors will
be discussed further.
The group of P1 adenosine receptors is divided into four subtypes known as A1, A2A,
A2B and A3. All are metabotropic G-protein coupled receptors with an intracellular
C-terminal and seven highly-conserved transmembrane domains of hydrophobic
amino acids that form a pocket for the binding of adenosine (figure 1.1) (Ralevic and
Burnstock 1998).
In general within the CNS, the A1 receptors (A1R) have the highest affinity for
adenosine and can couple to Gi1/2/3 and Go to inhibit adenylate cyclase or activate
phospholipase C and inhibit N-type Ca2+ channels or stimulate K+ channels.
Conversely, the A2A receptor (A2AR) primarily stimulates adenylate cyclase via
coupling to Gs proteins although it is also known to couple with Golf proteins in the
striatum and can stimulate transmitter release via activation of protein kinase C
(PKC). The lower affinity A2B receptor (A2BR) largely activates adenylate cyclase
via Gs proteins but can also stimulate PLC via Gq proteins. The poorly characterised
low-affinity A3 receptor (A3R) mediates inhibition of adenylate cyclase by coupling
to Gi2/3 and possibly stimulation of PLC via Gq/11 (see figure 1.2 for summary). The
development of knockout mice for A1R, A2AR and A3R suggests that none of these
receptors play a significant role in development (Dunwiddie and Masino 2001;
Burnstock 2007).
4Subtypes of P1 receptor were first described when binding and potency of adenosine
and its analogues were examined in either cultured mouse brain cells or isolated
membrane preparations from a number of different cells (van Calker, Muller et al.
1979; Londos, Cooper et al. 1980). In these independent studies only two subtypes
of adenosine receptor were originally detailed based on the ability of the adenosine
receptor to either inhibit or stimulate adenylate cyclase activity, via an associated G-
protein, to regulate production of cAMP. The nomenclature adapted by van Calker
to describe the two types of adenosine receptor (A1/A2) is now widely accepted in
preference to the alternative study’s use of Ri (A1), where receptor activation
mediates inhibition of adenylate cyclase and Ra (A2), where the receptor facilitates
stimulation of the enzyme. In this alternative nomenclature the ‘R’ is used to
represent the ‘ribose’ component that binds to the adenosine receptor (Londos,
Cooper et al. 1980). The studies describe A1 (Ri) receptors as those where adenylate
cyclase is inhibited by N6-(phenylisopropyl)adenosine (PIA) > adenosine > N-
ethylcarboxamidoadenosine (NECA) and A2 (Ra) receptors as those where adenylate
cyclase activity is enhanced with the reverse potency sequence of NECA > adenosine
≥ PIA.  Methylxanthines act as antagonists at both A1 and A2 receptors in the order
of potency 3-isobutyl-lmethylxanthine > theophylline > caffeine.
The A2A and A2B subtypes of A2 receptor were identified following observations by
Daly in 1983 of a group of A2 receptors within the rat striatum and nucleus
accumbens with a higher affinity for adenosine than those present in other areas of
the brain. A subsequent study described the high-affinity striatal A2AR as a receptor
where binding of the A1 and A2 receptor-selective compound [3H]adenosine-5'-(N-
ethylcarboxamide) ([3H]NECA) is observed in the presence of the A1R agonist N6-
5cyclopentyladenosine (CPA) (Bruns, Lu et al. 1986). Molecular cloning confirmed
the existence of two distinct A2 receptor subtypes which are broadly similar with the
exception of the A2AR having a larger intracellular C-terminal (Fredholm,
Abbracchio et al. 1994).
Molecular methods were used to identify the final P1 receptor subtype, the A3R. The
rat striatal cDNA sequence R226 was found to be a GPCR of the P1 receptor family
but without sufficient homology within the transmembrane regions to be considered
as an A1 or A2 receptor subtype. Functional expression found that the receptor was
able to bind recognised adenosine receptor agonists but with a different
pharmacological profile to the A1R, A2AR or A2BR although inhibition of adenylate
cyclase is observed in the same way as at the A1R. In contrast to the other adenosine
receptor subtypes the A3R is xanthine-insensitive (Zhou, Li et al. 1992). The A3R
subtype varies between species and is generally of low abundance. It is the least well
characterised of the P1 family of receptors.
Several species have now been used to clone all four subtypes of P1 adenosine
receptor and functional expression in mammalian cells or Xenopus oocytes has
enabled the biochemical and pharmacological characterisation of each (Ralevic and
Burnstock 1998). A number of subtype-selective agonists and antagonists have been
identified with the agonists differing only slightly in structure from that of adenosine
(Burnstock 2007; Abbracchio, Burnstock et al. 2009).
6Figure 1.1 Structure of the A1 receptor (A1R)
The A1R is one of four known P1 receptor subtypes. All are G-protein coupled
receptors (GPCR) consisting of seven highly-conserved hydrophobic transmembrane
domains (I – VII) that form a binding pocket for adenosine. Each hydrophobic
domain forms an α-helix connected by hydrophilic loops.  There is an extracellular 
N-terminal and intracellular C-terminal. The number of amino acids comprising the
hydrophilic loops and the N-terminal and C-terminal regions of the bovine A1R are
indicated in brackets (Ralevic and Burnstock 1998).
7Receptor Adenosine
affinity
G-protein Transduction
mechanismsa
Physiological actions in
brain
Distribution
in brain
A1 70 nM Gi and Go Inhibits adenylate cyclase
Activates GIRKs
Inhibits Ca2+ channels
Activates PLC
Inhibits synaptic
transmission
Hyperpolarizes neurons
Widespreadb
A2A 150 nM Gsc Activates adenylate cyclase
Inhibits Ca2+ channels
Activates Ca2+channels (?)
Facilitates transmitter
release
Inhibition of transmitter
release
Primarily
striatum
olfactory
tubercle
nucleus
accumbensd
A2B 5100 nM Gsc Activates adenylate cyclase
Activates PLC
Increases in cAMP in
brain slices
Modulation of Ca2+
channel function (?)
Widespreade
A3 6500 nM Gi3, Gq Activates PLC
Inhibits adenylate cyclase
Increases intracellular Ca2+
Uncouples A1, mGlu
receptors (?)
Widespreade
Figure 1.2 Adenosine receptors in the brain
aGIRKs, G-protein–dependent activation of inwardly rectifying K+ channels; PLC,
phospholipase C.
bBased upon numerous ligand binding studies and in situ hybridization studies.
cPrimary mechanism of coupling.
dLigand binding and in situ hybridization generally shows high levels in these
regions, very low levels elsewhere; reverse transcriptase–polymerase chain reaction
(RT-PCR) shows more widespread expression.
eRelatively low levels, not detectable with in situ hybridization but apparent with
RT-PCR
(Dunwiddie and Masino 2001)
81.2 Adenosine signalling in the CNS
1.2.1 The effects of adenosine in the CNS
Activation of high-affinity A1R at presynaptic terminals is linked to a decreased
release of excitatory and inhibitory neurotransmitters via inhibition of Ca2+ channels.
Inhibition of a number of ‘classical’ neurotransmitters including gamma-
aminobutyric acid (GABA) (Courjaret, Troger et al. 2009) and acetylcholine (De
Lorenzo, Veggetti et al. 2004) have been described although the inhibition of
excitatory glutamatergic transmission is the most frequently occurring. Activation of
A1R in the CNS is also associated with reduced neuronal activity via
hyperpolarisation of the resting membrane potential due to the G-protein dependent
activation of inwardly rectifying K+ channels (GIRKs) (Dunwiddie and Masino 2001;
Boison 2008).
Action of the purinergic messenger adenosine at its cell surface receptors within the
CNS is implicated in a diversity of physiological and pathophysiological conditions.
A number of studies have demonstrated a role for adenosine in promoting sleep and
reducing arousal. Measurement of extracellular adenosine concentrations in the
basal forebrain and thalamus of cats, where the efferent cholinergic neurones
involved in the control of electroencephalographic activation (EEG arousal) are
present, showed that increases in adenosine are linked to prolonged and deeper sleep
following periods of wakefulness. Microdialysis perfusion of adenosine into these
brain regions also induces sleep (Porkka-Heiskanen, Strecker et al. 1997).
Conversely, intravenous injections of the adenosine receptor antagonist caffeine into
9males during non-rapid eye movement (non-REM sleep) promotes arousal and
disturbs sleep (Lin, Uhde et al. 1997). Analysis of rat EEGs following the
administration of the A1R agonist N6-cyclopentyladenosine (CPA) and A1R
antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX) demonstrates a role for this
specific adenosine receptor subtype in sleep (Fulga and Stone 1998) although it is
unlikely that the A1R is solely responsible for sleep regulation. A comparison of
sleep patterns and response to sleep deprivation in A1R knockout mice and wildtype
mice of the same line demonstrated no significant differences between the two
groups (Stenberg, Litonius et al. 2003). This may partly be explained by a number
of studies which have more recently suggested a role for the high-affinity A2AR in
sleep (Dunwiddie and Masino 2001).
Extracellular adenosine plays a role in respiration via receptors located at carotid
bodies responsible for the detection of oxygen levels in the blood. A number of
studies have demonstrated an increased catecholamine discharge from the carotid
sinus nerve resulting in enhanced ventilation, which is reversible with adenosine
receptor antagonists like caffeine, following administration of intravenous adenosine
in different species (Lahiri, Mitchell et al. 2007). The A2AR located on type I cells,
which are the primary oxygen sensors of the carotid body, are thought to contribute
to this. Calcium imaging in rat carotid bodies demonstrated replication of the
increased [Ca2+]i response to adenosine with the A2AR agonist CGS-21680 which
could be blocked with the A2AR antagonist ZM-241385 (Xu, Xu et al. 2006).
A further physiological role for adenosine is in the regulation of locomotor activity
via A2AR within the striatum. The A2AR agonist CGS-21680 reduces locomotor
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activity in normal mice and has no effect on A2AR knockout mice, which also
demonstrate a reduced exploratory behaviour. The locomotor stimulatory effects of
caffeine are also absent in A2AR knockout mice (Ledent, Vaugeois et al. 1997).
Increased locomotor activity in A3R knockout mice suggests this adenosine receptor
subtype may also be involved in locomotion (Fredholm, Abbracchio et al. 1994).
A prolonged release of extracellular adenosine in response to the increased demand
for energy from ATP during pathological events is a well-documented
neuroprotective action that results in vasodilation and an increase in local cerebral
blood flow. Increased levels of extracellular adenosine have been described during
trauma, stress, pain, seizures, hypoxia and ischemia (Dunwiddie and Masino 2001;
Latini and Pedata 2001). Synaptic depression of extracellular field potentials during
periods of hypoxia induced in rat hippocampal slices can be blocked by the A1R
antagonist 8-cyclopentyltheophylline (8-CPT) (Fowler 1989; Gribkoff and Bauman
1992). Similarly, a complete depression of synaptic potentials as a result of
increased extracellular adenosine blocking glutamate release is observed during
periods of induced ischemia in rat hippocampal slices. Again, the synaptic
depression can be blocked by the addition of 8-CPT to the superfusate (Pedata, Latini
et al. 1993). The neuroprotective effects of adenosine are mediated primarily
through cellular pathways triggered by A1R activation. These mechanisms inhibit
some Ca2+ channels to reduce glutamate and other neurotransmitter release and
hyperpolarise neurones to limit the entry of Ca2+, which causes excitotoxic damage
and maintain stores of ATP that are needed to actively remove intracellular Ca2+
(Dunwiddie and Masino 2001).
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A role for adenosine as an endogenous anticonvulsant has been demonstrated in a
number of studies using models of epilepsy. Kainic acid-induced motor seizures in
rats are suppressed by the adenosine receptor agonist N-ethylcarboxamidoadenosine
(NECA) or the adenosine-uptake blocker dilazep (Zhang, Franklin et al. 1990).
Conversely, in rat hippocampal slices where the CA3 region is known to be the
primary generator of epileptiform activity, blockade of adenosine receptors by
theophylline and caffeine induces convulsant activity and enhances kainic-acid
induced burst firing (Ault, Olney et al. 1987). The adenosine system is also involved
in the astrocytic proliferation observed in epilepsy. This astrogliosis increases levels
of the enzyme adenosine kinase (AK) responsible for the regulation of intracellular
levels of adenosine. Its upregulation reduces the local inhibitory tone of adenosine
and is associated with spontaneous chronic seizures. Transgenic mice
overexpressing the AK enzyme are also prone to spontaneous seizures. Therapeutic
potential has been demonstrated for A1R agonists and AK inhibitors in the treatment
of epilepsy. (Boison 2008).
A neuromodulatory role for adenosine has been documented in a number of
neurological diseases. The action of adenosine, primarily at A2AR, plays a role in
Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and Schizophrenia
(Boison 2008).
There is growing evidence that adenosine plays an important role in the processing of
information by cerebellar circuits. Endogenous adenosine (Braas, Newby et al.
1986), A1R (Goodman and Snyder 1982; Rivkees, Price et al. 1995; Yoshioka,
Hosoda et al. 2002) and nucleoside transporters (Anderson, Baldwin et al. 1999;
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Anderson, Xiong et al. 1999) are all present within the cerebellum as are the
enzymes required for purine metabolism: ecto-ATPase (Wang and Guidotti 1998),
5’-nucleotidase (Schoen, Graeber et al. 1987) and adenosine deaminase (Geiger and
Nagy 1986) with activity comparable to or higher than in other brain regions (Wink,
Braganhol et al. 2003). Application of adenosine can selectively produce synaptic
inhibition in the cerebellum (Kocsis, Eng et al. 1984) and the tonic activation of A1R,
producing synaptic inhibition, provides indirect evidence for an extracellular tone of
adenosine in cerebellar slices (Takahashi, Kovalchuk et al. 1995). However the
physiological relevance of these studies remains unclear (Wall, Atterbury et al.
2007).
1.2.2 The formation and control of intracellular adenosine
Intracellular adenosine can be formed via the dephosphorylation of AMP by
cytosolic 5’-nucleotidase or via the hydrolysis of S-adenosylhomocysteine (SAH) by
SAH hydrolase (figure 1.3) (Boison 2006). It was first assumed that only metabolic
stress and increased ATP catabolism would result in the formation of adenosine via
dephosphorylation of AMP due to the Km of cytosolic 5’-nucleotidase (5 mM) being
higher than the physiological intracellular concentration of AMP (0.1 -0.5 mM)
(Dunwiddie and Masino 2001). However, COS-7 cells expressing cytosolic 5’-
nucleotidase cloned from pigeon heart have a significantly higher concentration of
adenosine than untransfected cells suggesting a basal activity of the enzyme in the
absence of metabolic stress. An abundance of cytosolic 5’-nucleotidase in brain
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tissue was also demonstrated using Northern blot and PCR techniques (Sala-Newby,
Skladanowski et al. 1999).
Immunohistochemistry has demonstrated localisation of the SAH hydrolase enzyme
in the neocortex, cerebellum, hippocampus and olfactory tubercle of the rat brain
(Patel and Tudball 1986) and adenosine can be formed via the action of this enzyme
in both glial and neuronal primary cell cultures from chick embryos (Ceballos, Tuttle
et al. 1994). In rat hippocampal slices the potent SAH hydrolase inhibitor adenosine-
2,3-dialdehyede has no effect on the outflow of adenosine as measured by HPLC
under ischemic conditions or following electrical stimulation. Tissue levels of SAH
are also low in these slices indicating that SAH hydrolase is unlikely to play a major
role in intracellular adenosine production and that its activity will be confined to
regions containing higher substrate levels (Latini, Corsi et al. 1995).
The adenosine concentration in the intracellular space is maintained at low levels by
the action of adenosine kinase (AK) which phosphorylates adenosine to form AMP
and adenosine deaminase (ADA) which deaminates adenosine to form inosine. The
phosphorylation of adenosine by AK is the predominant metabolic pathway as this
enzyme has a higher affinity for adenosine. The Km is 2 µM for AK and 17 - 45 µM
for ADA in the rat whole brain. Deamination of adenosine by ADA is likely to be
more important in pathological conditions when intracellular adenosine
concentrations are increased (Boison 2006).
A number of studies have demonstrated that AK is the key enzyme in the regulation
of adenosine metabolism. In rat hippocampal slices the inhibition of neuronal
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activity observed with application of adenosine is replicated with perfusion of the
AK inhibitor iodotubericidin but to a lesser extent or not at all with inhibition of
SAH hydrolase with adenosine-2,3-dyaldehyede or ADA with erythro-9-(2-hydroxy-
3-nonyl) adenine (EHNA) (Pak, Haas et al. 1994). In the rat prepiriform cortex the
ability of adenosine to suppress bicuculline methiodide-induced seizures is
potentiated following application of the AK inhibitor 5'-amino-5'-deoxyadenosine
again suggesting an important role for this enzyme in the control of extracellular
adenosine (Zhang, Franklin et al. 1993) and in rat hippocampal slices labelled with
[3H]-adenine a greater proportion of [3H]-adenosine is released following inhibition
of AK with iodotubericidin. In contrast blocking ADA with EHNA has no effect on
the proportion of [3H]-adenosine released under normoxic conditions (Lloyd and
Fredholm 1995).
Intracellular adenosine may potentially be inactivated via the reversible reaction of
SAH hydrolase which requires L-homocysteine in combination with adenosine to
form SAH. In rat hippocampal slices [14C] adenosine was incorporated primarily
into nucleotides with only a very small amount into other metabolites or SAH. The
addition of L-homocysteine increased the amount of [14C] adenosine incorporated
into SAH suggesting that the reversible reaction of SAH hydrolase contributes very
little to the metabolism of intracellular adenosine due to low levels of L-
homocysteine in the brain limiting the pathway (Reddington and Pusch 1983).
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1.2.3 The sources of extracellular adenosine
The extracellular concentration of adenosine in the brain varies by region but is
estimated to be between 25 nM and 250 nM (Dunwiddie and Diao 1994). There are
at least three mechanisms for adenosine to access the extracellular space to maintain
this basal concentration which is responsible for the tonic activation of high affinity
A1 and A2AR. Firstly, the extracellular ATP released from neurones (Edwards, Gibb
et al. 1992; Dale 1998) or through the opening of gap junction hemichannels
(Pearson, Dale et al. 2005) as a transmitter or co-transmitter can be rapidly converted
to adenosine by ectonucleotidases. Alternatively, adenosine that has been formed
intracellularly can be released directly into the extracellular space via facilitated
diffusion transporters (Craig and White 1993; Sweeney 1996) or, as more recent
studies have suggested, adenosine can be released into the extracellular space in a
neuronal activity-dependent manner (Wall and Dale 2008) (see figure 1.4 for
summary).
In support of extracellular ATP being the source of adenosine it has been shown that
application of adenine nucleotides (cAMP, AMP, ADP and ATP) to the cell bodies
of CA1 pyramidal neurones in the rat hippocampus results in the same postsynaptic
activation of A1R and subsequent stimulation of K+ channels to decrease excitatory
transmission that is observed with direct application of adenosine. Blockade of the
ectonucleotidase pathway demonstrates that the adenine nucleotides do not interact
directly with the A1R but that rapid conversion of the non-cyclic adenine nucleotides
to adenosine following their release into the extracellular space is essential for the
transient activation of A1R. The cyclic adenine nucleotide, cAMP, is more likely to
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account for slow changes in extracellular adenosine concentration (Dunwiddie, Diao
et al. 1997).
The ectonucleotidase enzyme families include: the plasma membrane-located E-
NTPDase (ecto-nucleoside triphosphate diphosphohydrolase) family (E-NTPDase 1-
6) responsible for the hydrolysis of ATP to ADP or AMP; the E-NPPase (ecto-
nucleotide pyrophosphatase/phosphodiesterase) family of membrane proteins (NPP1-
3) which use purine and pyrimidine nucleotides as substrates to primarily form AMP
via hydrolysis although NPP2 can also produce adenosine from AMP; the alkaline
phosphatases of which little evidence exists for a role in the metabolism of
extracellular nucleotides and the GPI (glycosylphosphatidylinositol)-anchored ecto-
5’-nucleotidase which catalyses the final step of extracellular nucleotide metabolism
by dephosphorylating AMP to form adenosine (Zimmermann 2000).
Nucleoside transporters may provide a further source of extracellular adenosine.
There are two structurally unrelated nucleoside transporter (NT) protein families; the
equilibrative nucleoside transporter (ENT) family passively mediate the transport of
nucleosides across the cell membrane in either direction to equilibrate extracellular
and intracellular concentrations, and the concentrative nucleoside transporter (CNT)
family are symporters that enable the active transport of nucleosides against their
concentration gradient into the cell coupled with the inward movement of Na+ down
its electrochemical gradient as a source of energy (Cass, Young et al. 1998).
The ENT transporter family are classified according to their sensitivity to the
nucleoside transport inhibitor nitrobenzylthioinosine (NBMPR). The es subtype of
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ENT (ENT1) is sensitive to inhibition by NBMPR and the is subtype of ENT (ENT2)
is insensitive to NBMPR or blocked only at high micromolar concentrations. Both
ENT1 and ENT2 proteins are equally sensitive to inhibition by dipyridamole (Cass,
Young et al. 1998). In-situ hybridisation and RT-PCR using the ENT1 transporter
cloned from rat jejunum (rENT1) shows a wide distribution of rENT1 mRNA
throughout the hippocampus, cortex, cerebellum and striatum of the rat brain with
[3H] NBMPR binding sites also present largely in the cortex and striatum and to a
lesser extent in the hippocampus and cerebellum (Anderson, Xiong et al. 1999). A
similar study using cloned rat cDNA for ENT2 (rENT2) shows a strong antisense
signal in a number of brain regions and suggests that ENT2 may be a more
predominant equilibrative transporter subtype than ENT1 in the rat brain (Anderson,
Baldwin et al. 1999).
Under normoxic conditions the widely distributed equilibrative transporters generally
remove adenosine from the extracellular space along its concentration gradient and a
number of studies demonstrate an increase in extracellular adenosine tone following
their pharmacological inhibition (Latini and Pedata 2001). However, the release of
preloaded L-[3H]adenosine from rat brain synaptosomal protein preparations
following their suspension in buffer can be partially blocked by both NBMPR and
dipyridamole indicating that some of this adenosine efflux is via equilibrative
transporters and that these have the potential to provide a source of extracellular
adenosine in vivo (Gu, Foga et al. 1995).
It is possible that the equilibrative transporters could provide a source of extracellular
adenosine in pathological situations where the usually low concentration of
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intracellular adenosine, maintained through activity of the AK enzyme, is
increasedInhibition of AK with NH2dAD can mimic the inhibition of spinal reflex
potentials observed following an acute increase in CO2 (hypercapnia) in the neonatal
rat isolated spinal cord. The fall in pHi inactivates the AK enzyme resulting in an
increase in extracellular adenosine presumably due to release along its reversed
concentration gradient via equilibrative transporters (Otsuguro, Yamaji et al. 2006).
However, inhibition of equilibrative transporters in rat hippocampal slices does not
prevent the release of adenosine during ischemia and microelectrode biosensor
recordings instead demonstrate that release is enhanced twofold indicating that
equilibrative transporters are unlikely to facilitate adenosine release during ischemia
(Frenguelli, Wigmore et al. 2007).
To support the involvement of equilibrative transporters in the removal of increased
intracellular adenosine resulting from the inhibition of AK to the extracellular space,
application of NBTI and dipyridamole to inhibit ENT1 and ENT2 proteins results in
blockade of inhibition at the PF-PC synapse caused by iodotubericidin in 50 % of
cerebellar slices (Wall, Atterbury et al. 2007).
In addition to increases in intracellular adenosine caused by the inhibition of AK, the
extra demand for energy during metabolic stress will increase the cytoplasmic
catabolism of ATP to adenosine (figure 1.3) and this increased intracellular
adenosine concentration will result in the facilitative release of adenosine along its
concentration gradient to the extracellular space possibly via equilibrative transporter
proteins (Latini and Pedata 2001).
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The involvement of the five known CNT transporter subtypes in the regulation of
extracellular adenosine levels is largely undetermined due to the lack of selective
inhibitors available although it is thought that the CNT proteins may enable release
of adenosine into the extracellular space in pathological conditions such as hypoxia,
ischemia and seizures where neurones are no longer able to maintain physiological
Na+ electrochemical gradients. This potentially could result in the release of
adenosine coupled to reversed Na+ transport in concentrative transporters
(Dunwiddie and Masino 2001; Latini and Pedata 2001).
Finally, it has been more recently recognised that adenosine can be released under
normal conditions in an activity-dependent manner. High frequency stimulation of
Schaffer-collateral axons in organotypic hippocampal slice cultures results in the
short-term depression of excitatory postsynaptic currents (ESPCs) recorded in CA1
cells which can be attenuated with application of the A1R antagonist DPCPX. The
short-term depression is not affected by inhibition of 5’-ectonucleotidase with α,β 
methylene-ADP or ENT protein inhibition with dipyridamole suggesting that the
adenosine released is not a result of extracellular ATP breakdown or facilitative
transport from the cytoplasm (Brager and Thompson 2003). Similarly, trains of
stimuli applied to the Calyx of Held which is a giant nerve terminal in the
mammalian auditory brainstem results in synaptic depression which can be reduced
with the A1R antagonist DPCPX and which is not affected by application of the
ectonucleotidase inhibitor ARL 67156 to prevent the breakdown of ATP to ADP
thereby suggesting direct release of adenosine (Wong, Billups et al. 2006).
Application of a physiological electrical stimulus to the molecular layer of rat
cerebellar slices results in an inhibition of excitatory postsynaptic potentials (EPSPs)
20
that can be blocked with A1R antagonists. A slow rising current can also be detected
on an adenosine microelectrode biosensor placed on the surface of the molecular
layer, but not on an ATP biosensor signal, that is not affected by the ENT protein
inhibitors NBTI or dipyridamole. This suggests either direct release of adenosine or
a rapid metabolism of ATP although the adenosine signal is not affected by blockade
of ATP metabolism with Evans Blue, ARL67156 or α,β methylene-ADP (Wall and 
Dale 2007).
Release of adenosine into the extracellular space under normal conditions that is not
the result of released ATP breakdown may be achieved via the exocytosis of a
neurotransmitter that acts on a neuron or astrocyte to enable adenosine release. This
mechanism is difficult to prove due to the large number of antagonists that would
need to be tested in order to block the unknown ‘interposed’ neurotransmitter release.
Alternatively adenosine may directly be released by exocytosis from synaptic
vesicles which will be unlikely if, as many studies suggest, AK is actively
maintaining a low intracellular adenosine concentration (Wall and Dale 2008).
1.2.4 The removal of adenosine from the extracellular space
Extracellular adenosine is primarily inactivated by its movement across neuronal or
glial cell membranes into the cytoplasm by facilitated diffusion using ENT1 or ENT2
proteins or active transport using CNT proteins (Dunwiddie and Masino 2001; Latini
and Pedata 2001). Application of NBTI via microdialysis to block ENT1 proteins in
vivo results in a 2.4 fold increase in interstitial adenosine levels in the pig cortex
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under normal conditions (Gidday, Kim et al. 1996). The effect of equilibrative
transporter protein inhibition is variable at the parallel fibre-Purkinje cell (PF-PC)
synapse in the rat cerebellum (Wall, Atterbury et al. 2007).
The enzyme ADA is responsible for the deamination of adenosine to inosine in the
extracellular as well as the intracellular space. Inosine is inactive at A2AR and A2BR
but a weak agonist with a low efficacy at A1R and A3R in CHO cells expressing
human adenosine receptors. Although inosine cannot be considered a natural ligand
at adenosine receptors it may activate A1R and A3R under some circumstances
(Fredholm, Irenius et al. 2001).
It has previously been discussed how the intracellular enzyme AK is more important
in the regulation of adenosine metabolism than ADA under normal conditions.
EctoADA is structurally and functionally identical to cytosolic ADA and is known to
be anchored to the cell surface by CD26 and A1R enabling extra-enzymatic co-
stimulatory functions (Franco, Casado et al. 1997). EctoADA is likely to play an
important role in the removal of adenosine from the extracellular space in
pathological conditions where the increased intracellular adenosine concentration
results in transporter proteins no longer being able to remove extracellular adenosine
(Dunwiddie and Masino 2001).
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1.2.5 The development of adenosine signalling in the CNS
Although the release, clearance and effects of adenosine are reasonably well-
documented within the mature CNS relatively little is known about how adenosine
signalling changes during postnatal development. Adenosine binding to presynaptic
A1R inhibits EPSCs at the glutamatergic synapse between the calyx of Held in the
auditory brainstem and a postsynaptic principal cell in the medial nucleus of the
trapezoid body (MNTB) of rats at postnatal days 5-7. A developmental decline in
the adenosine-induced presynaptic inhibition occurs during the second postnatal
week in parallel with a significant reduction in A1R immunoreactivity at the calyx of
Held synapse (Kimura, Saitoh et al. 2003). Conversely, presynaptic inhibition of
EPSPs following application of adenosine to CA1 hippocampal neurones does not
change in slices from rats aged between postnatal day 5 and postnatal day 120.
However, the increase in inhibition observed by blocking adenosine uptake with
NBTI is less obvious in younger animals suggesting that a developmental increase in
extracellular adenosine tone occurs although A1R properties are maintained
(Psarropoulou, Kostopoulos et al. 1990).
Hippocampal CA3 neurones act as a pacemaker of epileptiform activity possibly as a
result of the intrinsic recurrent excitatory circuits in this area (MacVicar and Dudek
1980). Adenosine is a less potent anti-epileptic at immature hippocampal CA3
neurones as inhibition of stimulus-induced postsynaptic potentials via activation of
A1R with the agonist N6-(phenylisopropyl) adenosine (PIA) is significantly less than
in the adult hippocampus. It is also likely that endogenous adenosine produces an
anti-epileptic tone in adult but not immature animals as the A1R antagonist 8-
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cyclopentyl-1,3-dipropylxanthine (DCPCX) induces proconvulsant spontaneous
bursts more frequently at adult hippocampal CA3 neurones (Descombes, Avoli et al.
1998).
In another study application of adenosine results in a similar inhibition of transmitter
release at CA3-CA1 neurones in both juvenile (postnatal day 15-21) and mature
(postnatal day 28-35) rat hippocampal slices. The inhibition results in an increase in
paired pulse facilitation (PPF) of EPSPs in mature but not juvenile slices suggesting
that the presynaptic ability of adenosine to affect transmitter release increases during
development. Application of adenosine increases the PPF in juvenile slices pre-
treated with Ca2+ to increase transmitter release suggesting that the increase in
probability of release known to occur during maturation is responsible for the
developmental differences in the affect of adenosine on PPF (Dumas and Foster
1998). However, a study using rat hippocampal slices and the A1R antagonist
DPCPX demonstrates that the deterioration in long-term potentiation (LTP) from
young adulthood to middle age in particular groups of synapses is likely to be due
age-related changes in A1R or the processes that they trigger (Rex, Kramar et al.
2005)
The role of AK, the key enzyme in the regulation of adenosine metabolism, is likely
to change during postnatal development. During early postnatal development of the
mouse hippocampus AK immunoreactivity is most prominent in neurones with a
gradual transition of expression to newly-formed GFAP-positive astrocytes until
around postnatal day 14 with neuronal expression being maintained in only a few
areas. Staining of myelin shows the switch in expression correlates with the onset of
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neuronal myelination suggesting that neuronal expression of AK may prevent
myelination during early postnatal development. The increased effect of A1R
antagonists on EPSPs during hippocampal development suggests that the astrocytic
expression of AK in mature slices allows regulation of adenosine concentration in
the mature hippocampus according to metabolic needs and synaptic activity thus
maintaining a greater tonic inhibition via A1R and the previously described decreased
excitability and susceptibility to seizures (Studer, Fedele et al. 2006).
25
Figure 1.3 The formation and control of intracellular adenosine
Intracellular adenosine can be formed via the dephosphorylation of AMP by
cytosolic 5’-nucleotidase or to a lesser extent via the hydrolysis of S-
adenosylhomocysteine (SAH) by SAH hydrolase (SAHH). Under normoxic
conditions a low intracellular concentration of adenosine is maintained
predominantly by the enzyme adenosine kinase (AK) which phosphorylates
adenosine to form AMP. Intracellular adenosine can also be deaminated by the
lower-affinity enzyme adenosine deaminase (ADA) to from inosine (Ino). During
metabolic stress the increased production of adenosine via cytoplasmic ATP
catabolism will result in an increased ADA activity and the removal of adenosine
from the intracellular space along its reversed concentration gradient via nucleoside
transporter (nt) proteins in the cell membrane. Cleavage of released ATP by
ectonucleotidases (EN) contributes to the extracelluar formation of adenosine
(Boison 2006).
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Figure 1.4 Possible sources of extracellular adenosine
There are at least three mechanisms for adenosine to access the extracellular space.
This could be (a) via the metabolism of extracellular ATP released by exocytosis or
through gap junction hemichannels. Alternatively, (b) adenosine that has been
formed intracellularly can be released into the extracellular space via equilibrative or
concentrative nucleoside transporters or (c) possibly by via neuronal activity-
dependent exocytosis.
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1.3 The mammalian cerebellum
1.3.1 The roles of the cerebellum
A number of lesion and neural recording studies provide evidence for at least three
ways in which the cerebellum is involved in the motor control of balance and
locomotion. Firstly, although the spinal cord and brainstem are responsible for the
basic generation of locomotor co-ordination (Morton and Bastian 2004), the
cerebellum contributes to the timing and rate of muscle activity during locomotion.
Cerebellar lesions in cats trained to walk on a motorised treadmill result in walking
and balance difficulties demonstrated by abnormal timings in limb movements and
decreased stride lengths (Yu and Eidelberg 1983) and in extracellular microelectrode
recording studies discharges of simple spikes from Purkinje cells in the anterior lobe
of the cerebellum in cats are recorded in time with stepping during steady walking on
a moving belt (Edgley and Lidierth 1988).
Secondly the cerebellum contributes to the control of balance during locomotion.
Postural ataxia frequently described as a ‘drunken gait’ with swaying and falling
during locomotion is observed in patients with lesions of the anterior lobe of the
cerebellum, cerebellar hemisphere and vestibulo-cerebellum (Mauritz, Dichgans et al.
1979). The cerebellar control of balance and gait are likely to be coupled and
separate from the cerebellar control of limb movement as cerebellar lesion patients
with impaired balance that perform poorly in a weight-shifting task are more likely to
demonstrate cerebellar gait ataxia or walking incoordination than those with only a
leg-placement deficit (Morton and Bastian 2003). Finally the cerebellum is likely to
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use motor learning to allow adaptations to the locomotor pattern. Patients with
cerebellar lesions and minimal ataxia are able to adapt sway and stride length to
repeated and predictable changes in treadmill speed during ongoing locomotion but
analysis of stepping patterns and electromyography (EMG) measurements of
antagonistic pairs of leg muscles highlight inconsistencies in both strategy and the
activation pattern of muscles when compared to control subjects (Rand, Wunderlich
et al. 1998).
In addition to the well-documented contribution to motor function and motor
learning the cerebellum has more recently been linked to non-motor cognitive
processes although evidence is often not convincing largely due to the motor control
required for cognitive tasks. Retrograde transneuronal transport of herpes simplex
virus type 1 from an area of the primate prefrontal cortex known to be involved in
spatial working memory labels neurones in the dentate nucleus of the cerebellum.
These neurones are not labelled from motor areas of the cerebral cortex thus
providing anatomical evidence of a cognitive role for the cerebellum (Middleton and
Strick 1994). A number of human functional neuroimaging studies also indicate an
involvement of the cerebellum in higher order cognitive functions (Timmann and
Daum 2007). In further human studies a ‘cerebellar cognitive affective syndrome’
defined by a number of cognitive disturbances including loss of verbal fluency,
memory and reasoning impairments and attention deficiency has been described in
patients with diseases restricted to the cerebellum (Schmahmann and Sherman 1998).
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1.3.2 The anatomy of the cerebellum
The cerebellum is attached to the brainstem beneath the occipital lobes of the
cerebral hemispheres. The mammalian cerebellum can be divided longitudinally into
a vermis in the midline region either side of which is a hemisphere with a flocculus
and paraflocculus structure extending outwards from its lower lateral edge (figure
1.5a). The outer surface of the cerebellum is repeatedly folded dividing the vermis
into ten lobules (I-X) separated by deep fissures along its anterior-posterior axis.
These lobules are most easily observed in saggital sections of the cerebellar vermis
and are divided into three lobes: the anterior lobe (I–V), the posterior lobe (VI–IX)
and the flocculonodular lobe (X) (figure 1.5b). The hemispheres, flocculus and
paraflocculus have their own distinct foliation patterns (Hawkes 2005; Sillitoe and
Joyner 2007).
The entire cerebellum can be divided into three distinct cellular layers: the outer
molecular layer, the Purkinje cell body monolayer and the inner granule layer that
covers a white matter core containing the afferent and efferent axons of the
cerebellum. The three pairs of deep cerebellar nuclei (DCN) which act as targets for
the efferent projections underlie the cerebellar cortex (figure 1.6).
The mossy fibres are the larger of two major glutamatergic afferent pathways into the
cerebellum. The ascending spinal, reticular and vestibular mossy fibres and
descending pontocerebellar mossy fibres enter as bundles through either the superior,
middle or inferior cerebellar peduncles. The climbing fibres from nuclei of the
inferior olive located within the medulla oblongata of the brainstem enter through the
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inferior cerebellar peduncle and are the second major afferent pathway into the
cerebellum. Both mossy fibres and climbing fibres also send collateral projections to
innervate neurones in the DCN. A third diffuse group of minor afferent projections
from the locus coeruleus, pedunculopontine nucleus and raphe nucleus form
noradrenergic, cholinergic and serotonergic synapses within the cerebellum. The
Purkinje cell axons are the only efferent pathway from the cerebellum to the
neurones of the DCN which interact with other areas of the CNS (Hawkes 2005;
Sillitoe and Joyner 2007).
1.3.3 The cells and circuitry of the cerebellum
The inner granule layer is densely packed with the small somata of glutamatergic
granule cells which are the most abundant neuronal cells in the brain. Granule cell
dendrites within this layer form synaptic glomeruli with inhibitory Golgi cell axons
and excitatory mossy fibre terminals. Granule cell axons extend upwards into the
molecular layer forming ascending synapses with the proximal dendrites of Purkinje
cells before branching medio-laterally at right angles to Purkinje cell dendrites as
long parallel fibres (preserved in transverse sections) that form synapses with the
larger diameter distal regions of the Purkinje cell dendritic tree (figure 1.7).
Approximately 20 % of these Purkinje cell interactions are with ascending axons and
the remainder with parallel fibres (Gundappa-Sulur, De Schutter et al. 1999).
A single mossy fibre interacts with 20-30 granule cells and each parallel fibre forms
synapses with around half of the Purkinje cells it traverses resulting in each Purkinje
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cell having around 150,000 - 175,000 parallel fibre synapses. The activation of
approximately 50 granule cells is required to release sufficient glutamate from
parallel fibres to generate a sodium-dependent action potential in a Purkinje cell
(Barbour 1993) through the activation of its alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPAR).
The somata of two inhibitory interneurones are also located within the granule layer.
The previously mentioned GABAergic Golgi cell interneurone axons extend from
somata within the granule layer to form part of the synaptic glomeruli and their
dendrites extend to the molecular layer to receive excitatory glutamatergic input from
parallel fibres allowing feedback inhibition to granule cells (figure 1.7). The Lugaro
cells are the second inhibitory interneurones with somata within the granule layer.
These are positioned just below the Purkinje cell layer although little is understood
about their function (Hawkes 2005; Sillitoe and Joyner 2007). An excitatory
interneurone has more recently been described within the granule layer.
Glutamatergic unipolar brush cells (UBCs) have a single dendrite that terminates in a
brush-like tip of dendrioles which receives excitatory input from afferent mossy
fibres. The dendrioles form dendro-dendritic excitatory synapses with granule cell
dendrites to enable amplification of the mossy fibre signal (figure 1.7) (Mugnaini,
Dino et al. 1997).
The Purkinje layer is predominantly a monolayer of large Purkinje cell bodies.
Purkinje cell axons extend out through the granule layer and white matter to form
GABAergic synapses with DCN to facilitate the sole output of the cerebellar cortex.
Some axonal projections also synapse with interneurones in the granule layer to
32
provide feedback inhibition (figure 1.7). The extensively branched dendritic trees of
Purkinje cells extend throughout the molecular layer flattened in the plane
perpendicular to the fissures and parallel fibres and are therefore maintained in
saggital sections (figure 1.5a) (Hawkes 2005; Sillitoe and Joyner 2007). The somata
of candelabrum cell interneurones with dendrites extending into the molecular layer
and the upper granule layer (Laine and Axelrad 1994) and Bergmann glia astrocytes
with processes that extend into the molecular layer are also interspersed between the
much larger and more numerous Purkinje cell bodies (figure 1.7).
The outer molecular layer is largely composed of overlapping Purkinje cell dendritic
trees receiving glutamatergic inputs from parallel fibres and climbing fibres (figure
1.7). In contrast to the mossy fibre input each Purkinje cell is innervated by only one
climbing fibre (in mature animals) which passes through the granule layer, branches
after passing the Purkinje cell soma and wraps around the large proximal dendrites of
its target cell to form several hundred synapses. The release of glutamate from a
climbing fibre through stimulation of the inferior olive activates Purkinje cell
AMPAR to generate a large excitatory postsynaptic potential in the Purkinje cell
dendrite which results in an all-or-nothing sodium-dependent action potential in the
Purkinje cell soma (Eccles, Llinas et al. 1966).
The molecular layer also contains two further inhibitory interneurones: stellate cells
and basket cells. The dendrites of basket cells receive glutamatergic input from
parallel fibres within the molecular layer. Their axons form inhibitory GABAergic
synapses with Purkinje cell bodies with each soma enveloped by the axons of
multiple basket cells. The small stellate cells are located in the outer third of the
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molecular layer with dendrites that receive excitatory inputs from parallel fibres.
Their axons form inhibitory synapses with Purkinje cell dendrites thus working with
basket cells to provide feed-forward inhibition (figure 1.7) (Hawkes 2005; Sillitoe
and Joyner 2007).
In summary, the climbing fibres and mossy fibres provide two excitatory inputs to
the cerebellum that converge on the Purkinje cells which also interact with inhibitory
interneurones. Purkinje cells integrate the information and provide the sole output of
the cerebellum by forming inhibitory GABAergic synapses with three pairs of DCN.
1.3.4 Postnatal development of the cerebellum
Around the time of birth granule cell precursors that form an external granule layer
over the entire surface of the cerebellum proliferate then remain at the top of the
external granule layer for up to 48 hours following the final mitosis. During this
period each granule cell develops uneven bipolar horizontal processes before
migrating tangentially across the external granule layer along the longer process
(figure 1.8). At the boundary of the external granule layer and molecular layer the
granule cells form descending processes to allow radial migration through the
molecular layer in association with Bergmann glia processes. (Komuro and
Yacubova 2003). The bipolar granule cell axons remain as bundles of parallel fibres
at the top of the molecular layer allowing the formation of glutamatergic synapses
with distal Purkinje cell dendrites from around postnatal day 5 in the rat cerebellum
(Altman 1972).
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Following a brief stationary period in the Purkinje layer the granule cells continue to
migrate independently of Bergmann glia processes into the internal granule layer
(figure 1.8). Migration of a granule cell from the top of the external granule layer
through the molecular and Purkinje layers to its final position in the internal granule
layer takes around two days with the external granule layer ceasing to exist in the
mouse by the end of the third postnatal week (Komuro and Yacubova 2003).
During the same postnatal period the Purkinje layer transforms from a multi-layered
structure to a monolayer of Purkinje cell bodies and the dendritic trees of Purkinje
cells branch extensively into the molecular layer. In addition the two major
glutamatergic inputs to the cerebellum are formed: the climbing fibres that synapse
with the large proximal Purkinje cell dendrites and the mossy fibres that form
synaptic glomeruli with granule cell axons and Golgi cell dendrites. (Goldowitz and
Hamre 1998).
In the adult cerebellum only one climbing fibre stimulates each Purkinje cell.
However in the early postnatal cerebellum Purkinje cells are innervated by multiple
climbing fibres. This was first reported when it was noted that two types of all-or-
none response are apparent in half of electrophysiological recordings from rat
cerebellar Purkinje cells at postnatal day 8 or 9 and that these are absent if climbing
fibres are destroyed with 3-acetyl pyridine. Whole cell patch clamp recordings in
cerebellar slices from mice frequently record five discrete climbing fibre excitatory
postsynaptic currents (CF EPSCs) at postnatal day 4 but during the next few
postnatal days functional differentiation of the climbing fibres occurs so that one
strong CF EPSC and possibly several weaker CF EPSCs are measurable at postnatal
day 10 suggesting that one climbing fibre is selectively strengthened during this
35
period of postnatal development (Hashimoto and Kano 2003). A ‘late phase’ of
climbing fibre elimination that is dependent on PF-PC synapse formation occurs
during the second and third postnatal weeks until each Purkinje cell is innervated by
one climbing fibre at around postnatal day 20 in mice (Hashimoto, Yoshida et al.
2009).
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Figure 1.5 The anatomy of the mammalian cerebellum
The mammalian cerebellum (a) consists of a vermis (V) in the midline region either
side of which is a hemisphere (H) with a flocculus (F) and paraflocculus structure at
its lower lateral edge. Folding of the outer surface of the cerebellum divides the
vermis into ten lobules (I-X) separated by deep fissures (b) which are most easily
observed in saggital sections (vertical line in (a)). The lobules form three lobes: the
anterior lobe (I–V), the posterior lobe (VI–IX) and the flocculonodular lobe (X)
(Hawkes 2005).
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Figure 1.6 The trilaminar organisation of the cerebellum
The entire cerebellum can be divided into three distinct cellular layers: the outer
molecular layer, the Purkinje layer and the inner granule cell layer that covers a
white matter core containing the afferent and efferent axons of the cerebellum. The
deep cerebellar nuclei which act as targets for the efferent projections underlie the
cerebellar cortex (FitzGerald 2002).
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Figure 1.7 The cells and circuitry of the cerebellum
Key: climbing fibre (cf), mossy fibre (mf), parallel fibre (pf), synaptic glomeruli (sg),
inferior olive (IO), deep cerebellar nuclei (DCN), spinocerebellar tract (SCT),
pontocerebellar tract (PCT), reticulocerebellar tract (RCT), vestibulocerebellar tract
(VCT), unipolar brush cell (UBC), Golgi cell (GC), Lugaro cell (LC), granule cell
(GrC), Purkinje cell (PC), Bergmann glia (BG), candelabrum cell (CC), basket cell
(BC), stellate cell (SC).
39
Figure 1.8 The postnatal migration of granule cells in the
cerebellum from the external granule layer to internal granule layer
1. Extension of uneven bipolar horizontal processes near the top of the external granule
layer (EGL).
2. Tangential migration in the middle of the EGL along the longer process.
3. Development of vertical process near the border between the EGL and the molecular
layer (ML).
4. Initiation of radial migration at the EGL-ML border.
5. Bergmann glia-associated radial migration in the ML.
6. Stationary state in the Purkinje cell layer (PCL).
7. Glia-independent radial migration in the internal graule layer (IGL).
8. Completion of migration in the middle or the bottom of the IGL.
(Komuro and Yacubova 2003)
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1.4 Adenosine in the cerebellum
1.4.1 Adenosine receptors in the cerebellum
Early autoradiographic studies indicate that adenosine receptors are highly localised
in some areas of the brain. Incubation of rat brain sections with the radiolabelled
A1R agonist [3H] cyclohexyladenosine produces A1R labelling throughout the brain
particularly in the cerebellum where dense staining is observed in the molecular layer,
moderate staining in the granule layer and very light staining in the white matter. In
brain sections from reeler mice with distorted cerebella the [3H] cyclohexyladenosine
labelling is distorted in a pattern corresponding to the parallel fibres of the granule
cells providing evidence for the specific localisation of A1R to these axons within the
molecular layer (Goodman and Snyder 1982).
Immunohistochemical detection of A1R using polyclonal antisera against identical
peptides from the rat and human A1R provides the resolution to individual processes
and cell bodies within the cerebellum not attained with autoradiography. The A1R
staining intensity within the molecular layer is not as intense with this detection
method as that seen with autoradiography which may be due to the protocol causing
degeneration of the many small unmyelinated axons and dendrites, or A1R present on
them, in this area of the brain. Immunohistochemical staining reveals moderate
labelling of granule cells in the granule layer and heavy labelling of basket cells that
often envelop the lightly-labelled Purkinje cells in the molecular layer of the
cerebellum suggesting the possibility that A1R may modulate interactions between
these two cell types (Rivkees, Price et al. 1995).
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Double immunolabelling shows co-localisation of the A1R and P2Y1 receptor in the
Purkinje cell and molecular cell layers of the rat cerebellum. Co-
immunoprecipitation of the the A1R with the P2Y1 receptor using an A1R antibody
confirms that the receptors interact as hetero-oligomers and are present in the
absence of any receptor activation by exogenous agonists so may be functionally
significant (Yoshioka, Hosoda et al. 2002).
Immunoprecipitation of rat cerebellum synaptosomes reveals areas where
metabotropic glutamate type 1α receptors (mGlu1αR) and A1R do not co-distribute
and areas where the two receptors interact to form heteromers dependent on the
mGlu1αR C-terminal tail. At the level of calcium mobilisation in response to
application of adenosine and glutamate agonists this interaction shows a synergistic
effect and therefore functional significance in transfected HEK293 cells (Ciruela,
Casado et al. 1995).
A number of studies describe A2AR expression in dopamine-innervated areas of the
rat brain but have provided little evidence for the presence of A2AR outside of the
striatum. A subpopulation of Purkinje cells within the rat cerebellum show a low
expression of A2AR when incubated with a 35S-labelled cRNA probe for the A2AR
(Svenningsson, Le Moine et al. 1997). Immunohistochemistry using a high affinity
monoclonal antibody specific to the A2AR shows a light labelling of scattered
Purkinje cells in the rat cerebellum correlating with low A2AR mRNA levels whilst
also confirming localisation of A2AR mainly to areas of the brain receiving
dopaminergic projections (Rosin, Robeva et al. 1998). Positron emission
tomography (PET) scans using the A2AR antagonist [11C]TMSX demonstrate that
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A2AR are enriched in the human striatum and are widespread in other areas of the
human brain with moderate levels of A2AR binding in the cerebellum (Mishina,
Ishiwata et al. 2007).
Minimal support exists for the presence of A2BR within the cerebellum although a
functional role has been suggested. Adenosine can synergistically potentiate the
rapid [Ca2+]i transient increase evoked by the action of ATP at P2Y receptors in the
majority of cerebellar astrocytes. This effect is mimicked by the A1R and A2A/BR
agonist NECA but not prevented by DPCPX, an antagonist at A1R and A2AR. A
similar number of the cerebellar astrocytes positively stain for A2BR antibody
(Jimenez, Castro et al. 1999). Application of ADA to eliminate endogenous
adenosine activity in cultured cerebellar granule cells either increases or decreases
[Ca2+]i depending on the cell state suggesting a role for multiple adenosine receptors
in the same cell type. The effects of various agonists and antagonists at adenosine
receptors and the identification of adenosine receptor subtype cDNA in the cerebellar
granule cells indicates the possible involvement of A1R, A2BR and possibly A3R in
calcium modulation (Vacas, Fernandez et al. 2003).
Few studies have demonstrated the presence or role for A3R in the cerebellum. The
radioligand [125I] AB-MECA binds specifically to A1R and A3R in mouse brain
membrane preparations and the majority of binding is displaced by the A1R
antagonist CPX leaving low levels of residual binding representing A3R. In the
mouse brain the highest levels of residual radioligand binding are localised in the
cerebellum and correspond with A3R mRNA detection although these levels are very
low (Jacobson, Nikodijevic et al. 1993). Application of X-gal to cerebellar slices of
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transgenic mice containing a construct with a promoter region of the A3R gene
coupled to the β-galactosidase reporter gene reveals β-galactosidase activity in the 
cerebellum in one of four transgenic lines (Yaar, Lamperti et al. 2002).
1.4.2 Adenosine signalling and the control of basal levels in the
cerebellum
High levels of endogenous adenosine demonstrated by intense adenosine
immunoreactivity in the soma and dendrites of rat cerebellar Purkinje cells (Braas,
Newby et al. 1986) in addition to the previously described high concentration of A1R
in the cerebellum (Goodman and Snyder 1982; Rivkees, Price et al. 1995; Yoshioka,
Hosoda et al. 2002) suggest that this area of the brain is likely to be an important site
of adenosine action. In addition the nucleoside transporters ENT1 and ENT2 are
expressed in the cerebellum (Anderson, Baldwin et al. 1999; Anderson, Xiong et al.
1999) and the cerebellum contains the enzymes involved in adenosine metabolism.
The soma and dendrites of rat cerebellar Purkinje cells show immunoreactivity for
ecto-ATPase with weaker staining present in the granule layer of the cerebellum
(Wang and Guidotti 1998). The enzyme 5’-nucleotidase is present on glial plasma
membranes in the molecular, Purkinje and granule layers of the cerebellum (Schoen,
Graeber et al. 1987) and ADA activity can be detected in the cerebellum using high-
pressure liquid chromatography (HPLC) to detect the formation of inosine and
hypoxanthine in homogenates of rat brain (Geiger and Nagy 1986). A later study
using a similar enzyme assay and synaptic membranes from porcine brain shows the
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activity of ADA in the cerebellum to be similar to that of the hippocampus and
medulla oblongata but lower than that of the cortex (Kukulski, Sevigny et al. 2004).
In electrophysiological studies it has been established that application of adenosine to
rat cerebellar slices can selectively block PF EPSPs in the cerebellum (Kocsis, Eng et
al. 1984). Application of the A1R antagonist 8-CPT to mature rat cerebellar slices
potentiates EPSCs providing indirect evidence that PF-PC synaptic transmission is
tonically inhibited by activation of A1R (Takahashi, Kovalchuk et al. 1995). This
continual activation of A1R is most likely to be due to endogenous adenosine as
application of adenosine to rat cerebellar slices reduces PF EPSP amplitude. The use
of microelectrode biosensors to directly measure a basal extracellular concentration
of adenosine in rat cerebellar slices detects a purine tone of the adenosine metabolites
inosine and hypoxanthine but does not reliably detect adenosine. This is most likely
to be due to a heterogeneous distribution of inosine and hypoxanthine in the
extracellular space resulting in technical difficulties when calculating adenosine
concentration from biosensor signals rather than low levels of adenosine (Wall,
Atterbury et al. 2007).
The possible sources of extracellular adenosine in the CNS have previously been
discussed. Within the cerebellum the direct release of adenosine has been recorded
(Wall and Dale 2007) and some studies have described ATP as a potential source of
extracellular adenosine. Inhibition of PF EPSPs occurs following application of ATP
to rat cerebellar slices which can be inhibited by blockade of A1R with 8-CPT
suggesting that the exogenous ATP is metabolised to adenosine (Wall, Atterbury et
al. 2007). The mean frequency of spontaneous postsynaptic currents (sPSCs) in
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Purkinje neurones, as a result of ATP acting at P2 receptors, increases in rat
cerebellar slices following application of the ecto-ATPase inhibitor ARL67156 from
the second postnatal week onwards. This suggests the tonic release of ATP and
therefore provides indirect evidence for a source of the basal extracellular adenosine
tone in the cerebellum (Casel, Brockhaus et al. 2005). Calcium signals in Bergmann
glia triggered by brief bursts of parallel fibre activity in rat cerebellar slices can be
blocked with application of the P2 receptor antagonist pyridoxal phosphate-6-
azophenyl-2,4-disulfonic acid (PPADS) suggestive of the release of ATP from
parallel fibres providing another possible source of extracellular adenosine (Beierlein
and Regehr 2006). However, direct measurement of ATP in cerebellar slices with
microelectrode biosensors does not reveal an ATP signal although this may be due to
a rapid breakdown of ATP (Wall, Atterbury et al. 2007).
It has previously been discussed how nucleoside transporters contribute to the
removal of adenosine from the extracellular space in the CNS. In the cerebellum
inhibition of ENT1 and ENT2 proteins with NBTI and dipyridamole decreases PF
EPSP amplitude in some slices which is reversible following blockade of A1R with
8-CPT and has little or no effect on PF EPSP amplitude in other slices suggesting
that these transporters contribute to the control of extracellular adenosine
concentration at only a subset of PF-PC synapses and that other NBTI/dipyridamole-
insensitive transporters are responsible for the removal of adenosine from the
extracellular space or that the ENT2 protein which is only weakly blocked by
NBTI/dipyridamole is more prevalent at some synapses than ENT1 (Wall, Atterbury
et al. 2007).
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In comparison to other areas of the brain (Zhang, Franklin et al. 1993; Pak, Haas et al.
1994; Lloyd and Fredholm 1995) AK appears to be the major determining factor in
the control of extracellular adenosine concentration in the cerebellum. In rat
cerebellar slices inhibition of AK with iodotubericidin increases the adenosine
concentration sufficiently to decrease PF EPSP amplitude by ~50 % and this increase
in purine concentration can be simultaneously measured on microelectrode
biosensors. In contrast synaptic transmission is reduced by only ~10 % when ADA
is inhibited with EHNA suggesting that AK is more important in regulating the
adenosine concentration (Wall, Atterbury et al. 2007).
Studies measuring developmental changes in the distribution of A1R or basal
adenosine tone and its regulation have not been described in the juvenile rat
cerebellum.
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1.5 Additional pharmacology of the cerebellar parallel
fibre-Purkinje cell synapse
Activation of four presynaptic receptor types is known to decrease the probability of
vesicle release at the PF-PC synapse. In addition to the previously described action
of adenosine at A1R, activation of gamma-aminobutyric acid type B (GABAB)
receptors, endocannabinoid type 1 (CB1) receptors and metabotropic glutamate type
4 receptors (mGluR4) can also inhibit transmission at this synapse.
A role for GABAB receptors at the PF-PC synapse was suggested following binding
study observations of a high density of these receptors in the molecular layer of the
cerebellum. Inhibition of Purkinje cell synaptic potentials generated by parallel fibre
stimulation in rat cerebellar slices is observed with the GABAB agonist baclofen and
reversed with GABAB antagonists acting at presynaptic receptors (Batchelor and
Garthwaite 1992). The involvement of CB1 receptors at the PF-PC synapse was
implicated when it was observed that the presynaptic inhibition of parallel fibre-
evoked EPSCs in Purkinje cells with the endocannabinoid receptor agonist WIN
55212-2 is blocked with application of the CB1 receptor antagonist SR 141716 in rat
cerebellar slices (Takahashi and Linden 2000).
The mGluR4 receptor is unlike the other three receptors in that it is unique to the PF-
PC synapse of the cerebellum. Its action at this synapse was identified when it was
observed that the inhibition of synaptic transmission in Purkinje cells following
application of L-(+)-2-amino-4-phosphonobutyric acid (L-AP4) to the cerebellar
slices of wildtype mice does not occur in slices from mGluR4 knockout mice. A
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presynaptic autoreceptor function at the PF-PC synapse was suggested whereby
synaptically released glutamate activates presynaptic mGluR4 to inhibit further
glutamate release and maintain presynaptic glutamate stores during elevated levels of
synaptic activity (Pekhletski, Gerlai et al. 1996). Although inhibition of EPSPs is
also observed at the PF-PC synapse in rat cerebellar slices following application of
L-AP4 (Neale, Garthwaite et al. 2001), conditions inducing activation of mGluR4 in
vivo have not yet been described. Immunogold labelling of rat cerebellar slices
confirms the presynaptic localisation of mGluR4 in clusters at PF terminals forming
synapses with PC dendrites although not all synapses are labelled with the antisera
suggesting that not all would be regulated by an autoreceptor function (Mateos,
Azkue et al. 1998).
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1.6 Aims
 To determine the presence and distribution of the A1R and A2AR at the PF-PC
synapse at different stages of development in the rat cerebellum using
immunohistochemistry.
 To examine the presynaptic pharmacology of immature PF-PC synapses in the rat
cerebellum using electrophysiology.
 To calculate the basal adenosine concentration and establish the importance of
nucleoside transporter proteins and metabolic enzymes in controlling adenosine in
the extracellular space at immature parallel fibre-Purkinje cell synapses in the rat
cerebellum using microelectrode biosensor measurements and electrophysiology.
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Chapter 2 Materials and Methods
2.1 Immunohistochemistry
2.1.1 Solutions for immunohistochemistry
The solution (pH 7.4) for cerebellar dissection contained (mM) NaCl 127, KH2PO4
1.2, KCl 1.9, NaHCO3 26, glucose 10, CaCl2 0.5 and MgCl2 7.
The phosphate-buffered saline (PBS) for washing slices (media prep, University of
Warwick) contained (g/l) NaCl 8, KCl 0.2, Na2HPO2 1.15 and KH2PO4 0.2.
The solution for fixing cerebellar blocks (PFA, pH 7.4) contained 4 %
paraformaldehyde in PBS.
The immuno PBS for diluting antibodies contained 0.4 % Triton X100 and 1 % BSA
in PBS.
The alternative immuno PBS for diluting antibodies contained 5 % BSA in PBS.
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2.1.2 Antibodies for immunohistochemistry
All of the antibodies were frozen in aliquots, thawed and diluted in immuno PBS for
immuohistochemistry. The primary antibodies used were:
 chicken anti-glial fibrillary protein (GFAP) (Millipore, AB5541)
 monoclonal mouse anti-calbindin D-28K (Sigma, C9848)
 rabbit anti-adenosine A1R (Calbiochem, 119117)
 rabbit anti-adenosine A2AR (Fisher Scientific, AFPA1042)
 rabbit anti-mGluR4 (Invitrogen, 513100)
 rabbit anti-vGluT1 (Invitrogen, 482400)
All of the secondary antibodies used as probes against the primary antibodies were
Alexa Fluor® IgG antibodies (Invitrogen). The antibodies used were:
 goat anti-mouse 405 nm for calbindin D-28K
 goat anti-rabbit 488 nm for A1R, A2AR, mGluR4 and vGluT1
 goat anti-rabbit 546 nm for A1R in sequential staining protocol
 goat anti-chicken 594 nm for GFAP
 goat anti-rabbit 633nm for GFP-labelled CHO cells transfected with A1R
2.1.3 Preparation of cerebellar slices for immunohistochemistry
In accordance with the Animals (Scientific Procedures) Act (1986) male Wistar rats
at postnatal days 2-3 (P2-3), 8-14 (P8-14) or 21-28 (P21-28) were killed by cervical
dislocation and decapitated. The cerebellum was rapidly removed whilst washing
with ice-cold dissection aCSF bubbled with 95 % O2 and 5 % CO2 and fixed in ice-
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cold 4 % PFA at 4 ºC overnight. The cerebellum was rinsed 3 times with PBS then
transferred to PBS and stored at 4 ºC until required. A Microm HM 650V
microsclicer was used to cut 40-125 µm transverse or parasagittal slices which were
placed into separate wells of a 24-well plate each containing 1 ml PBS.
In one instance, the cerebellum was rapidly removed with ice-cold dissection aCSF
bubbled with 95 % O2 and 5 % CO2, then parasaggital slices of cerebellar vermis
(250 µm) were cut on a Microm HM 650V microslicer in ice-cold dissection aCSF.
The slices were transferred to individual wells of a 24-well plate each containing 300
µl 4 % PFA and left to fix for 20 minutes at room temperature. The slices were
rinsed 3 times for 5 minutes with PBS and stored in 1 ml PBS until required.
2.1.4 Single immunoflourescence
The PBS was removed from each well and non-specific binding sites were blocked
with 500 µl 10 % normal goat serum diluted in immuno PBS for 1 hour at room
temperature with agitation. The slices were washed 5 times for 5 minutes with
agitation in PBS then incubated in 200 µl monoclonal mouse anti-calbindin D-28K
antibody (1:1000) diluted in immuno PBS for 1 hour at room temperature with
agitation then overnight at 4 ºC. Primary antibody dilutions were stored at 4 ºC and
re-used up to 3 times with no loss of activity. The slices were washed 5 times for 5
minutes with agitation in PBS then double-labelled with 300 µl Alexa Fluor® IgG
405 nm secondary antibody (1:500) diluted in immuno PBS for 4 hours at room
temperature with agitation. The secondary antibody was discarded and the slices
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washed 5 times for 5 minutes with agitation in PBS. The slices were mounted on
glass slides using a drop of VectaShield mounting medium (Vector Laboratories),
covered with glass coverslips, sealed and stored in the dark at 4 ºC.
2.1.5 Double immunofluorescence
The protocol used was the same as for single immunofluorescence. Double
immunofluorescence was used for combinations of monoclonal mouse anti-calbindin
D-28K antibody (1:1000) with either rabbit anti-adenosine A1R (1:100), rabbit anti-
adenosine A2AR (1:100), rabbit anti-mGluR4 (1:100) or rabbit anti-vGluT1 (1:100)
antibodies diluted in immuno PBS. The slices were double-labelled with
combinations of Alexa Fluor® IgG secondary antibodies (1:500) diluted in immuno
PBS. The secondary antibodies used were 405 nm against mouse for calbindin D-
28K and 488 nm against rabbit for A1R, A2AR, mGluR4 and vGluT1.
An alternative method was also used (personal correspondence, Frenguelli lab) to
ensure that the same antibody staining patterns were observed. The cerebellar block
was fixed in PFA and the slices transferred to individual wells of a 24-well plate in
the usual way. The PBS was removed from each well and the slices permeabilised
with 500 µl 0.5 % Triton X100 diluted in PBS overnight at 4 ºC. The
permeabilisation solution was discarded and non-specific binding sites blocked with
500 µl 20 % BSA diluted in PBS for 4 hours at room temperature. The blocking
solution was discarded and the slices incubated in 200 µl primary antibodies (see
previously described concentrations) diluted in alternative immuno PBS overnight at
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4 ºC. The slices were washed 3 times for 5 minutes with agitation in PBS then
double-labelled with combinations of Alexa Fluor® IgG secondary antibodies (see
previously described concentrations) diluted in alternative immuno PBS. The slices
were washed 3 times for 5 minutes with agitation in PBS then mounted on glass
slides using a drop of VectaShield mounting medium (Vector Laboratories), covered
with glass coverslips, sealed and stored in the dark at 4 ºC.
2.1.6 Triple immunofluorescence
The protocol used was the same as for single and double immunofluorescence.
Triple immunofluorescence was used for combinations of monoclonal mouse anti-
calbindin D-28K (1:1000) and chicken anti-GFAP (1:300) with either rabbit anti-
adenosine A1R (1:100), rabbit anti-adenosine A2AR (1:100) or rabbit anti-mGluR4
(1:100). The slices were double-labelled with combinations of Alexa Fluor® IgG
secondary antibodies (1:500) diluted in immuno PBS. The secondary antibodies
used were 405 nm against mouse for calbindin D-28K, 488 nm against rabbit for A1R,
A2AR and mGluR4 and 594 nm against chicken for GFAP.
In order to prevent secondary antibody cross-reaction, a sequential protocol was used
to attempt triple immunofluorescence where 2 of the primary antibodies were
generated in rabbit. The cerebellar block was fixed in PFA and the slices transferred
to individual wells of a 24-well plate in the usual way. The PBS was removed from
each well and non-specific binding sites were blocked with 500 µl 10 % normal goat
serum diluted in immuno PBS for 1 hour at room temperature with agitation. The
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slices were washed 5 times for 5 minutes with agitation in PBS then incubated in 200
µl rabbit anti-A1R antibody (1:100) diluted in immuno PBS for 1 hour at room
temperature with agitation then overnight at 4 ºC. Primary antibody dilutions were
removed and stored at 4 ºC. The slices were washed 5 times for 5 minutes with
agitation in PBS then double-labelled with 300 µl Alexa Fluor® IgG 546 nm
secondary antibody (1:500) diluted in immuno PBS for 4 hours at room temperature
with agitation. The secondary antibody was discarded and the slices washed 5 times
for 5 minutes with agitation in PBS. The non-specific binding sites were blocked
again with 500 µl 10 % normal goat serum diluted in immuno PBS for 1 hour at
room temperature with agitation. The slices were washed 5 times for 5 minutes with
agitation in PBS then incubated in 200 µl monoclonal mouse anti-calbindin (1:1000)
and either rabbit anti-vGluT1 antibody (1:100) or rabbit anti-mGluR4 antibody
(1:100) diluted in immuno PBS for 1 hour at room temperature with agitation then
overnight at 4 ºC. Primary antibody dilutions were removed and stored at 4 ºC. The
slices were washed 5 times for 5 minutes with agitation in PBS then double-labelled
with 300 µl Alexa Fluor® IgG 405 nm and 488 nm secondary antibodies (1:500)
diluted in immuno PBS for 4 hours at room temperature with agitation. The
secondary antibody was discarded and the slices washed 5 times for 5 minutes with
agitation in PBS. The slices were mounted on glass slides using a drop of
VectaShield mounting medium (Vector Laboratories), covered with glass coverslips,
sealed and stored in the dark at 4 ºC.
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2.1.7 Immunofluorescence for GFP-labelled CHO cells
Specificity of the anti-adenosine A1R primary antibody was tested using Chinese
hamster ovary (CHO) cells transiently transfected with a construct containing A1R
with GFP tagged to its intracellular C-terminal (Abigail Baines, Frenguelli lab). The
CHO cells were transfected as required prior to experiments.
Monolayers of the cells on circular borosilicate glass slides were fixed for 30 minutes
in separate wells of a 6-well plate each half-filled with 4 % PFA. The slides were
dipped in PBS to rinse and transferred to a humidified chamber. All subsequent
solutions were carefully applied to the slides using a pipette to create a bubble over
the cells. Non-specific binding sites were blocked with 200 µl 10 % normal goat
serum diluted in immuno PBS for 1 hour at room temperature with gentle agitation.
The normal goat serum was discarded and slides dipped in PBS to rinse. The slides
were incubated in 200 µl rabbit anti-adensoine A1R (1:100) diluted in immuno PBS
for 1 hour at room temperature with gentle agitation then overnight at 4 ºC. The
slides were washed 5 times for 5 minutes with gentle agitation in 200 µl PBS then
double-labelled with 200 µl Alexa Fluor® IgG 633 nm secondary antibody (1:500)
diluted in immuno PBS for 4 hours at room temperature with gentle agitation. The
secondary antibody was discarded and the slides washed 5 times for 5 minutes with
gentle agitation in 200 µl PBS. The slides were inverted onto glass microscope
slides over a drop of VectaShield mounting medium, sealed and stored in the dark at
4 ºC.
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2.1.8 Immunofluorescence controls
To ensure specificity of the secondary antibody labelling, negative controls were
performed for single, double and triple immunofluorescence experiments. Following
incubation with normal goat serum, slices were incubated in 200 µl immuno PBS
with no primary antibodies added and then incubated with secondary antibodies in
the usual way.
As a further control for double and triple immunofluorescence, to eliminate the
possibility of cross-reaction between secondary antibodies, one of the secondary
antibodies was omitted from the protocol.
2.1.9 Confocal microscopy
Immunofluorescence was analysed using a Leica SP2 confocal system linked to a
Leica DM RE7 upright microscope with an argon laser emitting at 488 nm,
helium/neon laser emitting at 543 nm and helium/neon laser emitting at 633 nm.
Images were created using 6 averages of 2 sections taken from stacks of 10 µm
thickness and analysed using Adobe Photoshop CS.
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2.2 Electrophysiology
2.2.1 Solutions for electrophysiology
The solution (pH 7.4) for cerebellar dissection contained (mM) NaCl 127, KH2PO4
1.2, KCl 1.9, NaHCO3 26, D-glucose 10, CaCl2 0.5 and MgCl2 7.
The aCSF (pH 7.4) for recording contained (mM) NaCl 127, KH2PO4 1.2, KCl 1.9,
NaHCO3 26, D-glucose 10, CaCl2 2.4 and MgCl2 1.3.
2.2.2 Drugs for electrophysiology
The drugs were made up as 10-100 mM stock solutions, frozen then thawed and
diluted with normal aCSF as required.
Adenosine, inosine, 6-[(4-nitrobenzyl)thiol]-9-β-D-ribofuranosylpurine (NBTI), 8-
cyclopentyl-theophylline (8-CPT), R(+)-baclofen hydrochloride, N6-
cyclopentyladenosine (CPA), cadmium and dipyridamole were purchased from
Sigma. Iodotubericidin was purchased from Sigma and Molekula Ltd. Erythro-9-(2-
hydroxy-3-nonyl) adenine (EHNA) was purchased from Tocris-Cookson. 6-cyano-7-
nitroquinoxaline-2, 3-dione (CNQX), kynurenic acid, (-)-bicuculline methochloride,
tetrodotoxin (TTX) and L-(+)-2-amino-4-phosphonobutyric acid (L-AP4) were
purchased from Ascent Scientific. ATP was purchased from Roche.
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2.2.3 Preparation of cerebellar slices for electrophysiology
In accordance with the Animals (Scientific Procedures) Act (1986) male Wistar rats
at postnatal days 8-14 (P8-14) or 21-28 (P21-28) were killed by cervical dislocation
and decapitated. The cerebellum was rapidly removed whilst washing with ice-cold
dissection aCSF bubbled with 95 % O2 and 5 % CO2. Transverse slices of cerebellar
vermis (400 µm) were cut on a Microm HM 650V microslicer in ice-cold dissection
aCSF and stored at room temperature in aCSF bubbled with 95 % O2 and 5 % CO2
for 1 - 6 hours before recording.
2.2.4 Extracellular recording
Individual slices were held on a suspended grid in a recording chamber with a U-
shaped stainless steel and nylon net. The chamber was continuously perfused at a
rate of 6 ml/min with aCSF at a temperature of 30-32 ºC using a peristaltic pump.
The suspended grid ensured that the slice was perfused from above and below, all
solutions were bubbled with 95 % O2 and 5 % CO2 and the tubing had low gas
permeability (Tygon) to inhibit induction of hypoxia. For experiments that required
hypoxic conditions the solutions were bubbled with 95 % N2 and 5 % CO2.
Slices were visualised using a BMZ stereomicroscope (Brunel Microscopes Ltd). A
concentric bipolar metal stimulating electrode (FHC) attached to an isolated pulse
stimulator (model 2100 AM systems Everett WA) was placed on the molecular layer
of the slice and set to apply a pair of stimuli (2-5 V, 200 μs duration) at 0.1 Hz with 
an interval of 50 ms. A glass recording microelectrode filled with aCSF was placed
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“on beam” in the molecular layer so that it was on the same track along which the
parallel fibres travel (Yuan and Atchison 1999) (figure 2.1). Extracellular recordings
of pairs of field EPSPs were made using an ISO-DAM extracellular amplifier (WPI)
filtered at 3 kHz and sampled at 10 kHz with a Micro CED (Mark 2) interface
controlled by Spike software (Vs 6.1).
2.2.5 Confirmation and components of PF EPSPs
Application of pairs of stimuli at the PF-PC synapse resulted in paired pulse
facilitation (PPF), where the amplitude of the second PF EPSP is larger than that of
the first. This was used as a primary confirmation of PF EPSP identity (Atluri and
Regehr 1996). The same stimulation of climbing fibres within the cerebellum would
generate a smaller second EPSP indicating paired pulse depression (PPD) (Konnerth,
Llano et al. 1990).
The amplitude of the first PF EPSP was used as a measure of A1R activation and the
paired pulse ratio (EPSP2/EPSP1) was used to test for a presynaptic action on release
probability. A significant increase in paired pulse ratio indicated an effect at
presynaptic receptors.
Further confirmation of PF EPSP identity was obtained by examining the
pharmacological profile. The PF EPSP amplitude was reduced by ~90 % with 25
μM baclofen due to its action as an agonist at presynaptic GABAB receptors
(Dittman and Regehr 1996).  In addition, 50 μM L-AP4 resulted in ~60 % inhibition 
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of PF EPSP amplitude due to its action as an agonist at presynaptic mGluR4
receptors present only on parallel fibres (Kinoshita, Ohishi et al. 1996).
The PF EPSPs consisted of two components, both of which could be completely
blocked with 1 µM TTX. The initial parallel fibre volley component was unaffected
by application of the glutamate receptor antagonists, 5 mM kynurenic acid or 10 µM
CNQX. The amplitude of the second component could be greatly reduced with
either 5 mM kynurenic acid or 10 µM CNQX (Clark and Barbour 1997). This
kynurenic acid-sensitive potential was used as an estimate of PF EPSP amplitude
when analysing data and was measured by deducting the potential remaining in
kynurenic acid from the control potential.
2.2.6 Purine biosensors
Purine biosensors obtained from Sarissa Biomedical Ltd (Coventry, UK) were used
to identify released substances in the cerebellar tissue. The biosensors contained
entrapped enzymes within a matrix deposited around a 50 µm polarised platinum
wire and had an exposed length of ~500 µm that was coated with enzymes to allow
the detection of purines (Llaudet, Botting et al. 2003).
Null sensors, containing a matrix with no enzymes, were used to control for the
release of non-specific electro-active interferents like 5-HT and noradrenaline. INO
biosensors containing the enzymes purine nucleoside phosphorylase (PNP) and
xanthine oxidase (XO) to detect inosine and hypoxanthine and ADO biosensors
62
containing adenosine deaminase (AD), PNP and XO to detect adenosine, inosine and
hypoxanthine were used. The breakdown of hypoxanthine by XO in the biosensor
matrix to uric acid and hydrogen peroxide (H2O2) resulted in the oxidation of H2O2
on the polarised platinum wire which produced a current proportional to the
concentration of H2O2.
Biosensors were screened to reduce the response to non-specific electro-active
interferents. This was checked via the response to application of 10 µM 5-HT. To
account for reduction in sensitivity during experiments biosensors were calibrated
with 10 μM of adenosine and inosine before the slice was added to the perfusion 
chamber and following its removal. Biosensors were inserted into (at an angle of
~70 deg), or bent parallel to the slice surface and placed above, the molecular cell
layer (Wall and Dale 2007). The biosensor signals were acquired using a Micro C
potentiostat (CED) with a Micro CED (Mark 2) interface at 1 kHz controlled by
Spike software (6.1).
2.2.7 Calculation of the specific adenosine signal
The signal on the ADO biosensor can be used as a measure of purine tone (produced
by adenosine and its metabolites inosine and hypoxanthine). The specific adenosine
tone could, in theory, be calculated by deducting the INO biosensor signal
(measuring adenosine metabolites) from the ADO biosensor signal (measuring
adenosine and its metabolites). However, the calculation of a specific adenosine
assumes that the concentration of purines within the slice is homogeneous and that
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there are no purine ‘hotspots’. This is unlikely to be the case, as often a negative
concentration of adenosine was implied when the INO biosensor signal was deducted
from that of the ADO biosensor. Thus, in most cases the purine tone was measured
and assumed to be inosine and hypoxanthine (Wall, Atterbury et al. 2007).
2.2.8 Statistical analysis
Results were analysed using OriginPro (v8.1) and are recorded as averages ± SEM.
The t-test, ANOVA and calculation of correlation coefficient were used for statistical
analysis. The significance values calculated using the t-test and ANOVA were
expressed as a p-value where significance was accepted at p = 0.05. All statistical
analysis was performed for data with n ≥ 3. 
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Figure 2.1 Extracellular recordings at parallel fibre-Purkinje cell
synapses in the rat cerebellum
A concentric bipolar metal stimulating electrode attached to an isolated pulse
stimulator is placed on the molecular layer of the transverse cerebellar slice and set
to apply a pair of stimuli. A glass recording microelectrode filled with aCSF is
placed “on beam” in the molecular layer so that it is on the same track along which
the parallel fibres travel (Yuan and Atchison 1999).
stimulating electrode
recording microelectrode
parallel fibres
Purkinje cell
granule cell
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Chapter 3 The presence and distribution of A1R
and A2AR in the rat cerebellum at different stages of
development
3.1 Introduction
The expression of A1R has been observed in mature rat cerebellar slices (Rivkees,
Price et al. 1995; Yoshioka, Hosoda et al. 2002) however its distribution during
cerebellar development or in relation to parallel fibre–Purkinje cell (PF-PC) synapses
has not previously been described.
This study used primary antibodies against calbindin, A1R and mGluR4 to determine
the distribution of A1R at PF-PC synapses in cerebellar slices at three developmental
stages; postnatal day 3 prior to PF-PC synapse formation, postnatal days 8-14 and
postnatal days 21-28. The distribution of A1R in relation to Bergmann glia has also
been examined at each developmental stage using a primary antibody against GFAP.
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3.2 Optimisation of the immunohistochemistry protocol
Transverse cerebellar slices (400 µm) were used for electrophysiological recordings
to ensure that parallel fibres in contact with Purkinje cell dendrites remained intact
and that climbing fibres were cut. However, single immunofluorescence on thin
transverse cerebellar slices (100 µm) using calbindin (1:1000) produced inconsistent
staining and cells were frequently damaged. Calbindin (1:1000) staining was only
reliable if the cerebellar slices were cut parasaggitally so the immunohistochemistry
protocol was optimised using calbindin primary antibody on cerebellar slices cut in
this orientation. Optimum confocal imaging was achieved using 6 averages of 2
sections taken from stacks of 10 µm thickness (10 µm optical stack).
The quality of calbindin staining was reduced in cerebellar slices cut thicker than 100
µm but was not optimised further in slices cut any thinner. Cerebellar slices for
immunohistochemistry were subsequently cut at 100 µm as they were less likely to
be damaged during the immunofluorescence protocol than thinner slices. In mature
parasaggital cerebellar slices (100 µm) stained for calbindin (1:1000) Purkinje cell
bodies, their axons in the granule layer and their dendrites in the molecular layer
were clearly visible as were protrusions from Purkinje cell dendrites, in high
magnification images, that were presumably dendritic spines (figure 3.1).
Single immunofluorescence was used on mature parasaggital cerebellar slices (100
µm) with various concentrations of each antibody prior to their use in experiments.
Antibody concentrations of 1:100, 1:300, 1:500 and 1:1000 were tested for each
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antibody so that future experiments allowed optimal staining whilst being cost-
effective.
Figure 3.1 Single staining for calbindin
Parasaggital sections (100 µm) from adult rat cerebella (A P25, B P23) stained for
calbindin (red, 1:1000). A low magnification image shows staining of Purkinje cell
(pc) bodies and their dendrites in the molecular layer (ml). The small holes that are
not stained within the molecular layer are presumably cell bodies of interneurones.
Granule cells in the granule layer (gl) were not stained but Purkinje cell axons are
visible (A). A high magnification image within the molecular layer shows Purkinje
cell dendrites with protrusions that are presumably dendritic spines (arrow). The
unstained holes around the dendrites are likely to be interneurone cell bodies (B).
Optical stack 10 µm. Scale bar A 45 µm, B 15 µm.
B
pc
ml
Agl
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3.3 Confirmation that the A1R antibody is specific for A1R
The specificity of the A1R antibody for the intracellular C-terminal of the A1R was
tested using Chinese hamster ovary (CHO) cells transiently transfected with a
construct containing A1R with GFP tagged to its intracellular C-terminal (Abigail
Baines, Frenguelli lab) (Bevan, Palmer et al. 1999). Any cell that contains GFP
should therefore contain the A1R so co-localisation of GFP and A1R would be
expected.
Immunohistochemistry revealed punctate staining for A1R (1:100) only in CHO cells
expressing GFP/A1R with no staining apparent in the CHO cell nucleus (as A1R is a
transmembrane protein, figure 1.1) thus confirming specificity of the A1R antibody
(figure 3.2, n = 2).
GFP A1R merge
Figure 3.2 Confirmation that the A1R antibody is specific for A1R
(A) The CHO cells were transfected with a construct containing A1R with GFP
tagged at its intracellular C-terminal (green). (B) The CHO cells were stained for
A1R (red, 1:100). (C) Co-localisation of GFP and A1R is yellow in the merged
image where two of the four GFP-labelled CHO cells were successfully stained for
A1R. Scale bar 25 µm.
A B
C
C
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3.4 vGluT1 primary antibody as a potential marker for
parallel fibres
It has previously been shown using double immunofluorescence in mature rat
cerebellar slices that within the molecular layer parallel fibres only express vGluT1
for vesicular glutamate uptake and climbing fibres only express vGluT2 (Hioki,
Fujiyama et al. 2003), allowing staining for vGluT1 to potentially be used in this
study as a marker for parallel fibres in the cerebellum. However, an
immunohistochemical study of the developing mouse cerebellum demonstrated that
during the first 10 days of postnatal life vGluT2 predominates in parallel fibre
terminals and that this is gradually replaced with expression of vGluT1 from the
distal molecular layer upwards until postnatal day 30 (Miyazaki, Fukaya et al. 2003).
As this study is looking at expression of A1R at PF-PC synapses during development,
the use of vGluT1 as a marker for parallel fibres would only be possible in mature
slices and an alternative would need to be used in immature slices.
Double immunofluorescence for calbindin (1:1000) and vGluT1 (1:50 and 1:100) in
mature parasaggital cerebellar slices (100 µm, n = 3) was unsuccessful as the vGluT1
antibody did not stain slices consistently. Consequently, it was decided to use an
alternative antibody to vGluT1 that could be used as a marker for parallel fibres in
both immature and mature cerebellar sections.
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3.5 mGluR4 primary antibody as a marker for parallel
fibres
An alternative parallel fibre marker is mGluR4. Previous immunohistochemical
studies have shown that this group III metabotropic glutamate receptor is located
presynaptically in parallel fibres of the molecular layer in the cerebellum where it
acts as an autoreceptor (Kinoshita, Ohishi et al. 1996; Mateos, Azkue et al. 1998).
Although no immunohistochemical studies are available for mGluR4 expression in
parallel fibres during development, it is known that mGluR4 mRNA expression
increases rapidly from postnatal days 3-30 (Catania, Landwehrmeyer et al. 1994).
Electrophysiological data obtained during this study also showed no significant
difference between inhibition at the PF-PC synapse of rats at postnatal days 9-14 and
21-28 due to L-AP4 acting at mGluR4 (p = 0.85) suggesting no significant changes
in mGluR4 expression during development. A primary antibody for mGluR4 was
therefore purchased as an alternative parallel fibre marker to vGluT1 that could be
used in both immature and mature cerebellar slices.
A parallel triple immunofluorescence technique, where all of the primary antibodies
are applied and then labelled with secondary antibodies simultaneously, was not
possible using primary antibodies for calbindin, mGluR4 and A1R. The only primary
antibodies available for mGluR4 and A1R were both generated in rabbit so a parallel
immunofluorescence protocol would allow the secondary antibodies to cross-react
with both the mGluR4 and A1R antibodies.
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In order to determine the distribution of A1R relative to parallel fibres and Purkinje
cells without antibody cross-reaction, triple immunofluorescence was attempted on
immature and mature parasaggital slices (100 µm, n = 3) using a sequential protocol
whereby double immunofluorescence with calbindin (1:1000) and A1R (1:100) was
completed prior to staining for mGluR4 (1:100).
This method was unsuccessful as antibody cross-over staining between A1R and
mGluR4 was observed in control slices. Staining for mGluR4 identical to that for
A1R (1:100) was observed in control slices (100 µm, n = 3) where the triple
immunofluorescence protocol was followed with the primary antibody for mGluR4
omitted.
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3.6 Comparison of double immunofluorescence for
calbindin/A1R and calbindin/mGluR4 in mature and
immature cerebellar slices
As an alternative to triple immunofluorescence with antibodies against calbindin,
A1R and mGluR4, the separate double staining of calbindin/A1R and
calbindin/mGluR4 was compared to analyse the distribution of A1R at PF-PC
synapses. Double immunofluorescence for calbindin (1:1000)/A1R (1:100) and
calbindin (1:1000)/mGluR4 (1:100) on mature parasaggital cerebellar slices (100 µm,
n = 5) revealed similar patterns of co-localisation for A1R and mGluR4 with
calbindin (figure 3.3). Identical staining patterns (figure 3.4) were also observed in
immature parasaggital cerebellar slices (100 µm, n = 5). Due to these similarities,
the immature and mature slice staining patterns will be discussed together.
A large number of Purkinje cell bodies showed co-localisation for both A1R and
mGluR4 in immature and mature cerebellar slices. Previous immunoreactivity
studies have not described mGluR4 staining at Purkinje cell bodies (Kinoshita,
Ohishi et al. 1996; Mateos, Azkue et al. 1998), although dense staining for A1R has
previously been observed, but not discussed, at Purkinje cell bodies in mature
cerebellar slices (Yoshioka, Hosoda et al. 2002). An earlier immunohistochemical
study describing light A1R staining at some Purkinje cell bodies suggested that this is
likely to be the result of A1R expression on basket cell processes that directly
synapse with the Purkinje cell bodies (Rivkees, Price et al. 1995). There were three
patterns of mGluR4 and A1R co-localisation with Purkinje cell bodies; Purkinje cell
bodies were densely stained with the exception of the nucleus (figure 3.5 C), lightly
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stained across the cell body (figure 3.5 F) or only stained at the edges (figure 3.5 I),
presumably where interneurones are in contact with the Purkinje cell body. A
quantitative analysis was carried out using two slices double stained for calbindin
(1:1000)/A1R (1:100) and calbindin (1:1000)/mGluR4 (1:100) from both immature
and mature cerebella. The Purkinje cell staining patterns were observed in five
random low magnification fields from each slice and only Purkinje cell bodies
positively stained for calbindin were included in the analysis (table 3.1). Dense or
light staining across the cell body was more frequently observed for the A1R in both
mature and immature cerebellar slices and was more likely to be only at the edges of
the cell body for mGluR4.
A1R and mGluR4 were densely distributed across Purkinje cell dendrites (figure 3.3
and 3.4) leaving small unstained holes within the molecular layer, presumably where
the interneurones are located in immature and mature cerebellar slices. The same
pattern of A1R staining within the molecular layer has previously been described in
the mature rat cerebellum (Yoshioka, Hosoda et al. 2002) and an early
autoradiographic study using [3H]CHA to label A1R observed the highest density of
A1R within the mature rat brain to be on parallel fibres within the molecular layer of
the cerebellum (Goodman and Snyder 1982). As parallel fibres form synapses with
the distal regions of the Purkinje cell dendritic tree (figure 1.7) the co-localisation of
A1R at proximal dendrites is unlikely to be at PF-PC synapses. It is possible that
these A1R are located on climbing fibres that wrap around the large proximal
branches of Purkinje cells (figure 1.7) as inhibition of climbing fibre excitatory
postsynaptic currents (CF EPSCs) is observed following application of adenosine to
rat cerebellar slices (Takahashi, Kovalchuk et al. 1995; Hashimoto and Kano 1998).
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Dense staining for mGluR4 within the molecular layer has been observed in
immunoreactivity studies which have also used electron microscopy to specifically
locate mGluR4 to the presynaptic sites made by parallel fibre axon terminals
(Kinoshita, Ohishi et al. 1996; Mateos, Azkue et al. 1998). The dense staining for
mGluR4 at proximal Purkinje cell dendrites is unusual as parallel fibres form
synapses with distal Purkinje cell dendrites. There is no evidence for mGluR4 on
climbing fibres that form synapses with the proximal Purkinje cell dendrites.
In high magnification images, different patterns of A1R and mGluR4 co-localisation
with Purkinje cell dendrites were observed in both mature and immature cerebellar
slices. The majority of dendrites showed dense co-localisation (figure 3.6 C, F) but
occasionally small areas were found where there was no A1R or mGluR4 co-
localisation with the Purkinje cell dendrites (figure 3.6 I) and in some instances there
was also a border with no staining around the dendrite (figure 3.6L). Quantitative
analysis was not possible due to the large numbers of Purkinje cell dendrites found
within the molecular layer.
Staining for both A1R and mGluR4 was present around granule cells within the
granule layer in both mature and immature cerebellar slices (figure 3.3 and 3.4).
Previous immunoreactivity studies have not described mGluR4 staining in the
granule layer (Kinoshita, Ohishi et al. 1996; Mateos, Azkue et al. 1998) and as
parallel fibres are only present within the molecular layer of the cerebellum staining
within the granule layer would not be expected. Light immunoreactivity for A1R
around granule cells has previously been observed (Rivkees, Price et al. 1995;
Yoshioka, Hosoda et al. 2002) and moderate labelling of A1R with [3H]CHA has also
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been described in the granule layer of the mature rat cerebellum (Goodman and
Snyder 1982). A recent study using the patch-clamp technique on rat cerebella slices
describes suppression of GABA input to granule cells via A1R activation although
the exact site of A1R expression within the granule layer still remains unclear
(Courjaret, Troger et al. 2009).
Identical staining patterns in the molecular layer, granule layer and Purkinje layer for
A1R and mGluR4 were also observed when an alternative protocol was used
(personal correspondence, Frenguelli lab) for double immunofluorescence of A1R
(1:100)/calbindin (1:1000) and mGluR4 (1:100)/calbindin (1:1000) on immature
cerebellar slices (n = 2).
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Figure 3.3 Comparison of double staining for calbindin/A1R and
calbindin/mGluR4 in mature sections
Parasaggital sections (100 µm) from adult rat cerebella (P23). Sections were stained
for calbindin (red, 1:1000) (A, D) and A1R (green, 1:100) (B) or mGluR4 (green
1:100) (E). Co-localisation of calbindin and A1R (C) or calbindin and mGluR4 (F) is
yellow in the merged images. A1R and mGluR4 were densely distributed across
dendrites throughout the molecular layer (ml). The small holes that are not stained
are presumably cell bodies of interneurones. A1R and mGluR4 were also densely co-
localised with Purkinje cell (pc) bodies although not at the nucleus. A1R and
mGluR4 staining in the granule layer (gl) is presumably on interneurones or mossy
fibres with the holes being unstained granule cells. Optical stack 10 µm. Scale bar
45 µm.
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Figure 3.4 Comparison of double staining for calbindin/A1R and
calbindin/mGluR4 in immature sections
Parasaggital sections (100 µm) from immature rat cerebella (A-C P12, D-F P11).
Sections were stained for calbindin (red, 1:1000) (A, D) and A1R (green, 1:100) (B)
or mGluR4 (green 1:100) (E). Co-localisation of calbindin and A1R (C) or calbindin
and mGluR4 (F) is yellow in the merged images. A1R and mGluR4 were densely
distributed across dendrites throughout the molecular layer (ml). The small holes
that are not stained are presumably cell bodies of interneurones. A1R and mGluR4
were also densely co-localised with Purkinje cell (pc) bodies although not at the
nucleus. A1R and mGluR4 staining in the internal granule layer (igl) is presumably
on interneurones or mossy fibres. Migration of granule cells is not complete at this
stage of development and the external granule layer (egl) is still visible. The staining
patterns are identical to those in adult sections (figure 3.3). Optical stack 10 µm.
Scale bar 45 µm.
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calbindin A1R merge
Figure 3.5 Comparison of double staining for calbindin/A1R on
Purkinje cell bodies
Parasaggital sections (100 µm) from rat cerebella (A-C P13, D-F P9, G-I P23).
Sections were stained for calbindin (red, 1:1000) (A, D, G) and A1R (green, 1:100)
(B, E, H). Co-localisation of calbindin and A1R is yellow in the merged images (C,
F, I). It was expected that A1R would only be present on distal Purkinje cell
dendrites where parallel fibre-Purkinje cell (PF-PC) synapses are formed, however
co-localisation was frequently seen at the Purkinje cell bodies. The majority of
Purkinje cell bodies were densely stained for A1R (C). A sparse co-localisation of
A1R was observed on a small number of Purkinje cell bodies (F). Occasionally there
was only co-localisation of A1R at the edges of the Purkinje cell bodies, presumably
present on interneurones in contact with the cell bodies (I). The same staining
patterns were observed for double staining with calbindin and mGluR4 (not shown).
Optical stack 10 µm. Scale bar A-C 9µm, D-F 6µm, G-I 12 µm.
D E F
G H I
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Figure 3.6 Comparison of double staining for calbindin/A1R on
Purkinje cell dendrites
Parasaggital sections (100 µm) from rat cerebella (A-C P22, D-F P13, G-I P23, J-L
P23). Sections were stained for calbindin (red, 1:1000) (A, D, G, J) and A1R (green,
1:100) (B, E, H, K). Co-localisation of calbindin and A1R is yellow in the merged
images (C, F, I, L). For immature and mature sections, the majority of Purkinje cell
dendrites showed dense co-localisation with A1R (C, F). Occasionally, dendrites did
not stain for A1R (I) and in some instances there was a border with no A1R staining
around these dendrites (L). Optical stack 10 µm. Scale bar A-C 8µm, D-F 3µm, G-I
4 µm, J-L 3 µm.
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% immature Purkinje cell
bodies stained (P12)
% mature Purkinje cell
bodies stained (P23)
A1R mGluR4 A1R mGluR4
Dense staining
(figure 3.5 C)
40.2 0 71.4 19.4
Light staining
(figure 3.5 F)
43.7 36.8 21.4 44.4
Staining at edges
(Figure 3.5 I)
16.1 63.2 7.2 36.2
Table 3.1 Quantitative analysis of Purkinje cell staining patterns
in mature and immature cerebellar slices
For each age (postnatal day 12 (P12) and P23), 2 parasaggital cerebellar slices were
double stained for calbindin (1:1000)/A1R (1:100) and calbindin (1:1000)/mGluR4
(1:100). The Purkinje cell staining patterns were observed in 5 random low
magnification fields from each slice and only Purkinje cell bodies positively stained
for calbindin were included. Dense staining is described where there is staining
across the entire cell body with the exception of the nucleus and light staining where
there is only a scattering of A1R/mGluR4 across the cell body.
81
3.7 Triple immunofluorescence with GFAP in
combination with A1R/calbindin and mGluR4/calbindin in
mature and immature cerebellar slices
Immunonstaining with calbindin using cerebellar organotypic slices from transgenic
GFAP-GFP mice that express GFP under the GFAP promoter in astrocytes shows
interaction between the cell bodies of Purkinje cells and Bermann glial cells
(Lordkipanidze and Dunaevsky 2005). It is therefore possible that the A1R staining
observed on Purkinje cell bodies (figure 3.5) could be on glial cell bodies
overlapping Purkinje cell bodies within the Purkinje cell layer of the cerebellar slices.
Triple immunofluorescence for calbindin (1:1000), GFAP (1:300) and A1R (1:100)
showed minimal interaction between glial and Purkinje cell bodies in immature (n =
5) and mature (n = 2) cerebellar slices (figure 3.7 E) and although A1R staining was
present on glial cell bodies it accounted for very little of the staining present on
Purkinje cell bodies (figure 3.7 F, G). There is no evidence for the expression of
A1R on Bergmann glia but their presence may contribute to the depression of glial
extrasynaptic currents (ESC) observed with application of the A1R agonist CPA
(Bellamy 2007).
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Figure 3.7 Triple staining for calbindin/A1R/GFAP
Parasaggital sections (100 µm) from immature rat cerebella (P11). Sections were
stained for calbindin (red, 1:1000) (A), A1R (green, 1:100) (B) and GFAP (blue,
1:300) (C). For merged images co-localisation of calbindin and A1R is yellow (D),
calbindin and GFAP is magenta (E), A1R and GFAP is cyan (F) and calbindin, A1R
and GFAP is white (G). A1R co-localisation was present on glial processes and cell
bodies although this did not account for the staining present on Purkinje cell bodies
(F, G). Optical stack 10 µm. Scale bar 45 µm.
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3.8 The distribution of A1R in cerebellar slices prior to
parallel fibre-Purkinje cell synapse formation
Postnatally, granule cells migrate parallel to the external granule layer for 1-2 days
along bipolar axons before migrating radially through the molecular layer towards
the internal granule layer for a further 2-3 days along a perpendicular axon (figure
1.8). The leading bipolar axons then create bundles of parallel fibres that form
synapses with expanding Purkinje cell dendritic trees (Kawaji, Umeshima et al.
2004). The PF-PC synapse is formed around postnatal day 5 (Altman 1972) and a
recent study using in vitro preparations of rat cerebellum-medulla-pons blocks
describes postnatal day 5 as a critical developmental stage. Prior to this at postnatal
days 0-3 PF EPSPs were usually absent and at postnatal day 4 were uncommon
(Arata and Ito 2004).
The distribution of A1R in cerebellar slices prior to synapse formation has not
previously been studied. Double immunofluorescence of calbindin (1:1000) and A1R
(1:100) on parasaggital cerebellar slices (100 µm) at postnatal day 3 (n = 2) revealed
dense co-localisation around the edges of Purkinje cell bodies with light A1R staining
across some cell bodies (figure 3.8) similar to that described in mature cerebellar
slices (figure 3.5). The A1R staining shows similarities with low magnification
cocaine- and amphetamine-regulated transcript (CART) peptide immunofluorescence
at postnatal day 4 that is associated with climbing fibres in the rat cerebellum (Press
and Wall 2008). It is possible that the A1R/calbindin co-localisation prior to parallel
fibre synapse formation (figure 3.8) may be due to the presence of A1R on climbing
fibres interacting with sprouting Purkinje cell dendrites. CF EPSCs are frequently
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recorded at postnatal day 4 (Hashimoto and Kano 2003) so it is possible that
climbing fibre-Purkinje cell (CF-PC) synapses are present in rats at postnatal day 3
used in this study. Dense A1R staining was also present around granule cells in the
external and internal granule layers. Activation of A1R within the granule layer has
recently been described in mature rats although the exact site of A1R remains unclear
(Courjaret, Troger et al. 2009).
Identical staining patterns were observed for double immunofluorescence of
calbindin (1:1000) and mGluR4 (1:100) on parasaggital cerebellar slices (100 µm) at
P3 (n = 2, figure 3.9). Co-localisation was unexpected as PF-PC synapses are not
functional at this stage of development (Arata and Ito 2004). The same staining was
obtained using an alternative protocol (personal correspondence, Frenguelli lab) for
double immunofluorescence of calbindin (1:1000) and mGluR4 (1:100) on
parasaggital cerebellar slices at postnatal day 3 (n = 2).
Triple immunofluorescence of calbindin (1:1000), mGluR4 (1:100) and GFAP
(1:300) on parasaggital cerebellar slices (100 µm) at postnatal day 3 (n = 2, figure
3.10) showed that glial cell bodies were positioned around Purkinje cell bodies and
did not account for any of the mGluR4 staining observed although some light
staining was apparent on glial processes (figure 3.10 F). Triple immunofluorescence
of calbindin (1:1000), A1R (1:100) and GFAP (1:300) was unsuccessful (n = 2)
despite being effective in mature cerebellar slices (figure 3.7).
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Figure 3.8 Double staining for calbindin/A1R prior to parallel
fibre-Purkinje cell synapse formation
Parasaggital sections (100 µm) from rat cerebella (P3). Sections were stained for
calbindin (red, 1:1000) (A, D) and A1R (green, 1:100) (B, E). Co-localisation of
calbindin and A1R is yellow in the merged images (C, F). There was dense A1R co-
localisation around the edges of Purkinje cell (pc) bodies. Dense A1R staining was
also present around granule cells in the external and internal granule layers (egl and
igl) (C). There was sparse A1R co-localisation across some Purkinje cell bodies (F)
as previously described in older rats (figure 3.5). Optical stack 10 µm. Scale bar A-
C 33 µm, D-F 8 µm.
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Figure 3.9 Double staining for calbindin/mGluR4 prior to parallel
fibre-Purkinje cell synapse formation
Parasaggital sections (100 µm) from immature rat cerebella (P3). Sections were
stained for calbindin (red, 1:1000) (A, D) and mGluR4 (green, 1:100) (B, E). Co-
localisation of calbindin and A1R is yellow in the merged images (C, F). Although
parallel fibre-Purkinje cell (PF-PC) synapses are not formed at this stage of
development, mGluR4 co-localisation is present at Purkinje cell (pc) bodies and
between cells in the external and internal granule layers (egl and igl) (C). In some
cases, there was mGluR4 co-localisation across the Purkinje cell bodies, as
previously described in older rats (figure 3.5). Optical stack 10 µm. Scale bar A-C
33 µm, D-F 7 µm.
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Figure 3.10 Triple staining prior to synapse formation
for calbindin/mGluR4/GFAP
Parasaggital sections (100 µm) from immature rat cerebella (P3). Sections were
stained for calbindin (red, 1:1000) (A), mGluR4 (green, 1:100) (B) and GFAP (blue,
1:300) (C). For merged images co-localisation of calbindin and mGluR4 is yellow
(D), calbindin and GFAP is magenta (E), mGluR4 and GFAP is cyan (F) and
calbindin, mGluR4 and GFAP is white (G). Glial cell bodies were positioned around
Purkinje cell (pc) bodies (E). There was some co-localisation of mGluR4 with glial
processes but none with glial cell bodies (F, G). Optical stack 10 µm. Scale bar 18
µm.
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3.9 The distribution of A2AR in immature cerebellar slices
An immunohistochemical study using a high-affinity monoclonal antibody has
suggested a discrete population of A2AR exist at Purkinje cells in the cerebellum
(Rosin, Robeva et al. 1998). This correlates with a low A2AR mRNA expression
observed in a subpopulation of Purkinje cells using in-situ hybridisation with a 35S-
labelled cRNA probe for A2AR (Svenningsson, Le Moine et al. 1997).
Triple immunofluorescence using calbindin (1:1000), A2AR (1:100) and GFAP
(1:300) on immature parasaggital cerebellar slices (100 µm, n = 2) showed a dense
co-localisation of A2AR across Purkinje cell bodies and dendrites and further
staining for A2AR around granule cells in the internal granule layer and on glial cell
processes (figure 3.11). The staining is contradictory to the light staining of a small
population of Purkinje cells observed in a previous study using mature cerebellar
slices (Rosin, Robeva et al. 1998) and is unexpected as a role for A2AR within the
cerebellum has not previously been described. Comparable staining patterns for
A2AR were observed when immature cerebellar slices (250 µm, n = 1) were fixed
separately instead of fixing the cerebellar block prior to slicing.
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Figure 3.11 Triple staining for calbindin/A2AR/GFAP
Parasaggital sections (100 µm) from immature rat cerebella (P12). Sections were
stained for calbinidin (red, 1:1000) (A), A2AR (green, 1:100) (B) and GFAP (blue,
1:300) (C). For merged images co-localisation of calbindin and A2AR is yellow (D),
calbindin and GFAP is magenta (E), A2AR and GFAP is cyan (F) and calbindin,
A2AR and GFAP is white (G). A2AR was densely distributed across Purkinje cell (pc)
bodies and dendrites throughout the molecular layer (ml). Staining was also present
around cells in the internal granule layer (igl) but not external granule layer (egl) (D).
Some co-localisation of A2AR with glial cell processes was observed but glia do not
account for the staining observed over Purkinje cell bodies (F, G). Optical stack 10
µm. Scale bar 45 µm.
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3.10 Controls
To confirm that secondary antibodies bound specifically to their primary antibodies
the immunofluorescence protocol was followed using parasaggital cerebellar sections
(100 µm) with the primary antibody omitted (figure 3.12). Only minimal staining
was observed, confirming that any unexpected staining patterns previously described
were not due to a lack of secondary antibody specificity.
Further controls were carried out to eliminate the possibility that the unpredicted
staining may have been a result of secondary antibody cross-over reactions. When
parasaggital cerebellar sections (100 µm) were stained for calbindin (1:1000) and
A1R (1:100) with the secondary antibody for A1R omitted no staining was observed
for A1R (figure 3.13 A, B), confirming that the secondary antibody for calbindin
does not cross-react with the A1R primary antibody. Cross-reaction of the secondary
antibody for A1R with calbindin primary antibody was also eliminated in the same
way by omitting the secondary antibody for calbindin (figure 3.13 C, D).
No staining for GFAP was observed using triple immunofluorescence with calbindin
(1:1000), A1R (1:100) and GFAP (1:300) on parasaggital cerebellar sections (100 µm)
with the secondary antibody for GFAP omitted (figure 3.13 E-G) confirming that the
secondary antibodies for calbindin and A1R do not cross-react with the primary
antibody for GFAP. The same control experiments were repeated using mGluR4
(1:100) and A2AR (1:100) in place of A1R primary antibody (not shown).
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Figure 3.12 Controls for secondary antibody specificity
Parasaggital sections (100 µm) from rat cerebella (A, C-F P23, D P12). When the
immunofluorescence protocol was followed with the primary antibody omitted no
specific antibody staining was observed. Sections were stained with secondary
antibodies for calbindin (red, 1:1000) (A), A1R (green, 1:100) (B), mGluR4 (green,
1:100) (C), A2AR (green, 1:100) (D) and GFAP (blue, 1:300) (E). Optical stack 10
µm. Scale bar 45 µm.
A B C
D E
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Figure 3.13 Controls for secondary antibody cross-over
Parasaggital sections (100 µm) from rat cerebella (A-B P21, C-D P23, E-G P12).
When sections were stained for calbindin and A1R with the secondary antibody for
A1R omitted no staining was observed for A1R, confirming that the secondary
antibody for calbindin does not cross-react with the A1R primary antibody (A, B).
The same control was performed with the secondary antibody for calbindin omitted
and no staining was observed for calbindin (C, D). For triple immunofluorescence
with calbindin, A1R and GFAP the secondary antibody for GFAP was omitted. No
staining was observed for GFAP confirming that the secondary antibodies for
calbindin and A1R do not cross-react with the GFAP primary antibody (D, E, F).
Optical stack 10 µm. Scale bar 45 µm.
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3.11 Summary
The immunohistochemistry suggests that A1R and mGluR4 are widely distributed
across Purkinje cell bodies, their dendrites and within the granule layer of the
cerebellum throughout development. The same staining patterns were also observed
in cerebellar slices prior to PF-PC synapse formation.
There is only minor co-localisation of A1R and mGluR4 with glial cell bodies or
their processes, eliminating their involvement in the staining observed. Although
these results were replicated using an alternative protocol, care should be taken in
their interpretation as they are partly contradictory to the expression of A1R and
mGluR4 described in previous studies and there is also no evidence for parallel fibre
expression at Purkinje cell bodies or within the granule layer.
The widespread expression of A2AR within cerebellar slices which is identical to that
of A1R is, in particular, contradictory to a number of previous immunohistochemical
studies and a role for A2AR has not previously been described within the cerebellum.
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Chapter 4 Presynaptic pharmacology of
immature parallel fibre-Purkinje cell synapses in the
rat cerebellum
4.1 Introduction
The activation of presynaptic A1R, mGluR4, GABAB and CB1 receptors at cerebellar
parallel fibre terminals is known to decrease the probability of vesicle release and
inhibit synaptic transmission (Bellamy 2007).
Separate studies have previously described the inhibitory effects of GABAB
(Batchelor and Garthwaite 1992; Dittman and Regehr 1996), mGluR4 (Neale,
Garthwaite et al. 2001) and A1R (Takahashi, Kovalchuk et al. 1995) activation on
PF-PC synapse transmission at various stages of postnatal development prior to
completion of the internal granule layer at around postnatal day 21. This study used
cerebellar slices from rats at postnatal days 9-14 to investigate the pharmacological
profile of the immature rat PF-PC synapse.
Although it would have been ideal to examine the effect of presynaptic receptor
activation from the initial formation of PF-PC synapses at around postnatal day 5
(Altman 1972), extracellular field recordings were frequently not possible to obtain
below postnatal day 9 due to the low number of synapses present at this early stage
of development.
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4.2 Identification of parallel fibre excitatory postsynaptic
potentials
Extracellular recordings of pairs of parallel fibre excitatory postsynaptic potentials
(PF EPSPs) were recorded from the molecular layer of immature (postnatal day 9-14)
and mature (postnatal day 21-28) rat cerebellar vermis. The cerebellar slices (400
µm) used for the measurements were cut transversely to ensure that the parallel
fibres in contact with the Purkinje cell dendrites remained intact. This orientation
also ensured that any climbing fibres forming synapses with proximal Purkinje cell
dendrites were cut as climbing fibres run at a 90° angle to parallel fibres (figure 1.6).
Pairs of stimuli (2-5 V, 200 µs duration) at a frequency of 0.1 Hz resulted in paired
pulse facilitation (PPF) where the amplitude of the second PF EPSP was larger than
that of the first (figure 4.1A). The PPF, which provides a primary confirmation of
PF EPSP identity (Atluri and Regehr 1996), occurs because the rapid arrival of a
second action potential whilst Ca2+ remains elevated in the parallel fibre terminal
from the first depolarisation increases the probability of glutamate release from the
readily-releasable pool of vesicles (Zucker and Regehr 2002). The paired pulse ratio
(PPR, 1.4 ± 0.01, n = 220) was measured as EPSP2/EPSP1 and was used as a test of
presynaptic action on release probability where an increase in PPR indicated an
effect at presynaptic receptors. Application of the same pairs of stimuli at climbing
fibre-Purkinje cell synapses in the molecular layer would have resulted in paired
pulse depression (PPD) where the amplitude of the second EPSP is smaller than that
of the first (Konnerth, Llano et al. 1990). This is thought to be due to a depletion of
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the pool of readily-releasable glutamate vesicles in the climbing fibre terminal
(Zucker and Regehr 2002).
The field potential consists of two components, both of which can be eliminated with
application of the Na+ channel inhibitor tetradotoxin (TTX, 1 µM) (figure 4.1C). The
initial parallel fibre volley component was unaffected by application of the glutamate
receptor antagonist kynurenic acid (5 mM) as it represents propagating action
potentials that do not require the release of transmitter to be generated (Clark and
Barbour 1997) but the amplitude of the second component was almost completely
inhibited following its application (figure 4.1D). This verified that EPSP production
was via postsynaptic glutamate receptor activation and further confirmed the identity
of PF EPSPs (figure 4.1B) (Clark and Barbour 1997). The kynurenic acid-sensitive
potential was deducted from the control potential and used as a measurement of PF
EPSP amplitude in all electrophysiological experiments.
The residual potential persisting in kynurenic acid (5 mM) could be inhibited by 71.9
± 7.7 % with cadmium (100 µM) which blocks voltage-dependent Ca2+ channels and
prevents the release of glutamate (n = 7, figure 4.1B, E). In whole cell patch clamp
recordings from Bergmann glia in rat cerebellar slices the cadmium-sensitive
component of the current generated by stimulation of parallel fibres was previously
concluded to be a ‘transporter current’ produced by the uptake of synaptically
released glutamate (Clark and Barbour 1997).
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Figure 4.1 Confirmation of parallel fibre excitatory postsynaptic
potentials in extracellular recordings from the molecular layer of rat
cerebellar slices
(A) Average of 50 pairs of parallel fibre excitatory postsynaptic potentials (PF
EPSPs) obtained with pairs of stimuli (2-5 V, 200 µs duration) at a frequency of 0.1
Hz with an interval of 50 ms. Paired pulse facilitation (PPF) is illustrated by the
greater amplitude of the second EPSP compared to the first (see dotted line). The
field potential consisted of two components that could be blocked with tetrodotoxin
(TTX, 1 µM) (C). The initial parallel fibre volley component was unaffected by
application of kynurenic acid (5 mM) (D). The kynurenic acid-sensitive component
was used as an estimate of PF EPSP amplitude. (B) Graph plotting amplitude of
individual EPSPs against time in an immature (P12) rat cerebellar slice. Application
of kynurenic acid (5 mM) resulted in almost complete inhibition. Application of
cadmium (100 µM) inhibited the residual potential persisting in kynurenic acid (5
mM) (E).
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4.3 A variable GABAA response was present at immature
parallel fibre-Purkinje cell synapses
Within the molecular layer, basket cell axons form GABAergic synapses with
Purkinje cell bodies and stellate cell axons form GABAergic synapses with Purkinje
cell dendrites to provide feed-forward inhibition (figure 1.7) (Hawkes 2005; Sillitoe
and Joyner 2007). In addition activation of presynaptic GABAA at parallel fibre
terminals has also been shown to result in the release of glutamate onto Purkinje cells
and interneurones (Stell, Rostaing et al. 2007). It is possible that the pairs of stimuli
in the molecular layer may have stimulated the release of GABA from the
interneurones which could have affected the EPSP amplitudes recorded via
activation of GABAA on Purkinje cells or at parallel fibre terminals.
Application of the GABAA antagonist bicuculline (10 µM) to immature cerebellar
slices, where PF EPSP identity had been confirmed via PPF and inhibition with
kynurenic acid (5mM), resulted in a net reduction in EPSP amplitude of 5.6 ± 4.6 %
(n = 7) although the effect was variable. An inhibition of 12.5 ± 5.6 % (figure 4.2A)
was observed in 4 slices, no effect in 2 slices (figure 4.2B) and an increase of 11 %
in 1 slice (figure 4.2C). If GABA released from inhibitory interneurones was
significantly affecting the EPSPs via activation of GABAA on Purkinje cells or at
parallel fibre terminals a large change in amplitude would have been expected with
bicuculline. As the effect was variable with no large increases or decreases in EPSP
amplitude observed it is unlikely that stimulation of inhibitory interneurones was
affecting extracellular recordings in this study.
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Figure 4.2 A variable GABAA response was present at immature
parallel fibre-Purkinje cell synapses
Graphs plotting amplitude of individual EPSPs against time in immature (P12-13)
cerebellar slices. Application of bicuculline (10 µM) inhibited EPSP amplitude by
12.5 ± 5.6 % in 4 slices (A), had no effect in 2 slices (B) and increased EPSP
amplitude by 11 % in 1 slice (C). PF EPSP identity was confirmed by inhibition
with kynurenic acid (5 mM).
100
4.4 Confirmation of presynaptic GABAB and mGluR4
responses at parallel fibre-Purkinje cell synapses
It has previously been reported that GABAB receptors are expressed at high levels in
the rat cerebellum both pre- and postsynaptically during postnatal development
(Lujan and Shigemoto 2006) and that the GABAB agonist baclofen inhibits PF-PC
synaptic transmission in mature (Batchelor and Garthwaite 1992) and immature
(Batchelor and Garthwaite 1992; Dittman and Regehr 1996) rat cerebellar slices due
to its action at presynaptic receptors. Confirming these previous observations in
mature cerebellar slices baclofen (10 µM) reliably inhibited PF EPSP amplitude by
98.8 ± 0.2 % and significantly increased the PPR from 1.4 ± 0.05 to 2.9 ± 0.4 (p <
0.001, n = 5) indicating the presynaptic effect of baclofen. A similar inhibition of
97.3 ± 1.3 % and significant increase in PPR from 1.3 ± 0.03 to 2.6 ± 0.2 (p < 0.001,
n = 16, figure 4.3A) was observed in immature slices suggesting little developmental
difference in the activation of presynaptic GABAB receptors at PF-PC synapses
(figure 4.4). However as the maximal effect of baclofen was obtained at the
concentration used (10 µM) a developmental difference in presynaptic GABAB
receptor activation may not have been observed.
Binding studies show a progressive increase in mGluR4 mRNA labelling in the rat
cerebellum from very low levels at postnatal day 3 to very high levels at postnatal
day 30 in line with the development of cerebellar circuitry (Catania, Landwehrmeyer
et al. 1994) where mGluR4 are suggested to have a presynaptic autoreceptor function
at the PF-PC synapse (Pekhletski, Gerlai et al. 1996). Previous electrophysiological
studies have shown that application of the mGluR4 agonist L-(+)-2-amino-4-
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phosphonobutyric acid (L-AP4) to rat cerebellar slices inhibits glutamatergic
transmission at the PF-PC synapse at postnatal days 12-16 (Neale, Garthwaite et al.
2001) and in mature animals from postnatal day 21 onwards (Miniaci, Bonsi et al.
2001; Lorez, Humbel et al. 2003).
In mature cerebellar slices L-AP4 (50 µM) inhibited PF EPSP amplitude by 55.8 ±
6.4 % and increased PPR from 1.6 ± 0.07 to 1.9 ± 0.2 (n = 5). Similarly, application
of L-AP4 (50 µM) to immature slices resulted in a 57.2 ± 2.3 % reduction in EPSP
amplitude and significant increase in PPR from 1.4 ± 0.03 to 1.7 ± 0.05 (p < 0.001, n
= 47, figure 4.3B) demonstrating an effect at presynaptic mGluR4 receptors and no
significant developmental difference in inhibition of PF-PC synaptic transmission
(figure 4.4).
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Figure 4.3 Synaptic transmission at the immature parallel fibre-
Purkinje cell synapse is inhibited by activation of presynaptic
GABAB and mGluR4 receptors
(A) Graphs plotting amplitude of individual EPSPs against time and PPR against
time for the same experiment in an immature (P11) cerebellar slice. Application of
baclofen (10 µM) inhibited PF EPSP amplitude and increased the PPR demonstrating
an effect at presynaptic GABAB receptors. (B) Graphs plotting amplitude of
individual EPSPs against time and PPR against time for the same experiment in an
immature (P12) slice. Application of L-AP4 (50 µM) blocked synaptic transmission
and increased PPR due to action at presynaptic mGluR4 receptors.
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Figure 4.4 There are no developmental differences in presynaptic
inhibition via GABAB and mGluR4 receptors at parallel fibre-
Purkinje cell synapses
Graph comparing the inhibition resulting from application of baclofen (10 µM) to
immature (P9-14, n = 16) and mature (P21-28, n = 5) cerebellar slices and L-AP4 (50
µM) to immature (n = 47) and mature (n = 5) slices. There were no significant
developmental differences in inhibition at PF-PC synapses due to activation of
presynaptic GABAB and mGluR4 receptors. However as the maximal effect of
baclofen was obtained at the concentration used (10 µM) a developmental difference
in presynaptic GABAB receptor activation may not have been observed.
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4.5 The response to adenosine was variable at immature
parallel fibre-Purkinje cell synapses
Previous studies have described inhibition following application of adenosine to
mature (Kocsis, Eng et al. 1984) and immature (postnatal days 10-15) (Takahashi,
Kovalchuk et al. 1995) rat cerebellar slices and stated that this inhibition occurs via
the activation of A1R as it can be replicated with the A1R agonist CPA and blocked
with the A1R antagonist 8-CPT (Takahashi, Kovalchuk et al. 1995). Application of
adenosine (100 µM) to mature cerebellar slices resulted in a 59.9 ± 2.1 % decrease in
EPSP amplitude (n = 53) and a significant increase in PPR from 1.5 ± 0.03 to 1.9 ±
0.06 (p < 0.001) due to the action of adenosine at presynaptic A1R.
Application of adenosine (100 µM) to immature slices resulted in a variable PF
EPSP amplitude reduction (figure 4.5). The expected inhibition of PF EPSPs was
present at most synapses but little or no adenosine-mediated inhibition was also
frequently observed despite clear PPF indicative of PF EPSP recordings. Further
confirmation of PF EPSP identity with the mGluR4 agonist L-AP4 (50 µM) or
GABAB agonist baclofen (10 µM) was obtained even when adenosine had little
effect on synaptic transmission.
On average adenosine (100 µM) inhibited synaptic transmission by 47.7 ± 2.3 % (n =
167) and significantly increased PPR from 1.4 ± 0.01 to 1.7 ± 0.03 (p < 0.001) in
immature slices indicating an action at presynaptic A1R (figure 4.6A). No inhibition
or obvious changes in PPR were seen in 21 of the 167 (~12.5 %) slices (figure 4.6B)
and confirmation of PF EPSP identity was obtained at these synapses with L-AP4
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(50 µM, 57.3 ± 3.1 % inhibition, n = 19) or baclofen (10 µM, 96.5 ± 2.8 %, n = 6) in
addition to almost complete inhibition with the glutamate receptor antagonist
kynurenic acid (5 mM) (figure 4.6D).
In the slices where no adenosine-mediated inhibition was observed the reliable
reduction in EPSP amplitude with L-AP4 (50 µM, figure 4.7A) provided the
strongest evidence that the extracellular recordings were from PF-PC synapses as
mGluR4 are unique to this synapse in the cerebellum (Pekhletski, Gerlai et al. 1996).
In these slices the mean inhibition with L-AP4 (50 µM, 57.3 ± 3.1 %, n = 19) was
almost identical to that observed with application of L-AP4 (50 µM, 57.1 ± 3.2 %, n
= 28) to immature cerebellar slices where adenosine (100 µM) resulted in inhibition
(figure 4.7B) suggesting no differences in the mGluR4 response between the two
groups.
The PF-PC synapse properties in control were compared in immature slices where
adenosine had little or no effect on PPF or synaptic transmission (inhibition < 15 %,
n = 25) and slices where adenosine inhibited EPSP amplitude by more than 50 % and
increased PPR (n = 98). There was no significant difference in either EPSP
amplitude (-0.35 ± 0.02 mV and -0.3 ± 0.03 mV, p = 0.19) or the degree of PPF (1.38
± 0.04 and 1.34 ± 0.03, p = 0.22). Thus other than the differential effect of adenosine
on EPSP amplitude in immature slices, the synapses appeared identical in their
properties and inhibition in response to baclofen, L-AP4 and kynurenic acid.
The variation in adenosine-mediated inhibition is unlikely to be due to
developmental differences occurring within the immature age range tested (postnatal
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days 9-14) as no inhibition with adenosine (100 µM) was observed in at least one
animal at each postnatal day within this range. Similarly 100 % inhibition was
observed in 4 animals at different ages within the range (postnatal days 9, 10, 12 and
13). A calculation of correlation coefficient confirms that there is no relationship
between age and adenosine-mediated inhibition in rats between postnatal days 9 and
14 (r = 0.04).
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Figure 4.5 Adenosine had a variable effect at presynaptic A1R at
immature parallel fibre-Purkinje cell synapses
Graph summarising the % EPSP amplitude reduction observed with application of
adenosine (100 µM) to immature (P9-14) cerebellar slices (n = 167). Adenosine had
a variable effect (47.7 ± 2.3 % mean inhibition) and had no effect at 21 of the 167
slices (~12.5 %) tested.
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Figure 4.6 Confirmation of parallel fibre excitatory postsynaptic
potentials at synapses with no adenosine-mediated inhibition
(A) Graphs plotting amplitude of individual EPSPs against time and PPR against
time for the same experiment in an immature (P13) cerebellar slice. Application of
adenosine (100 µM) inhibited PF EPSP amplitude and increased the PPR
demonstrating an effect at presynaptic A1R. (B) Graphs plotting amplitude of
individual EPSPs against time and PPR against time for the same experiment in an
immature (P9) slice. Adenosine had very little inhibitory effect on the EPSP
amplitude and did not affect the PPR. (C) There is no relationship between baseline
PPR and the magnitude of adenosine inhibition (r = 0.03) and a strong positive
correlation between the increase in PPR and the magnitude of adenosine inhibition (r
= 0.70) suggesting presynaptic inhibition. (D) Graph plotting amplitude of
individual EPSPs against time in an immature (P12) slice. Application of adenosine
(100 µM) resulted in little inhibition so confirmation of PF EPSPs was obtained by
reduction in EPSP amplitude with L-AP4 (50 µM), baclofen (10 µM) and kynurenic
acid (5 mM).
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Figure 4.7 Inhibition with L-AP4 at immature parallel fibre-
Purkinje cell synapses
(A) Graph demonstrating that application of L-AP4 (50 µM) reliably inhibited EPSP
amplitude by 57.3 ± 3.1 % in immature (P9-14) cerebellar slices with no adenosine-
mediated inhibition (100 µM, n = 19). (B) Graph showing the range of EPSP
amplitude reduction with L-AP4 (50 µM, 57.1 ± 3.2 %, n = 28) in immature
cerebellar slices with adenosine-mediated inhibition. The range of inhibition is
similar to that of slices that do not respond to adenosine.
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4.6 Parallel fibre excitatory postsynaptic potentials are
unlikely to be a balance between A1R and A2AR activation
The earlier immunohistochemistry experiments in this study suggest a widespread
distribution of both A1R and A2AR in the molecular layer which could indicate that
adenosine is binding to both receptor subtypes at parallel fibre terminals and that the
resultant EPSP amplitude is a balance of the inhibitory effect of A1R activation and
the facilitatory effect of A2AR activation on glutamate release. At synapses where
there are more A2AR this may have the net effect of adenosine having little or no
effect on synaptic transmission.
To test this concept adenosine-mediated inhibition was measured in immature slices.
The A1R antagonist 8-CPT (2 µM) was then applied followed by co-application of
adenosine (100 µM) and 8-CPT. If both A1R and A2AR are functional at PF-PC
synapses an increase in EPSP amplitude should be seen due to the action of
adenosine at A2AR whilst A1R are blocked with 8-CPT. This increase should be
greater in slices with little or no adenosine-mediated inhibition.
In 11 out of 12 slices tested adenosine (100 µM) inhibited EPSP amplitude between
45 and 91 %. In these slices simultaneous application of 8-CPT (2 µM) and
adenosine had no effect on EPSP amplitude in 8 out of the 11 (~73 %) slices and
increased EPSP amplitude by only 8.7 ± 3.2 % in the remaining 3 slices (figure 4.8).
No effect on PPR was observed. This would be expected as adenosine-mediated
inhibition via presynaptic A1R was apparent in these slices.
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In the remaining slice adenosine (100 µM) inhibited EPSP amplitude by only 24 %
and simultaneous application of 8-CPT (2 µM) and adenosine increased EPSP
amplitude by 10 %. Identification of PF EPSPs was confirmed by inhibition with
kynurenic acid (5 mM). This suggests the possibility that the presence of facilitatory
A2AR may contribute to the reduced adenosine-mediated inhibition at some PF-PC
synapses. However it is difficult to draw conclusions as in the 12 slices tested a low
adenosine-mediated inhibition was only observed in one and it is in these slices
where adenosine and 8-CPT co-application would be expected to have an effect.
These results suggest that if A2AR are present at PF-PC synapses they are unlikely to
significantly influence EPSP amplitude. It may be that A2AR are functional or
clustered at only a small number of PF-PC synapses and differences in A1R
expression and affinity or adenosine metabolism has a greater effect on the
variability in adenosine-mediated inhibition observed in immature slices.
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Figure 4.8 Application of adenosine with 8-CPT had little effect at
immature parallel fibre-Purkinje cell synapses
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. Adenosine (100 µM) inhibited EPSP amplitude by ~50 % and a
small increase in PF EPSP amplitude was observed with 8-CPT (2 µM, arrow)
indicating a low extracellular adenosine tone. Application of adenosine (100 µM)
and 8-CPT (2 µM) resulted in a small increase in EPSP amplitude (arrow). (B)
Graph plotting paired pulse ratio against time for the same experiment. The
presynaptic action of 8-CPT was confirmed by a decrease in the paired pulse ratio as
PF EPSP amplitude increased. Application of adenosine with 8-CPT had no further
effect on PPR.
A
B
114
4.7 A low expression of A1R is unlikely to explain the
variable adenosine-mediated inhibition in immature
cerebellar slices
A concentration of 100 µM adenosine had been used to determine PF EPSP
inhibition in immature cerebellar slices as this was the maximum concentration
applied to slices in a previous electrophysiological study using rats of a similar age
(Takahashi, Kovalchuk et al. 1995). In addition the extracellular concentration of
adenosine in the brain is only estimated to vary between 25 nM and 250 nM
(Dunwiddie and Masino 2001) so a response to adenosine should have been observed
at 100 µM.
In immature slices where no inhibition was observed with application of adenosine
(100 µM) a 42.3 ± 6.1 % decrease in EPSP amplitude and an increase in PPR from
1.5 ± 0.2 to 1.6 ± 0.03 was observed with a higher concentration of adenosine (300
µM) in 3 out of 4 slices indicating that functional A1R were present at these PF-PC
synapses. In the other slice neither 100 nor 300 µM adenosine had any effect on
EPSP amplitude. Confirmation of PF EPSP identity was obtained with application of
L-AP4 (50 µM, 51.7 ± 6.7 % inhibition) and almost complete inhibition with
kynurenic acid (5 mM) (figure 4.9).
The previously described immunohistochemistry experiments in this study suggested
a dense co-localisation of A1R at all PF-PC synapses throughout development which
also indicates that it is unlikely that the large variability in presynaptic inhibition
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through activation of A1R would be due to a low expression of A1R at some
immature PF-PC synapses.
To further confirm the presence of A1R the non-hydrolysable A1R agonist N6-
cyclopentyladenosine (CPA, 1 µM) was applied to immature cerebellar slices with
no adenosine-mediated inhibition at PF-PC synapses where confirmation of PF EPSP
identity had been obtained by inhibition with L-AP4 (50 µM, 59.6 ± 3.7 % inhibition,
n = 8) or baclofen (10 µM, 100.0 ± 0.0 % inhibition, n = 6) and almost complete
inhibition with kynurenic acid (5 mM, n = 8). The CPA reliably inhibited EPSP
amplitude by 68.0 ± 5.0 % and significantly increased PPR from 1.4 ± 0.1 to 1.9 ±
0.1 (p < 0.001, n = 8) demonstrating its action at presynaptic A1R and confirming
that the absence of adenosine-mediated inhibition at some immature PF-PC synapses
is unlikely to be due to a low expression of A1R (figure 4.10).
The CPA is not metabolised and removed as adenosine would be in the extracellular
space so its inhibitory effect at A1R that do not respond to adenosine (100 µM) may
indicate a more rapid metabolism or uptake of adenosine by transporter proteins at
some immature PF-PC synapses resulting in the removal of adenosine from the
extracellular space before it can activate A1R. Alternatively, the inhibition observed
with CPA or a higher concentration of adenosine (300 µM) at PF-PC synapses that
do not respond to adenosine (100 µM) may indicate that presynaptic A1R with a
lower affinity for adenosine may be present at these synapses.
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Figure 4.9 A higher concentration of adenosine resulted in
inhibition at some immature parallel fibre-Purkinje cell synapses
where 100 µM adenosine had little inhibitory effect
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. Application of adenosine (100 µM) had little effect on PF EPSP
amplitude although a higher concentration (300 µM) resulted in 54 % inhibition
indicating the presence of functional A1R. PF EPSP identity was confirmed with
inhibition following application of L-AP4 (50 µM) and kynurenic acid (5 mM). (B)
Graph plotting PPR against time for the same experiment showing that the response
to the higher concentration of adenosine was due to an effect at presynaptic receptors.
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Figure 4.10 The absence of adenosine-mediated inhibition at some
immature parallel fibre-Purkinje cell synapses is unlikely to be due
to a low expression of A1R
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. PF EPSP identity was confirmed by inhibition via activation of
presynaptic mGluR4 receptors with L-AP4 (50 µM), presynaptic GABAB receptors
with baclofen (10 µM) and with the glutamate receptor antagonist kynurenic acid (5
mM). Application of the A1R agonist CPA (1 µM) decreased PF EPSP amplitude
demonstrating that functional A1R were present at this PF-PC synapse even though
no adenosine-mediated inhibition was observed with 2 applications of adenosine
(100 µM). The slow wash-off of CPA has not been included. (B) Graph plotting
paired pulse ratio against time for the same experiment. The presynaptic action of
CPA was confirmed by an increase in the paired pulse ratio as PF EPSP amplitude
decreased.
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4.8 The variable inhibitory effect of adenosine acting at
A1R at immature parallel fibre-Purkinje cell synapses may
be due to differences in A1R efficacy
To further test the possibility that inconsistent adenosine-mediated inhibition at
immature PF-PC synapses may be the result of a variability in A1R efficacy, two log
concentration-response curves for EPSP amplitude reduction (figure 4.11) elicited by
application of the A1R agonist CPA (0.001 µM – 100 µM) were generated. These
were for slices where application of adenosine (100 µM) resulted in a greater than
50 % inhibition of PF EPSP amplitude (n = 4) and slices that showed little or no
adenosine-mediated inhibition but where PF EPSP identity had been confirmed by
inhibition with both L-AP4 (50 µM) and kynurenic acid (5 mM) (n = 6, figure 4.12).
The PF EPSP amplitude reduction resulting from application of CPA was greater at
PF-PC synapses that were inhibited by application of adenosine (100 µM) than those
where no adenosine-mediated inhibition was observed for each concentration of CPA
tested (table 4.1). The lower IC50 of 0.08 µM in slices that respond to adenosine
compared to 2.10 µM in slices where there is no adenosine-mediated inhibition
suggests that A1R efficacy may be lower at some immature PF-PC synapses and that
this may account for the variability in response to adenosine. The log concentration-
response curves (figure 4.12) also suggest that there may be differences in the
efficacy of adenosine in immature slices.
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concentration
of CPA (µM)
mean PF EPSP amplitude reduction (%)
adenosine-mediated
inhibition
no adenosine-
mediated inhibition
0.001 0 0
0.003 7.5 1.4
0.01 15.8 6.0
0.3 32.0 10.2
0.1 58.2 10.2
0.3 76.3 18.5
1 91.3 26.2
3 100.0 32.5
10 - 39.3
30 - 51.5
100 - 59.0
Table 4.1 Comparison of inhibition with CPA in immature
cerebellar slices
The mean % EPSP amplitude reduction resulting from application of CPA (0.001
µM - 100 µM) to immature cerebellar slices was greater at PF-PC synapses that were
inhibited by application of adenosine (100 µM, n = 4) than those where no
adenosine-mediated inhibition was observed (n = 6) for each concentration of CPA
tested.
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Figure 4.11 Comparison of inhibition with CPA at immature
parallel fibre-Purkinje cell synapses in the absence and presence of
adenosine-mediated inhibition
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P10)
cerebellar slice with no adenosine-mediated inhibition. Application of the A1R
agonist CPA (1 nM – 10 µM) decreased PF EPSP by 58 % and was reversed with
application of 8-CPT (2 µM). Identification of EPSPs was confirmed by inhibition
with kynurenic acid (5 mM). (B) Graph plotting amplitude of individual EPSPs
against time in an immature (P12) cerebellar slice with adenosine-mediated
inhibition (75 %). Application of the A1R agonist CPA (1 nM – 1 µM) decreased PF
EPSP by 97 % and was reversed with application of 8-CPT (2 µM). Identification of
EPSPs was confirmed by inhibition with kynurenic acid (5 mM).
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Figure 4.12 The variable adenosine-mediated inhibition at
immature parallel fibre-Purkinje cell synapses may be due to
differences in A1R efficacy
Log concentration-response curves for the reduction in PF EPSP amplitude by the
A1R agonist CPA (0.001 µM – 100 µM) in immature (P9-14) cerebellar slices where
EPSP amplitude was reduced by application of adenosine (100 µM, n = 4) and slices
where there was no adenosine-mediated inhibition (n = 6). The IC50 was higher in
slices with no adenosine-mediated inhibition (IC50 = 2.10 µM) than in those where
PF EPSP amplitude was reduced by adenosine (IC50 = 0.08 µM) suggesting
variability in A1R efficacy at immature PF-PC synapses. At synapses where
adenosine had little or no effect on EPSP amplitude, the concentration response
curve was shifted to the right when normalised to 100 %. Thus synapses show
variation in the efficacy of CPA suggesting that the variation stems from receptor
properties (and possibly downstream signalling) rather than differences in adenosine
uptake and metabolism.
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4.9 The variability in adenosine-mediated inhibition in
immature cerebellar slices is not gender-specific
In a study looking at the effects of neonatal caffeine exposure on epileptogenesis,
rats exposed at postnatal days 2-6 to the A1R antagonist caffeine were infused
intravenously with convulsants acting at various CNS receptors at postnatal days 70-
90. The threshold for seizures induced by caffeine increases as a result of neonatal
caffeine exposure and is significantly higher in females than males suggesting gender
specificity in how developmental exposure to caffeine affects adult seizure
susceptibility at the A1R (Guillet and Dunham 1995).
The A1R-mediated inhibition at the PF-PC synapse in immature female cerebellar
slices was compared to that of males to see whether the variability in inhibition was
gender-specific. Application of adenosine (100 µM) to immature female cerebellar
slices (400 µm) resulted in a similar range of inhibition of PF EPSP amplitude
(figure 4.13A) to that of immature male cerebellar slices (figure 4.4) with an average
adenosine-mediated inhibition of 34.6 ± 7.5 % (n = 16) and increase in PPR from 1.4
± 0.05 to 1.6 ± 0.1. Although lower than the PF EPSP amplitude reduction seen with
application of adenosine (100 µM) to male immature cerebellar slices (47.7 ± 2.3 %,
n = 167) the difference was not significant (p = 0.09) (figure 4.13B).
No adenosine-mediated inhibition or obvious changes in PPR were seen in 3 of the
16 (~18.8 %) female immature cerebellar slices compared with 12.5 % in male and
confirmation of PF EPSP identity was obtained at these synapses with the mGluR4
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agonist L-AP4 (50 µM, 68.3 ± 3.3 % inhibition) in addition to almost complete
inhibition with the glutamate receptor antagonist kynurenic acid (5 mM).
As a final observation, a lack of A1R-mediated inhibition was often observed in
batches of slices taken from the same litter of rats. This may indicate a genetic
component for the response to adenosine.
Figure 4.13 Comparison of adenosine-mediated inhibition at
immature parallel fibre-Purkinje cell synapses in male and female
rats
(A) Graph summarising the % EPSP amplitude reduction observed with application
of adenosine (100 µM) to immature (P9-14) female cerebellar slices (n = 16).
Adenosine had a variable effect (34.6 ± 7.5 % mean inhibition) and had no effect at 3
of the 16 slices (~18.8 %) tested. (B) Graph comparing the inhibition resulting from
application of adenosine (100 µM) to immature male (n = 167) and female (n = 16)
slices. Although the mean PF EPSP amplitude reduction is less at female (34.6 ±
7.5 %, n = 16) than male PF-PC synapses (47.7 ± 2.3 %, n = 167) the difference is
not significant (p = 0.09).
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4.10 Summary
The release of GABA from inhibitory interneurones in the molecular layer appeared
to have little effect on EPSP amplitude at immature PF-PC synapses via activation of
GABAA receptors. Reduction in EPSP amplitude due to activation of presynaptic
mGluR4 and GABAB receptors was confirmed in slices at postnatal days 9-14 and
found to be comparable to that obtained in slices at postnatal days 21-28.
The A1R-mediated inhibition was found to be variable in immature slices with
~12.5 % of confirmed PF-PC synapses showing no response to adenosine. The
variability in A1R-mediated inhibition was not found to be gender-specific or
correlated with age of rat (P9-14) and the synapses otherwise appeared identical in
their properties and inhibition in response to baclofen, L-AP4 and kynurenic acid.
Previous immunohistochemistry experiments suggesting the widespread presence of
A2AR in the molecular layer may indicate that adenosine could be acting at receptors
other than A1R although co-application of adenosine and 8-CPT indicates that
activation of A2AR is unlikely to contribute significantly to PF EPSP amplitude.
In immature slices with no A1R-mediated inhibition the widespread distribution of
A1R in the molecular was assumed from prior immunohistochemistry experiments
and confirmed by inhibition of PF EPSP amplitude with a higher concentration of
adenosine (300 µM) in 3 out of 4 slices and inhibition with the non-hydrolysable
A1R agonist CPA.
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A comparison of log concentration-response curves generated for the inhibition of PF
EPSP amplitude at immature PF-PC synapses that respond to adenosine and those
without A1R-mediated inhibition suggest that some A1R may have a lower efficacy
at this stage of development and that this may explain the variability in PF EPSP
amplitude reduction observed with application of adenosine.
126
Chapter 5 Adenosine signalling at immature
parallel fibre-Purkinje cell synapses in the rat
cerebellum
5.1 Introduction
The release (Wall and Dale 2008) and clearance (Baldwin, Beal et al. 2004; Noji,
Karasawa et al. 2004; Boison 2007) of adenosine are reasonably well-documented in
the mature CNS but relatively little is known about how adenosine signalling
changes during postnatal development. In the mature cerebellum blockade of
presynaptic A1R at PF-PC synapses enhances synaptic transmission suggesting the
presence of an inhibitory adenosine tone (Wall, Atterbury et al. 2007).
The enzyme adenosine kinase is the major determinant of adenosine levels at PF-PC
synapses and an extracellular purine tone is detectable with microelectrode
biosensors under basal conditions (Wall, Atterbury et al. 2007). The active release of
adenosine can also be stimulated with trains of activity in the molecular layer of
mature cerebellar slices although this does not appear to be a source of the basal
extracellular adenosine tone (Wall and Dale 2008).
Electrophysiology and microelectrode biosensors were used to examine immature
adenosine signalling in cerebellar slices at postnatal days 9-12 shortly after the initial
development of PF-PC synapses around postnatal day 5 in the rat (Altman 1972).
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5.2 Tonic inhibition by endogenous adenosine is low or
absent at immature parallel fibre-Purkinje cell synapses
Application of 8-CPT to block A1R in cerebellar slices potentiates synaptic
transmission at the PF-PC synapse suggesting the tonic activation of A1R with an
endogenous inhibitory tone of adenosine (Takahashi, Kovalchuk et al. 1995; Wall,
Atterbury et al. 2007). To investigate whether this tonic A1R-mediated inhibition is
present at an early developmental stage soon after the formation of PF-PC synapses
around postnatal day 5 (Altman 1972) the effect of 8-CPT on PF EPSP amplitude
was observed in immature rat cerebellar slices (400 µm) at postnatal days 9-12.
Previously described electrophysiology experiments in this study suggested that
some immature PF-PC synapses may express low efficacy A1R or adenosine
receptors other than A1R (see Chapter 4). Presumably these synapses will have no
A1R tone so were not included in this study. In all experiments, slices were only
analysed where at least 50 % inhibition of PF EPSP amplitude was observed
following application of adenosine (100 µM). Identification of PF EPSP was
confirmed in all slices by the presence of PPF and an almost complete inhibition with
kynurenic acid (5 mM).
Application of 8-CPT (2µM) increased PF EPSP amplitude by 7.4 ± 5.6 % (n = 20)
with no effect on synaptic transmission or PPR observed in 9 of the 20 (45 %) slices
(figure 5.1A). In these 9 slices the effect of 8-CPT was confirmed by applying
adenosine (100 µM) in the presence of 8-CPT. This resulted in no reduction in EPSP
amplitude (figure 5.1B). In the slices where 8-CPT had an effect, EPSP amplitude
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was increased by 13.4 ± 2.6 % and the PPR was significantly decreased from 1.22 ±
0.03 to 1.16 ± 0.03 (n = 11, p < 0.001, figure 5.1C). The enhanced EPSP amplitude
could be attributed to block of A1R as addition of adenosine (100 µM) in the
presence of 8-CPT no longer blocked synaptic transmission. The overall increase in
EPSP amplitude (7.4 ± 5.6 %, n = 20) was significantly less (p < 0.001) than that
observed at mature PF-PC synapses at postnatal days 21-28 where EPSP amplitude
was increased by 45.6 ± 7.0 % in ~89 % slices (n = 8, figure 5.2) and see (Wall,
Atterbury et al. 2007).
The lower inhibitory A1R tone at immature PF-PC synapses is unlikely to be due to
developmental differences occurring within the age range tested (postnatal days 9-12)
as no increase in PF EPSP amplitude was observed with 8-CPT (2 µM) in at least
one animal at each postnatal day within this range.
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Figure 5.1 Tonic activation of A1R is low or absent at immature
parallel fibre-Purkinje cell synapses
(A) Superimposed averages of PF EPSPs from an immature cerebellar slice in
control, adenosine (100 µM) and 8-CPT (2 µM). (B) Graphs plotting amplitude of
individual EPSPs against time and PPR against time for the same experiment in an
immature (P12) cerebellar slice. Application of 8-CPT had little effect on EPSP
amplitude or PPR. Binding of 8-CPT to A1R was confirmed by no inhibition
following application of adenosine in the presence of 8-CPT. Identification of PF
EPSPs was confirmed by inhibition with kynurenic acid (5 mM). (C) Graphs
plotting amplitude of individual EPSPs against time and PPR against time for the
same experiment in an immature slice (P12). Application of 8-CPT enhanced EPSP
amplitude slightly and decreased PPR indicating a small tonic activation of
presynaptic inhibitory A1R.
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Figure 5.2 Comparison of adenosine tone at immature and mature
parallel fibre-Purkinje cell synapses
Graph comparing the increase in PF EPSP amplitude resulting from application of 8-
CPT (2 µM) to immature (P9-12, n = 20) and mature (P21-28, n = 8) cerebellar slices.
The increase in EPSP amplitude at immature synapses (7.4 ± 5.6 %) was
significantly less (p < 0.001) than that observed at mature synapses (45.6 ± 7.0 %).
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5.3 The low adenosine tone in immature slices does not
appear to result from changes in A1R expression or efficacy
The reduced adenosine tone at immature PF-PC synapses is unlikely to be the result
of a low A1R expression as only slices where adenosine (100 µM) inhibited EPSP
amplitude by at least 50 % were analysed. In addition the reduction in EPSP
amplitude with adenosine (100 µM) was similar (70.5 ± 5.4 % and 68.5 ± 4.7 %) in
the 9 immature slices where no inhibitory A1R tone was observed with 8-CPT and in
the 11 immature slices where 8-CPT increased EPSP amplitude by 13.4 ± 2.6 %
(figure 5.3A, B). Furthermore, the adenosine-mediated inhibition in immature slices
with no A1R tone is also not significantly different to the inhibition seen with
adenosine (61.5 ± 2.1 %) at mature synapses where EPSP amplitude was increased
by 45.6 ± 7.0 % with 8-CPT (figure 5.3C).
It has previously been described how differences in A1R-mediated inhibition in
immature slices may be the result of a variable A1R efficacy (see Chapter 4). To
confirm that the significantly reduced adenosine tone at immature PF-PC synapses in
comparison to mature synapses is not due to a lower A1R efficacy, a log
concentration-response curve for the non-hydrolysable A1R agonist N6-
cyclopentyladenosine (CPA) was generated at mature synapses and compared to the
curve produced in earlier experiments for immature synapses with an adenosine-
mediated inhibition greater than 50 % (figures 4.10, 5.4). The curves were almost
identical suggesting that the lower inhibitory A1R tone at immature PF-PC synapses
is unlikely to be the result of a lower A1R efficacy.
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Figure 5.3 A difference in A1R expression does not appear to
account for an absence in adenosine tone at immature synapses
Graphs comparing EPSP amplitude reduction with adenosine (100 µM) and increase
in EPSP amplitude following application of 8-CPT (2 µM) in cerebellar slices. There
is no difference in the inhibition with adenosine (70.5 ± 5.4 %) in immature (P9-12)
slices where no inhibitory A1R tone was observed with 8-CPT (A) and the inhibition
measured with adenosine (68.5 ± 4.7 %) in immature slices where 8-CPT increased
EPSP amplitude by 13.4 ± 2.6 % (B). The adenosine-mediated inhibition in
immature slices with no A1R tone is also not significantly different to the inhibition
seen with adenosine (61.5 ± 2.1 %) at mature synapses (P21-28) where EPSP
amplitude was increased by 45.6 ± 7.0 % with 8-CPT (C).
tone
no tone
mature slices
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Figure 5.4 A low adenosine tone at immature parallel fibre-
Purkinje cell synapses does not appear to be due to a lower A1R
efficacy
Log concentration-response curves for the reduction in PF EPSP amplitude by the
A1R agonist CPA (0.001 µM – 3 µM) in immature (P9-12, n = 6) and mature (P21-
28, n = 5) cerebellar slices. The curves and IC50 values were similar for both age
groups suggesting a minimal difference in A1R efficacy.
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5.4 There is a low concentration of extracellular adenosine
metabolites in immature slices
In the study using mature cerebellar slices (postnatal days 21-28) where an inhibitory
A1R tone was indicated by an increase in EPSP amplitude with 8-CPT,
microelectrode biosensors were placed into or above the slices to measure the
extracellular concentration of adenosine and its metabolites (Wall, Atterbury et al.
2007). The biosensors measured a purine tone of inosine and hypoxanthine although
the heterogeneous distribution of these metabolites resulted in the unreliable
calculation of an adenosine concentration. The concentration of inosine and
hypoxanthine could be lower in immature cerebellar slices if the low basal adenosine
tone is due to a rapid uptake of adenosine or reduced adenosine release to the
extracellular space. Alternatively, the concentration of inosine and hypoxanthine
may be higher if the reduced A1R tone is the result of an enhanced metabolism of
adenosine in the extracellular space.
The extracellular purine tone was measured using ADO biosensors containing the
enzymes adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP) and
xanthine oxidase (XO) to detect adenosine, inosine and hypoxanthine and INO
biosensors containing PNP and XO to detect inosine and hypoxanthine. In addition
null sensors containing a matrix with no enzymes were used to control for non-
specific electro-active interferents like 5-HT and noradrenaline.
For this study the biosensors were not inserted into the immature cerebellar slices
thus eliminating the possibility that any signal detected was due to the release of
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purines in response to tissue damage by the biosensors. Instead the extracellular
purine tone was measured in a non-invasive way by moving the biosensors close to
the surface of the slice over the molecular layer as done previously by Wall,
Atterbury et al (2007). As in this previous study the biosensors were bent so that
their longitudinal surface was parallel to the slice in order to increase the surface area
close to the tissue thereby increasing the detection of an extracellular purine tone.
A small rapid increase of 43.4 ± 4.1 pA was detected when ADO biosensors were
moved close to the surface of immature slices and a similar increase of 61.7 ± 18 pA
was detected using INO biosensors (n = 15, figure 5.5). Following corrections for
calibration (using 10 µM adenosine for ADO and 10 µM inosine for INO biosensors
before and after each experiment) there was no significant difference between the
current measured on either biosensor. As ADO biosensors detect adenosine, inosine
and hypoxanthine and INO biosensors detect inosine and hypoxanthine it can be
assumed that the small purine tone detected represents only inosine and
hypoxanthine in the immature slices (Wall, Atterbury et al. 2007).
Using the assumption that all of the extracellular purine tone measured by the
biosensors was inosine, the inosine concentration at the surface of immature slices
was calculated using the calibration data (current measured at slice surface/current
measured during calibration x concentration of inosine used in calibration).
The mean concentration of inosine at the immature slice surface was found to be 0.25
± 0.03 µM compared to 1.6 ± 0.3 µM at the surface of mature cerebellar slices at
postnatal days 21-28 (224.3 ± 35.9 pA increase in current, n = 8, figure 5.5). If the
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low inhibitory A1R tone in immature slices was the result of an enhanced metabolism
of extracellular adenosine in comparison to mature slices where an adenosine tone is
present, a higher concentration of extracellular metabolites would have been
expected (figure 5.6).
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Figure 5.5 There is a low concentration of extracellular adenosine
metabolites in immature slices
Example biosensor traces from experiments to measure the concentration of
adenosine metabolites at the surface of immature (P9) and mature (P23) cerebellar
slices. The INO biosensor was moved close to the surface of the slices over the
molecular layer. A rapid increase in current of ~350 pA (P23) and ~100 pA (P9) was
observed. The null sensor showed no change in current when moved close to the
surface of either slice (P23 illustrated).
138
0
1
2
3
P21-28
in
os
in
e
co
nc
en
tra
tio
n
(
M
)
P9-12
Figure 5.6 The low inhibitory A1R tone in immature slices is
unlikely to be the result of an enhanced metabolism of extracellular
adenosine in comparison to mature slices
The INO biosensor was moved close to the surface of immature (P9-12, n = 15) and
mature (P21-28, n = 8) cerebellar slices over the molecular layer. The mean
concentration of inosine at the surface of immature slices was found to be 0.25 ±
0.03 µM compared to 1.6 ± 0.3 µM at the surface of mature slices. The
concentration assumes that all of the current arises from inosine and is determined
following calibration of the biosensors.
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5.5 Confirmation of a low extracellular adenosine
metabolism in immature slices
The biosensor results suggest that the lack of an inhibitory A1R tone is unlikely to be
the result of an enhanced metabolism of extracellular adenosine in immature
cerebellar slices. To further investigate the role of the enzyme ectoADA that
catalyses the deamination of adenosine to inosine, extracellular recordings of PF
EPSPs were made in the presence of the ADA inhibitor erythro-9-(2-hydroxy-3-
nonyl) adenine (EHNA) (Agarwal 1982). If ADA is active in immature slices its
inhibition with EHNA should result in an increased extracellular concentration of
adenosine and a reduction in EPSP amplitude via activation of presynaptic A1R.
In immature slices application of EHNA (20 µM) inhibited synaptic transmission by
only 1.2 ± 1.6 % (range 0 to 12 %, n = 5, figure 5.7) and did not significantly affect
the PPR (1.33 ± 0.3 to 1.34 ± 0.3). In the one slice where an EPSP amplitude
reduction of 12 % was observed this could be reversed with application of 8-CPT (2
µM) in the presence of EHNA thus confirming an action of adenosine at presynaptic
A1R. Taken together with the INO biosensor data (figure 5.6), these results suggest
that the action of ADA is unlikely to contribute to the low inhibitory A1R tone
observed in immature slices. A small EPSP amplitude reduction of 1.2 ± 0.7 % was
also observed in mature slices (n = 6, figure 5.14) and the activity of ADA was not
found to be a major regulator of extracellular adenosine tone in a previous study
using mature cerebellar slices (Wall, Atterbury et al. 2007).
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Figure 5.7 Inhibition of adenosine deaminase has little effect on
synaptic transmission in immature slices
(A) Graph plotting amplitude of individual EPSPs against time an immature (P12)
cerebellar slice. Although adenosine (100 µM) inhibited synaptic transmission by
~50 %, application of EHNA (20 µM) to block adenosine deaminase (ADA) activity
had no effect on EPSP amplitude. Identification of PF EPSPs was confirmed by
inhibition with kynurenic acid (5mM). (B) Graph plotting PPR against time for the
same experiment. Application of adenosine increased PPR indicating activation of
presynaptic inhibitory A1R. Inhibition of ADA with EHNA had no effect on PPR.
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5.6 Inhibition of equilibrative transport has a variable
effect on synaptic transmission in immature slices
If the reduced adenosine tone at immature PF-PC synapses is not the result of
enhanced extracellular adenosine metabolism by ADA it may be due to the rapid
transport of adenosine across neuronal or glial membranes by facilitated diffusion
using the equilibrative transporters ENT1 or ENT2. The effect of these proteins has
previously been found to be variable at mature rat PF-PC synapses (Wall, Atterbury
et al. 2007) using 6-[(4-nitrobenzyl)thiol]-9-β-D-ribofuranosylpurine (NBTI) to 
inhibit ENT1 transporters and dipyridamole to inhibit both ENT1 and ENT2 proteins
(Cass, Young et al. 1998). If the activity of ENT1 or ENT2 is enhanced in immature
slices their inhibition with NBTI/dipyridamole should result in an increased
extracellular concentration of adenosine and a reduction in EPSP amplitude via
activation of presynaptic A1R.
In immature slices application of NBTI (5 µM) and dipyridamole (10 µM) for 30
minutes inhibited EPSP amplitude by 16.9 ± 3.5 % (n = 31) although no effect on
synaptic transmission was observed in 15 of these slices. In the 16 slices where
inhibition was observed the mean reduction in EPSP amplitude was 32.7 ± 4.0 %
with an increase in PPR from 1.4 ± 0.05 to 1.6 ± 0.08 (figure 5.8B) indicating the
action of increased extracellular adenosine on presynaptic A1R. To confirm
activation of A1R the inhibition observed with NBTI/dipyridamole could be reversed
with application of the A1R antagonist 8-CPT (2 µM, figure 5.8A). A similar
reduction in EPSP amplitude of 37.5 ± 6.9 % was observed in 6 mature slices (figure
5.14) and the variability in response to application of NBTI/dipyridamole was similar
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to that observed in a previous study using mature slices where EPSP amplitude was
reduced by 47 ± 8 % in 9 out of 18 slices (Wall, Atterbury et al. 2007). There was no
correlation between the reduction in EPSP amplitude with NBTI/dipyridamole and
the absence of an inhibitory A1R tone in the immature slices.
Although previous experiments suggest that the activity of ADA is unlikely to be a
major regulator of extracellular adenosine tone in immature slices, any increased
extracellular adenosine resulting from the inhibition of equilibrative transporter
proteins may be metabolised to inosine by ADA before activating presynaptic A1R at
PF-PC synapses to inhibit synaptic transmission. If this is the case application of
EHNA with NBTI/dipyridamole should result in a reduction in EPSP amplitude.
In immature slices NBTI (5 µM) and dipyridamole (10 µM) were applied for 30
minutes prior to the addition of EHNA (20 µM, n = 9). In 6 of the 9 slices neither
application of NBTI/dipyridamole nor the addition of EHNA in the presence of
NBTI/dipyridamole had an effect on synaptic transmission (figure 5.9A). In the
remaining 3 slices NBTI/dipyridamole inhibited EPSP amplitude by 30.0 ± 0.5 %
and application of EHNA in the presence of NBTI/dipyridamole produced a further
inhibition of 27.0 ± 3.0 % (figure 5.9B) suggesting that some of the increased
extracellular adenosine resulting from blockade of ENT1 and ENT2 was metabolised
to inosine by ADA. To confirm activation of A1R the inhibition observed with
NBTI/dipyridamole and EHNA could be reversed with application of the A1R
antagonist 8-CPT (2 µM, figure 5.9B).
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Figure 5.8 Inhibition of equilibrative transport has little effect on
synaptic transmission
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. Adenosine (100 µM) inhibited synaptic transmission by ~50 % and
application of NBTI (5 µM) and dipyridamole (10 µM) to block equilibrative
transport inhibited EPSP amplitude ~15 % and was reversed with application of 8-
CPT (2 µM). Identification of PF EPSPs was confirmed by inhibition with
kynurenic acid (5 mM). (B) Graph plotting PPR against time for the same
experiment. Application of NBTI and dipyridamole increased PPR and application
of 8-CPT at the same time decreased PPR indicating activation of presynaptic
inhibitory A1R.
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Figure 5.9 Some extracellular adenosine is metabolised when
equilibrative transporter proteins are inhibited
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. Adenosine (100 µM) inhibited synaptic transmission by ~50 % but
application of NBTI (5 µM) and dipyridamole (10 µM) to block equilibrative
transport and EHNA (20 µM) in the presence of NBTI/dipyridamole had no effect on
synaptic transmission. Identification of PF EPSPs was confirmed by inhibition with
kynurenic acid (5mM) (B) Graph plotting amplitude of individual EPSPs against
time an immature (P11) slice. Adenosine (100 µM) inhibited synaptic transmission
by ~70 % and application of NBTI/dipyridamole inhibited EPSP amplitude by ~30%.
EPSP amplitude was reduced further by ~15 % with EHNA in the presence of
NBTI/dipyridamole. The block was reversed with application of 8-CPT (2 µM).
Inset (red box area) illustrates that EPSP amplitude had stabilised prior to application
of EHNA.
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5.7 Inhibition of intracellular adenosine conversion has
minor effects on the inhibitory adenosine tone in immature
slices
It appears unlikely that the lack of an inhibitory A1R tone in immature slices is due to
the rapid removal of adenosine from the extracellular space by metabolism to inosine
with ADA or by facilitated transport via ENT1 or ENT2. It is possible that the low
adenosine tone could be the result of enhanced intracellular phosphorylation of
adenosine by adenosine kinase (AK) to form AMP thereby preventing adenosine
efflux via equilibrative transporters (Boison 2006). If AK is active in immature
slices its inhibition with iodotubericidin should increase the intracellular adenosine
concentration resulting in the facilitative release of adenosine along its concentration
gradient to the extracellular space via equilibrative transporter proteins and the
subsequent reduction in EPSP amplitude via presynaptic A1R at PF-PC synapses
(Latini and Pedata 2001).
In immature slices application of iodotubericidin (2 µM) inhibited EPSP amplitude
by 25 ± 3 % and increased the PPR from 1.3 ± 0.1 to 1.5 ± 0.1 in 14 out of 21
(~67 %) slices indicating an action at presynaptic A1R at PF-PC synapses.
Activation of A1R was confirmed by reversal of inhibition with the A1R antagonist 8-
CPT (2 µM) (figure 5.10). In the remaining 7 slices iodotubericidin had no effect on
synaptic transmission. The inhibition in synaptic transmission was significantly
smaller and less reliable than that observed in mature slices (51.0 ± 2.0 %, p < 0.05,
n = 10, figure 5.14).
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The increased extracellular adenosine resulting from the inhibition of AK may be
metabolised to inosine by ADA before activating presynaptic A1R at PF-PC synapses
to inhibit synaptic transmission. If this is the case application of EHNA with
iodotubericidin should result in a greater reduction in EPSP amplitude than observed
with iodotubericidin alone. In immature slices co-application of EHNA (20 µM) and
iodotubericidin (2 µM) inhibited EPSP amplitude by 50.7 ± 7.8 % and increased PPR
from 1.4 ± 0.07 to 1.6 ± 0.1 (n = 6, figure 5.11). The inhibition of synaptic
transmission was significantly higher than that observed with iodotubericidin alone
(25 ± 3 %, p < 0.05) and could be reversed with application of 8-CPT (2 µM) to
confirm activation of presynaptic A1R. A similar reduction in EPSP amplitude of 54
± 3.5 % following co-application of EHNA and iodotubericidin was also observed in
mature slices (n = 3, figure 5.14).
To look at the effect of metabolism on the increased extracellular adenosine resulting
from the inhibition of AK in more detail, iodotubericidin (2 µM) was applied to
immature slices prior to co-application of iodotubercidin and EHNA (20 µM).
Application of EHNA had little or no effect on synaptic transmission in 3 slices
(figure 5.12A) but inhibited EPSP amplitude by 47.6 ± 4.2 % in another 4 slices
(figure 5.12 B).
To investigate whether the equilibrative transporters facilitate any increase in
extracellular adenosine during the inhibition of AK by iodotubericidin, the
transporter proteins ENT1 and ENT2 were blocked with application of
NBTI/dipyridamole prior to application of iodotubericidin in immature slices. In 4
out of 10 slices neither application of NBTI (5 µM) and dipyridamole (10 µM) nor
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application of iodotubericidin (2 µM) in the presence of NBTI/dipyridamole had an
effect on synaptic transmission suggesting that there was little or no transport of
adenosine via equilibrative proteins in these slices (figure 5.13A). In the remaining 6
slices the inhibition resulting from AK block was not prevented by prior application
of NBTI/dipyridamole and EPSP amplitude was still inhibited by 25.3 ± 3.5 % with
iodotubericidin (figure 5.13B).
In mature cerebellar slices effective block of equilibrative transporters by
NBTI/dipyridamole to prevent the efflux of an increased intracellular adenosine
concentration due to inhibition of AK by iodotubericidin was only observed in 4 out
of 8 slices suggesting a heterogeneous distribution of NBTI/dipyridamole-sensitive
transporters at PF-PC synapses (Wall, Atterbury et al. 2007).
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Figure 5.10 Inhibition of adenosine kinase has minor effects on
synaptic transmission
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P10)
cerebellar slice. Adenosine (100 µM) inhibited synaptic transmission by ~50 % and
application of iodotubericidin (2 µM) to block adenosine kinase inhibited EPSP
amplitude by ~30 % and was reversed with application of 8-CPT (2 µM).
Identification of PF EPSPs was confirmed by inhibition with kynurenic acid (5 mM).
(B) Graph plotting PPR against time for the same experiment. Application of
iodotubericidin increased PPR and application of 8-CPT at the same time decreased
PPR indicating activation of presynaptic inhibitory A1R.
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Figure 5.11 Inhibition of adenosine kinase and adenosine deaminase
inhibits synaptic transmission in some immature slices
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. Adenosine (100 µM) inhibited synaptic transmission by ~80 % and
application of iodotubericidin (2 µM) with EHNA (20 µM) to block adenosine
kinase and adenosine deaminase inhibited EPSP amplitude by ~50 % and was
reversed with application of 8-CPT (2 µM). Identification of PF EPSPs was
confirmed by inhibition with kynurenic acid (5mM). (B) Graph plotting PPR
against time for the same experiment. Application of iodotubericidin and EHNA
increased PPR and application of 8-CPT at the same time decreased PPR indicating
activation of presynaptic inhibitory A1R.
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Figure 5.12 Inhibition of adenosine kinase and adenosine deaminase
in immature slices
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P12)
cerebellar slice. Adenosine (100 µM) inhibited synaptic transmission by ~50 % and
application of iodotubericidin (2 µM) to block adenosine kinase inhibited EPSP
amplitude by ~20 %. Co-application of EHNA (20 µM) with iodotubericidin did not
increase the block which was reversed with application of 8-CPT (2 µM).
Identification of PF EPSPs was confirmed by inhibition with kynurenic acid (5mM).
(B) Graph plotting amplitude of individual EPSPs against time an immature (P12)
slice. Application of iodotubericidin inhibited EPSP amplitude by ~15 %. Co-
application of EHNA with iodotubericidin produced a marked increase in EPSP
amplitude reduction which was reversed with application of 8-CPT.
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Figure 5.13 Inhibition of equilibrative transporters had a variable
effect on the effect of iodotubericidin in immature slices
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P9)
cerebellar slice. Adenosine (100 µM) inhibited synaptic transmission by ~80 % and
application of NBTI (5 µM) and dipyridamole (10 µM) to block equilibrative
transporters had no effect. Co-application of iodotubericidin (2 µM) with
NBTI/dipyridamole also had no effect on EPSP amplitude. Identification of PF
EPSPs was confirmed by inhibition with kynurenic acid (5mM). (B) Graph plotting
amplitude of individual EPSPs against time an immature (P12) slice. Pre-incubation
with NBTI/dipyridamole (not illustrated) did not prevent inhibition with
iodotubericidin. The block was reversed with application of 8-CPT (2 µM)
demonstrating activation of presynaptic A1R.
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Figure 5.14 Comparison of the effects of interrupting adenosine
clearance at immature and mature parallel fibre-Purkinje cell
synapses
Graph comparing the inhibition of PF EPSP amplitude resulting from application of
EHNA (20 µM) to immature (P9-12, n = 5) and mature (P21-28, n = 6) cerebellar
slices, NBTI (5 µM) and dipyridamole (10 µM) to immature (n = 16) and mature (n
= 6) slices, iodotubericidin (2 µM) to immature (n = 14) and mature (n = 10) slices
and co-application of EHNA and iodotubericidin to immature (n = 6) and mature (n
=3) slices where application of adenosine (100 µM) inhibited synaptic transmission
by at least 50 %. ANOVA shows no significant difference between the groups (p =
0.89).
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5.8 Adenosine release is delayed and slower at immature
parallel fibre-Purkinje cell synapses during hypoxia
These results demonstrate that the tonic inhibition of PF-PC synapses by endogenous
adenosine is greatly reduced or absent in immature cerebellar slices and that blocking
the clearance of adenosine via metabolism or equilibrative transporters has little
effect on the inhibitory tone. As this suggests that there is little release of adenosine
under basal conditions, hypoxia and electrical stimulation were used to investigate
the active release of adenosine in immature slices.
A 10 min period of hypoxia in immature slices reduced PF EPSP amplitude by 64 ±
7 % at steady state and increased PPR from 1.25 ± 0.04 to 1.8 ± 0.1 suggesting
activation of A1R (n = 11). This was confirmed by reversal of inhibition with
application of the A1R antagonist 8-CPT (2 µM, figure 5.15A). As an indication of
the speed of increase in extracellular adenosine concentration during hypoxia the
delay until the start of EPSP amplitude reduction was 3.7 ± 0.6 min with a steady
state reached after 5.4 ± 0.7 min from the start of hypoxia. Re-oxygenation reversed
the inhibition after 5.3 ± 0.5 min (n = 8).
A 10 min period of hypoxia in mature slices (P21-28) rapidly reduced PF EPSP
amplitude by 81.3 ± 6.6 % at steady state although this could only be reversed with
application of 8-CPT in 2 out of 5 slices. This is unlikely to indicate a mechanism of
inhibition other than via presynaptic A1R as reversal of EPSP amplitude depression
(73.0 ± 5.4 %) was observed in 6 out of 8 slices following a shorter period of
hypoxia (5 min, figure 5.15B). In slices where reversal of inhibition was observed
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with 8-CPT, the speed of increase in extracellular adenosine to a steady state was
double that measured in immature slices (2.3 ± 0.3 min, n = 8) with a delay until the
start of EPSP amplitude reduction of only 1.1 ± 0.4 min.
The purine release during hypoxia was measured with ADO, INO and null
biosensors held over the molecular layer close to the slice surface. As previously
described the biosensors were bent so that their longitudinal surface was parallel to
the surface of the slice. A 10 min period of hypoxia produced a large current on
ADO and INO biosensors in both immature and mature slices resulting from the
release of purines as no current change was observed on the null biosensors (figure
5.16). Following corrections for calibration (using 10 µM adenosine for ADO and
10 µM inosine for INO biosensors before and after each experiment) there was no
significant difference between the current measured on either biosensor in terms of
rise or amplitude. As ADO biosensors detect adenosine, inosine and hypoxanthine
and INO biosensors detect inosine and hypoxanthine it can be assumed that the
biosensors detected the adenosine metabolites inosine and hypoxanthine.
Using the assumption that the all of the purine release measured by the biosensors
was inosine, the maximum inosine concentration at the slice surface following
hypoxia was calculated using the calibration data (current measured at slice
surface/current measured during calibration x concentration of inosine used in
calibration). The mean maximum concentration of inosine at the surface of mature
slices was found to be significantly greater (5.5 ± 0.7 µM, p > 0.05, n = 8) than at
immature cerebellar slices (3.5 ± 0.4 µM, n = 8). The bath inflow and outflow
speeds were exactly the same for mature and immature slices so this difference is
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most likely to be due to the greater delay in the start of purine release and slower rise
in purine concentration resulting in the sensor current not reaching steady state after
10 mins of hypoxia in all 8 immature slices but reaching a plateau after 5.3 ± 0.5 min
in the mature slices (figure 5.16). It is possible that adenosine release is delayed in
immature slices due to better maintenance of ATP levels. The peak of ATP release
during ischemia is smaller and delayed in hippocampal slices from younger rats
(Frenguelli, Wigmore et al. 2007).
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Figure 5.15 Inhibition is delayed or reduced during hypoxia in
immature slices
(A) Graph plotting amplitude of individual EPSPs against time in an immature (P11)
cerebellar slice during perfusion with aCSF bubbled with N2 (95 %)-CO2 (5 %) for
10 min. Hypoxia caused a slow reduction in EPSP amplitude of ~45 % which was
reversed with the antagonist 8-CPT demonstrating activation of presynaptic A1R.
Identification of PF EPSPs was confirmed by inhibition with kynurenic acid (5 mM).
(B) Graph plotting amplitude of individual EPSPs against time for the same
experiment in a mature (P22) slice. The reduction in EPSP amplitude was larger and
more rapid than in the immature slice. Inhibition was reversed with 8-CPT to an
EPSP amplitude higher than in control due to the presence of an inhibitory A1R tone
at PF-PC synapses.
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Figure 5.16 Release of adenosine is delayed or reduced during
hypoxia in immature slices
Example ADO biosensor traces from experiments to measure the concentration of
adenosine metabolites at the surface of immature (P11) and mature (P22) cerebellar
slices during perfusion with aCSF bubbled with N2 (95 %)-CO2 (5 %) for 10 min. (A)
Hypoxia caused an increase in extracellular purine concentration for both slices. The
null sensor showed no change in current when moved close to the surface of either
slice (P22 illustrated). (B) Traces from A expanded to show the greater delay in the
start of purine release and slower rise in purine concentration during hypoxia in the
immature slice.
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5.9 Trains of activity do not release adenosine at
immature parallel fibre-Purkinje cell synapses
During trains of stimuli (30 EPSPs, 20 Hz) transmission in slices from immature rats
was facilitated and then depressed (n = 6, figure 5.17). The PF EPSP amplitude was
increased to a maximum of 155 ± 8.0 % of the first EPSP amplitude at around the
14th EPSP and then decreased to approximately the same level as the first EPSP
amplitude by the 30th EPSP. In subsequent experiments by Mark Wall measuring
100 EPSPs (20 Hz) rather than 30 in immature slices, the EPSP amplitude was
facilitated in a similar way (maximum of 157 ± 10.9 % by the 10th EPSP) and was
found to decrease to an amplitude less than the 1st EPSP amplitude by around the 70th
EPSP (Atterbury and Wall 2009). An earlier study described a peak enhancement of
EPSP amplitude relative to the first EPSP of up to 250 % in immature cerebellar
slices during trains of activity at 50 Hz (Kreitzer and Regehr 2000).
Application of the A1R antagonist 8-CPT relieves the inhibition of EPSC amplitude
at the Calyx of Held synapse observed during repetitive stimulation in rat brainstem
slices. This suggests that endogenous adenosine inhibits EPSCs via activation of
presynaptic A1R during high frequency activity to change the probability of release
thus limiting transmitter depletion and allowing synaptic transmission to be
maintained during trains of stimuli (Kimura, Saitoh et al. 2003). It has previously
been described that adenosine that has been formed intracellularly may be released
into the extracellular space of mature cerebellar slices in a neuronal activity-
dependent manner (Wall and Dale 2007). As little or no adenosine tone is present at
immature PF-PC synapses if the trains of stimuli applied to the immature slices had
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resulted in an activation of presynaptic A1R due to a direct release of adenosine it
would be expected that application of 8-CPT would have an effect on the facilitation
and depression of EPSP amplitudes recorded.
Application of 8-CPT (2 µM) to block A1R during trains of stimuli (30 EPSPs, 20 Hz)
had no significant effect on the amplitude of EPSPs. The PF EPSP amplitude was
initially facilitated to a maximum of 157 ± 12.2 % of the first EPSP amplitude at
around the 16th EPSP and then decreased to approximately the same level as the first
EPSP amplitude by the 30th EPSP (figure 5.17). Subsequent experiments by Mark
Wall measuring the effect of 8-CPT (2 µM) during trains of stimuli of 100 EPSPs
(20 Hz) also demonstrated no significant effect of A1R blockade during EPSP
facilitation and depression (Atterbury and Wall 2009). In addition to confirming an
absence of adenosine tone these results also indicate that there is no significant
adenosine release during trains of stimuli in immature slices.
ADO, INO and null biosensors placed over the molecular layer close to the slice
surface were used to confirm that no adenosine was released during trains of
electrical stimuli in immature slices. The response of the null sensor and ADO/INO
sensors were indistinguishable even with prolonged high frequency stimulation in the
molecular layer of immature slices (200 stimuli, 20-40 Hz, n = 15). In comparison,
trains of stimuli (200 stimuli, 20 Hz) in mature slices produced a current on an ADO
biosensor in 4 out of 4 slices (figure 5.18). This is comparable to the previously
reported reliable activity-dependent release of adenosine at parallel fibre-Purkinje
cell synapses in mature rats (Wall and Dale 2007).
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Figure 5.17 Blocking A1R has no significant effect on synaptic
transmission during trains of activity in immature slices
(A) A graph plotting normalised EPSP amplitude (relative to first EPSP amplitude)
against stimulus number in control and 8-CPT (2 µM) during trains of activity (20
Hz) at immature (P9-12) PF-PC synapses (n = 6). (B) A graph using data from
Mark Wall (Atterbury and Wall 2009) for comparison with (A) plotting normalised
EPSP amplitude (relative to first EPSP amplitude) against stimulus number in control,
adenosine (100 µM) and 8-CPT (2 µM) during trains of activity (20 Hz) at mature
(P24-28) PF-PC synapses (n = 5). Addition of adenosine (100 µM) caused a marked
increase in the degree of facilitation. Addition of 8-CPT (2 µM) caused a small
reduction in facilitation followed by almost complete depression of transmission of
EPSP amplitude and then recovery to ~50 % of the first EPSP.
A P9-12
161
P12ADO
25 s
25 pA
ADO
electrical
stimulation
P22
Figure 5.18 Trains of activity do not release adenosine at immature
parallel fibre-Purkinje cell synapses
Example ADO biosensor traces from experiments to measure the release of
adenosine metabolites at the surface of immature (P12) and mature (P22) cerebellar
slices during trains of activity. Electrical stimulation (bar, 20 Hz) caused an increase
in extracellular purine concentration in a mature slice but no detectable release in a
P12 slice.
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5.10 Summary
The effect of the A1R antagonist 8-CPT on PF EPSP amplitude was investigated in
immature rat cerebellar slices at postnatal days 9-12. Application of 8-CPT had a
significantly smaller effect on EPSP amplitude than in mature slices and suggested
that an inhibitory adenosine tone is low or absent at this stage of development.
The reduced adenosine tone at immature synapses is unlikely to be the result of a low
A1R expression as only slices where adenosine inhibited synaptic transmission were
used. A log concentration-response curve generated for the A1R agonist CPA in
immature slices was very similar to that generated in mature slices suggesting that
the low adenosine tone is also not due to developmental differences in A1R efficacy.
Inhibition of adenosine clearance via adenosine deaminase, adenosine kinase and
equilibrative transporters had little effect on synaptic transmission suggesting that
little adenosine is moving between the intracellular and extracellular spaces under
basal conditions. Active adenosine release measured by EPSP amplitude reduction
and microelectrode biosensors could be stimulated with hypoxia in immature slices
but this was delayed and slower in comparison to the release observed in mature
slices. Adenosine could not be actively released at immature PF-PC synapses in
response to electrical stimulation in the molecular layer.
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Chapter 6 Discussion
6.1 The presence and distribution of A1R and A2AR in the
rat cerebellum at different stages of development
6.1.1 Summary of key findings
 A1R and mGluR4 are widely distributed across Purkinje cell bodies and their
dendrites and within the granule layer of the cerebellum throughout postnatal
development.
 There is only minor co-localisation of A1R and mGluR4 with glial cell bodies or
their processes, eliminating their involvement in the staining observed.
 A2AR are widely distributed within cerebellar slices with co-localisation identical to
that of A1R. A role for A2AR has not previously been described within the
cerebellum.
6.1.2 Confirmation of antibody specificity
Immunohistochemistry revealed punctate staining for A1R (1:100) only in those
CHO cells expressing GFP with no obvious background staining (figure 3.2).
Although this result provides a control for specificity of the A1R primary antibody, it
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only confirms that the A1R antibody does not bind non-specifically to any native
CHO cell proteins in a well containing only CHO cells. It should therefore not be
assumed that all staining observed with this antibody in cerebellar slices is specific,
as cerebellar slices are densely packed with many cell types expressing different
proteins that the A1R antibody may recognise.
In the CHO cell control experiments not all of the cells expressing GFP were stained
for A1R. This could be because the affinity of the A1R antibody may be low or the
secondary antibody binding may not be optimal. Alternatively, the Triton X100
concentration may be too low for complete permeabilisation of the CHO cells, in
order to access the intracellular C-terminal of the A1R for antibody binding although
this seems unlikely as the concentration of Triton X100 was quite high (0.4 %).
No primary antibody specificity controls were conducted during this study for A2AR
or mGluR4 primary antibodies in CHO cells although the manufacturer’s
information for each states that these antibodies have been tested for specificity in rat
tissue using Western blot. Sufficient controls for secondary antibody specificity and
cross-over reactions have been carried out in this study (figure 3.12, 3.13).
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6.1.3 Interpretation of the immunofluorescence for A1R, mGluR4
and A2AR in mature and immature cerebellar slices
Although immunofluorescence could be replicated using an alternative protocol, care
should be taken in the interpretation of the immunohistochemistry in this study for
the reasons outlined below.
Both immature (P8-14) and mature (P21-28) cerebellar slices showed co-localisation
for A1R and mGluR4 across a large number of Purkinje cell bodies (figures 3.3, 3.4).
Dense staining for A1R at Purkinje cell bodies is unusual as many
electrophysiological studies describe the modulation of Purkinje cell activity via
activation of presynaptic A1R (Burnstock 2006) but none suggest the presence of
A1R on Purkinje cell bodies. There is also no reported electrophysiological evidence
for the presence of mGluR4 at Purkinje cell bodies and previous immunoreactivity
studies also indicate no such co-localisation (Kinoshita, Ohishi et al. 1996; Mateos,
Azkue et al. 1998).
Triple immunohistochemistry with GFAP eliminated the possibility of the presence
of these receptors on Bergmann glial cell bodies overlapping Purkinje cell bodies
(figure 3.7). However, an earlier immunohistochemical study explained the very
light A1R staining of Purkinje cell bodies as the result of A1R expression on basket
cell processes that synapse with Purkinje cell bodies (Rivkees, Price et al. 1995). It
is possible that A1R on basket cell processes enveloping Purkinje cell bodies would
account for some but not all of the staining observed in this study as many cells are
densely stained. There is also no evidence for the presence of mGluR4 on basket
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cell processes so mGluR4 staining at Purkinje cell bodies is unlikely to be explained
in the same way.
The difference in Purkinje cell body staining between studies may be the result of
different fixation and staining methodologies. The Rivkees study fixed brain tissue
in-situ by perfusion with 5 % paraformaldehyde (PFA) in contrast to this study which
fixed isolated brain tissue with 4 % PFA. Similarly, the previous mGluR4
immunoreactivity studies fixed brain tissue in situ by perfusion with 4 % PFA
(Kinoshita, Ohishi et al. 1996; Mateos, Azkue et al. 1998). Both PFA concentration
and fixation via perfusion have been reported to impact on antibody affinity and
selectivity (Fritschy 2008). The difference in the intensity of Purkinje cell body
staining may alternatively be due to the sensitivity of alternative detection methods
to immunofluorescence. The Rivkees A1R study used peroxidise anti-peroxidise
(PAP)/3,3’ diaminobenzidine (DAB) detection and the two mGluR4 studies used an
alkaline phosphatase-labelled secondary antibody and an immunogold labelling
method.
The dense A1R staining of rat Purkinje cell bodies is comparable with that of another
immunofluorescence study using a different A1R antibody that is generated in mice
(Yoshioka, Hosoda et al. 2002), suggesting that the staining observed in this study is
not specific to the particular A1R antibody used. The possibility of yielding false-
positive results within brain tissue when using concentrations of Triton X100 greater
than 0.1 – 0.2 % (Weruaga, Alonso et al. 1998) may explain the dense Purkinje cell
body staining observed in this study (0.4 % Triton X100) and the Yoshioka study
(0.5 % Triton X100) but not in the earlier A1R study (Rivkees, Price et al. 1995)
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(0.02 % Triton) or the mGluR4 immunoreactivity studies (Kinoshita, Ohishi et al.
1996; Mateos, Azkue et al. 1998) (no Triton). The alternative protocol (personal
correspondence, Frenguelli lab) used in this study to confirm A1R antibody staining
also used a higher concentration of Triton X100 (0.5 %). However, the specificity
and possible low affinity of the A1R antibody was confirmed in CHO cells
transfected with a GFP-tagged A1R construct when using 0.4 % Triton (figure 3.2).
The permeabilisation of cells with Triton X100 in order to allow the A1R and
mGluR4 antibodies access to the intracellular C-terminals to which they bind may
also result in contact with intracellular membrane compartments through which these
molecules are shipped to the cell surface and binding to A1R or mGluR4 proteins that
may be present internally but are not trafficked to the cell surface. This, in theory,
could be overcome by using antibodies generated against the extracellular N-terminal
of these receptors and no Triton X100. However, although available, no N-terminal-
directed antibodies for these receptors have yet been reported as specific.
The use of Triton X100 may explain the differential staining patterns for A1R at
Purkinje dendrites (figure 3.6). Areas of dendrites with no staining may be due to
insufficient permeabilisation with Triton X100. However, cerebellar slices were
agitated for one hour during incubation with primary antibody before being left
overnight at 4°C which should minimise this risk.
The primary antibodies calbindin and GFAP are commonly used in
immunohistochemical studies of brain tissue. The fact that their immunoreactivity
observed in this study is comparable to that observed in other cerebellar sections, for
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example (Nakamura and Uchihara 2004), provides an indicator of reliability for the
methodology although does not take into consideration specificity issues or cross-
over reactions that may be occurring with primary antibodies against A1R or
mGluR4. It has also recently been reported that antibodies against G-protein coupled
receptors (GPCR) such as A1R and mGluR4 are generally considered unreliable
unless data is accompanied by rigorous controls such as the absence of staining in
knockout mice. This particular review reports that in 49 antibodies against various
GPCR tested none were found to be selective and that this may be due to the
antibodies recognising structural similarities not just between members of the same
family (for example, A1R, A2AR, A2BR and A3R) but between the family of GPCR as
a whole (Michel, Wieland et al. 2009). This may explain the identical mGluR4 and
A1R staining in cerebellar slices and the unexpected widespread distribution of A2AR
similar to that of A1R. The primary antibodies used in this study for A1R, A2AR and
mGluR4 have, however, been generated against the less conserved C-terminal
regions.
As a further consideration, the widespread immunoreactivity for A1R, A2AR and
mGluR4 in cerebellar slices may be the result of damage caused to cells in the
cerebellar tissue during the sectioning process as mechanical lesions to histological
sections are known to increase the risk of non-specific binding of IgGs (Fritschy
2008).
Given the factors that are potentially affecting the immunohistochemical results in
this study, it is unwise to draw strong conclusions from any of the data without first
performing more thorough controls for each primary antibody. This is of particular
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importance given that staining for A2AR was contradictory to previous
immunohistochemical and hybridisation studies (Svenningsson, Le Moine et al. 1997;
Rosin, Robeva et al. 1998) and that there is no reported functional role for A2AR in
the cerebellum. However, calcium signalling due to A2AR activation has recently
been described in mouse olfactory bulb glial cells (Doengi, Deitmer et al. 2008) and
staining for A2AR was present on glial cell processes (figure 3.11) in this study. The
electrophysiological data in this study suggests that all the actions of adenosine on
PF EPSPs are via the activation of A1R with no evidence for A2AR activation (figure
4.8). Thus if the widespread A2AR staining within the molecular layer is real perhaps
it plays some other role perhaps in interneurone signalling.
Staining for the parallel fibre marker, mGluR4, around and over Purkinje cell bodies
at an early developmental stage (figure 3.9) prior to the formation of functional PF-
PC synapses (Altman 1972; Arata and Ito 2004), that is identical to the staining
observed for A1R at this age (figure 3.8) provides a further indicator that the primary
antibodies may be binding non-specifically. It is possible that the A1R staining is
associated with climbing fibres shown to be present (Press and Wall 2008) and
functional (Hashimoto and Kano 2003) at postnatal day 4 but there are no reports of
mGluR4 expression by climbing fibres at any stage of cerebellar development.
6.1.4 Future work
The specificity of the A1R antibody for this study was confirmed in CHO cells
transfected with A1R tagged with GFP (figure 3.2). The possibility of antibody
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cross-reaction between subtypes of the adenosine receptor family could be
eliminated by testing the A1R or A2AR antibody in CHO cells transfected with A1R,
A2AR, A2BR and A3R (Rivkees, Price et al. 1995).
Accurate interpretation of the immunohistochemistry results in this study would
require further experiments to establish the specificity of the A1R, A2AR and mGluR4
primary antibodies. This could primarily be attempted by proving that each antibody
stains only one band corresponding to the size of the relevant receptor on a Western
blot. The process could then be applied to tissue preparations from cerebellar slices
at different points from birth to postnatal day 21 to establish A1R, A2AR and mGluR4
protein levels during development as the immunohistochemistry is difficult to
quantify.
A complete absence of staining for the corresponding antibody in cerebellar sections
obtained from an A1R, A2AR or mGluR4 knockout mice would provide the most
convincing control and give significant weight to the reliability of the confocal
images obtained in this study. As a minor point, this study used cerebellar tissue
from rats so even a comparison with mouse tissue would not be definitive. In
addition, antibody staining may still be observed in a knockout animal if a truncated
version of the protein is expressed or other homologous proteins that cross-react with
the primary antibody are upregulated by the knockout (Lorincz and Nusser 2008).
The reactivity of the primary antibodies used in this study with mouse tissue would
also need to be considered.
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A more cost-effective control would be to demonstrate a loss of staining when the
primary antibody is pre-incubated with the synthetic peptide used to immunise the
animal in which it was generated (possible for A1R, A2AR and mGluR4 primary
antibodies used in this study) thus indicating that the antibody is antigen-specific.
Alternatively, in-situ hybridisation could be used as a control by comparing primary
antibody immunoreactivity with the pattern of mRNA expression.
To address the possibility of A1R staining on Purkinje cell bodies being the result of
A1R present on basket cell processes enveloping Purkinje cells,
immunohistochemistry using primary antibodies against calbindin, A1R and a basket
cell protein could be used. A possible antibody marker for basket cells would be the
voltage-gated K+ channel subunit Kv1.2 which is most densely localised to basket
cells in the rat cerebellum (Chung, Shin et al. 2001). However, triple
immunofluorescence would not be a possibility as this is only available as a primary
antibody generated in the rabbit.
The potential for the staining of A1R at proximal Purkinje cell dendrites (figure 3.6)
to be located on climbing fibres and not parallel fibres, especially prior to PF-PC
synapse formation (figure 3.8), could be investigated with immunohistochemistry.
The use of a vGluT2 primary antibody would not be an ideal marker to distinguish
climbing fibres from parallel fibres as vGluT2 is also expressed at parallel fibre
terminals and gradually replaced with vGluT1 until postnatal day 30 (Miyazaki,
Fukaya et al. 2003). The CART peptide has been found to be localised to climbing
fibres within the vestibular cerebellum (Press and Wall 2008) so a primary antibody
against this peptide could be used as an alternative marker for these climbing fibres
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during development. Immunohistochemistry using cerebellar slices from birth until
postnatal day 2 could also be attempted.
The inhibition of CF EPSCs following application of adenosine has already been
demonstrated in rat cerebellar slices at postnatal days 10-20 (Takahashi, Kovalchuk
et al. 1995; Hashimoto and Kano 1998). As CF EPSCs are frequently recorded at
postnatal day 4 (Hashimoto and Kano 2003) the effect of adenosine and therefore the
presence of A1Rs can be studied during development using whole-cell patch
clamping of Purkinje cells. This could also be attempted on rats at postnatal day 3,
where the presence of A1R has been implicated by immunohistochemistry (figure
3.8), as the stage of cerebellar development may not be very different between a rat
at postnatal day 3 born in the morning and a rat at postnatal day 4 born in the evening.
To investigate whether mechanical damage to cells in cerebellar sections caused by
use of the vibratome affects staining patterns, an alternative preparation method
could be attempted such as cryostat sectioning of cerebellar slices or using cardiac
perfusion with PFA. The effect of using concentrations of Triton X100 lower than
0.1 % (Weruaga, Alonso et al. 1998) in the immuno PBS to permeabilise cells could
also be examined. An alternative to Triton X100 would be an organic solvent, such
as methanol, which would dissolve membrane lipids and allow the primary antibody
access to intracellular components.
Following confirmation of primary antibody specificity with the controls outlined in
this section, the immunohistochemistry could be extended to look at the presence of
other cerebellar proteins during development. For example, primary antibodies
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against the metabolic proteins adenosine deaminase and adenosine kinase could be
used to compare their distribution in the molecular layer. In addition, co-localisation
of mGluR4 and adenosine receptors could be examined at single Purkinje cells
injected with a fluorescent dye via a patch pipette. This would allow the
characterisation of receptor distribution on individual Purkinje cells which is
currently very difficult because of the overlap of dendrites (particularly distal
dendrites) from neighbouring cells.
If immunohistochemical controls failed to confirm antibody specificity, real-time
PCR could be used as a tool to quantitatively determine levels of A1R gene
expression in cerebellar tissue during development.
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6.2 Presynaptic pharmacology of immature parallel fibre-
Purkinje cell synapses in the rat cerebellum
6.2.1 Summary of key findings
 The release of GABA from inhibitory interneurones in the molecular layer
appeared to have little effect on EPSP amplitude at immature PF-PC synapses
via activation of GABAA receptors.
 Reduction in EPSP amplitude due to activation of presynaptic mGluR4 and
GABAB was confirmed in slices at postnatal days 9-14 and found to be
comparable to that obtained in slices at postnatal days 21-28.
 The A1R-mediated inhibition was found to be variable in immature slices
with ~12.5 % of confirmed PF-PC synapses showing no response to
adenosine.
6.2.2 Possible explanations for the variable response to adenosine at
immature parallel fibre-Purkinje cell synapses
The use of rats in the second postnatal week is ideal for studying the development of
PF-PC synapse responses as this is a major period for the development of these
synaptic connections in the rat cerebellum. The formation of glutamatergic synapses
between parallel fibres and distal Purkinje cell dendrites commences from around
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postnatal day 5 (Altman 1972) with the external granule cell layer ceasing to exist by
the end of the third postnatal week (Komuro and Yacubova 2003).
Application of adenosine (100 µM) to immature slices (P9-14) resulted in a variable
PF EPSP amplitude reduction (figure 4.5). A number of possible explanations for
the variability in A1R-mediated inhibition were tested:
i. There may be variability in the expression of A1R at PF-PC synapses
The previously described immunohistochemistry experiments in this study (chapter 3)
showed dense A1R expression throughout development indicating that it is unlikely
that the large variability in presynaptic inhibition through activation of A1R would be
due to low expression of A1R. However, it is not possible to exclude the lack of
expression at individual synapses as it was not feasible to co-label synapses with a
marker and with A1R.
This was confirmed with application of the A1R agonist N6-cyclopentyladenosine
(CPA, at high concentrations up to 100 M) which was found to reliably inhibit
EPSP amplitude and increase PPF in immature cerebellar slices with no adenosine-
mediated inhibition indicating the presence of A1R in these slices (figure 4.10). This
result could have been made more reliable by blockade of inhibition with co-
application of the A1R antagonist 8-CPT to confirm that the effect of CPA was via
A1R activation and not an alternative mechanism. However, the adenosine analogue
CPA has been used in previous studies of the rat PF-PC synapse as a specific agonist
of A1R with an effect that is reversible with an A1R antagonist, for example (Kreitzer
and Regehr 2000).
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ii. PF EPSP amplitude may be a balance between A1R and A2AR activation
The earlier immunohistochemistry experiments in this study (chapter 3) suggested a
widespread distribution of both A1R and A2AR in the molecular layer which could
indicate that adenosine is binding to both receptor subtypes at parallel fibre terminals
and that the resultant EPSP amplitude is a balance of the inhibitory effect of A1R
activation and the facilitatory effect of A2AR activation on glutamate release. At
synapses where there are more A2AR this may have the net effect of adenosine
having little or no effect on synaptic transmission.
Co-application of adenosine and the specific A1R antagonist 8-CPT indicated that
activation of A2AR is unlikely to significantly contribute to EPSP amplitude (figure
4.8) although only 1 slice out of 12 had no adenosine-mediated inhibition. It was
difficult to test this effect as a lack of adenosine-mediated inhibition in control did
not occur frequently; however similar experiments showed adenosine had no effect
in 8-CPT whether or not adenosine produced a large inhibition in control (personal
correspondence, Mark Wall).
iii. A lack of A1R-mediated inhibition may be due to rapid adenosine breakdown
It is possible that the lack of adenosine-mediated inhibition in some slices could be
the result of a rapid adenosine breakdown resulting in the metabolism of adenosine
before it could activate presynaptic A1R.
The non-hydrolysable A1R agonist CPA reliably inhibited EPSP amplitude and
significantly increased PPR at immature PF-PC synapses (figure 4.10). The CPA is
not metabolised as adenosine would be in the extracellular space so its inhibitory
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effect at A1R that do not respond to adenosine (100 µM) may indicate a more rapid
metabolism or uptake of adenosine by transporter proteins at some immature PF-PC
synapses resulting in the removal of adenosine from the extracellular space before it
can activate A1R. However, the shifted log concentration-response curve generated
for CPA (figure 4.12) in immature slices with no A1R-mediated inhibition suggests
that adenosine metabolism does not explain the variable response to adenosine – as
CPA is not metabolised its effect would have been the same regardless of response to
adenosine if adenosine metabolism was affecting A1R-mediated inhibition.
Subsequent electrophysiology experiments (chapter 5) also suggested that adenosine
clearance via adenosine deaminase, adenosine kinase and equilibrative transporters
has only minor effects on synaptic transmission in immature slices.
iv. There may be a variability in A1R efficacy
The log concentration-response curves for EPSP amplitude reduction elicited by
application of the A1R agonist CPA (0.001 µM – 100 µM) suggest a variability in
A1R efficacy (figure 4.12). The lower IC50 in immature slices that respond to
adenosine (0.08 µM) compared to slices where there is no adenosine-mediated
inhibition (2.10 µM) suggests that A1R efficacy may be lower at some immature PF-
PC synapses and that this may account for the variability in response to adenosine.
Both of the IC50 values are higher than that described for EPSP amplitude reduction
with CPA in hippocampal slices (~0.019 µM) (Rebola, Coelho et al. 2003).
There may be a heterogeneous population of low affinity and high affinity
presynaptic A1R at immature parallel fibre terminals resulting in the observed
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variability in A1R-mediated inhibition. This could be present within populations of
PF-PC cell synapses or alternatively, as parallel fibre terminals also form excitatory
synapses with basket cells and stellate cells in the molecular layer (Sillitoe and
Joyner 2007), it may be that the low efficacy A1R are present only at these synapses.
However, there was no significant difference in either EPSP amplitude (- 0.35 ± 0.02
mV and -0.3 ± 0.03 mV, p = 0.19) or the degree of PPF (1.38 ± 0.04 and 1.34 ± 0.03,
p = 0.22) at synapses which were or weren’t inhibited by adenosine. The synapses
also appeared identical in their responses to baclofen, L-AP4 and kynurenic acid.
Whole cell patch clamp recording from Purkinje cells or interneurones and
stimulating parallel fibres could test the possibility of differential A1R expression.
v. Other possible explanations for a variable A1R-mediated inhibition
The variability in A1R-mediated inhibition was not found to be gender-specific
(figure 4.12) - the lower PF EPSP amplitude reduction seen in female cerebellar
slices was probably due to a much smaller sample size (16 female Vs 167 males).
There was also no correlation with the age of rat (P9-14) and adenosine-mediated
inhibition suggesting no developmental shift.
Other possibilities for the variability in adenosine response should also be considered.
The functional association of presynaptic A1R with other receptor types may affect
the response to adenosine. Interaction of A1R and P2Y1R as hetero-oligomers in the
molecular layer of the rat cerebellum has previously been demonstrated (Yoshioka,
Hosoda et al. 2002) as has an interaction between A1R and mGlu1αR (Ciruela,
Escriche et al. 2001). Such an interaction could reduce affinity and/or efficacy of
signalling.
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Alternatively, the variable response to adenosine may be due to differences in the
expression or efficacy of G-proteins or other downstream signalling mechanisms at
this stage in development. An immunocytochemical study of the expression of G-
protein subunits in the developing murine cerebellum showed that Go, which is
coupled to A1R (figure 1.2), was only detectable in the molecular layer from
postnatal day 8 with levels increasing until postnatal day 15. Similarly, Gi2 staining
in the molecular layer was very weak at postnatal day 8 and increased in intensity
until adulthood (Schuller, Lamp et al. 2001). It is possible that the variable
expression of G-proteins that interact with presynaptic A1R may have influenced the
ability of adenosine to inhibit synaptic transmission at PF-PC synapses at the age of
rat used in this study (P9-14).
6.2.3 Future work
Activation of four presynaptic receptor types is known to decrease the probability of
vesicle release at the PF-PC synapse (Bellamy 2007). This study discussed
presynaptic GABAB, mGluR4 and A1R responses at immature synapses but did not
confirm the effect of endocannabinoid type 1 (CB1) receptor activation. A previous
study has demonstrated that the presynaptic inhibition of rat parallel fibre-evoked
EPSCs in Purkinje cells with the endocannabinoid receptor agonist WIN 55212-2 can
be reversed with the CB1 receptor antagonist SR 141716 (Takahashi and Linden
2000).
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Microelectrode biosensors could be used to compare the concentration of
downstream adenosine metabolites in cerebellar slices with adenosine-mediated
inhibition and in slices where EPSP amplitude is reduced by adenosine. The effect
of inhibitors of adenosine clearance in immature slices with no adenosine-mediated
inhibition could also be examined. To more accurately test the effect of A2AR at PF-
PC synapses, an A2AR agonist could be used.
The age of rat used in this study (P9-14) is the earliest at which extracellular field PF
EPSPs can be successfully recorded (Atterbury and Wall 2009). To examine
whether the variability in adenosine-mediated inhibition is apparent at an earlier
stage in development, patch clamp recordings from individual Purkinje cells (with
parallel fibre stimulation) could be used.
The effect of adenosine on EPSP amplitude could also be examined in older rats at
postnatal days 21-28 to establish whether variable adenosine-mediated inhibition is
present throughout development or just at an early stage. Preliminary data suggests
that A1R-mediated inhibition may also be variable in this age group.
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6.3 Adenosine signalling at immature parallel fibre-
Purkinje cell synapses in the rat cerebellum
6.3.1 Summary of key findings
 Blockade of A1R suggested that an inhibitory adenosine tone is low or absent
at postnatal days 9-12.
 Inhibition of adenosine clearance had little effect on synaptic transmission in
immature slices suggesting that little adenosine is moving between the
intracellular and extracellular spaces under basal conditions.
 Active adenosine release could be stimulated with hypoxia in immature slices
but this was delayed and slow. Adenosine could not be actively released in
response to electrical stimulation in the molecular layer in immature slices.
6.3.2 A low or absent tonic inhibition by endogenous adenosine at
immature parallel fibre-Purkinje cell synapses
This study suggests that an inhibitory adenosine tone is often low or absent at
postnatal days 9-12 but increases during development. Application of the A1R
antagonist 8-CPT had a significantly smaller effect on PF EPSP amplitude in
immature slices at postnatal days 9-12 than in mature slices at postnatal days 21-28
(figure 5.2).
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There are no previous studies that have measured the basal adenosine tone or its
regulation in the juvenile rat cerebellum. However at CA1 hippocampal neurones,
the increase in presynaptic inhibition of EPSPs observed by blocking adenosine
uptake with NBTI is less obvious in younger rats suggesting that a developmental
increase in extracellular adenosine tone also occurs in this region (Psarropoulou,
Kostopoulos et al. 1990). Conversely, a developmental decline in A1R-mediated
presynaptic inhibition and A1R immunoreactivity is observed at the glutamatergic
synapse between the calyx of Held and principal cell in the MNTB of mice during
the second postnatal week (Kimura, Saitoh et al. 2003).
6.3.3 Possible explanations for a low or absent basal adenosine tone
in immature slices
A number of possible explanations for the reduced adenosine tone at immature PF-
PC synapses were tested:
i. There may be a low expression of A1R in immature slices
A basal adenosine tone may be present in immature slices but undetectable due to a
low expression of A1R at PF-PC synapses. This is unlikely as the previously
described immunohistochemistry experiments in this study (chapter 3) suggested a
dense co-localisation of A1R at all PF-PC synapses throughout development.
All experiments measuring tonic A1R activation only used slices where adenosine
(100 µM) inhibited EPSP amplitude by at least 50 %. Thus the lack of tone is not the
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result of low receptor expression or the expression of low affinity receptors. In
addition, the A1R-mediated inhibition was not affected by a low or absent basal
adenosine tone (figure 5.3).
ii. The A1R efficacy may differ between immature and mature slices
It has previously been discussed how differences in A1R-mediated inhibition in
immature slices may be the result of a variable A1R efficacy (chapter 4). Log
concentration-response curves for the A1R agonist N6-cyclopentyladenosine (CPA)
at mature synapses and immature synapses with an adenosine-mediated inhibition
greater than 50 % (figures 4.10, 5.4) were almost identical suggesting that the lower
inhibitory A1R tone at immature PF-PC synapses is unlikely to be the result of a
difference in A1R efficacy.
iii. There may be an enhanced adenosine clearance in immature slices
The low concentration of extracellular adenosine metabolites measured by
microelectrode biosensors (figure 5.5, 5.6) indicates that the lack of an inhibitory
A1R tone at immature PF-PC synapses is unlikely to be the result of an enhanced
extracellular adenosine metabolism. The low concentration could, however, indicate
reduced adenosine release or rapid adenosine uptake from the extracellular space.
As expected from the microelectrode biosensor data, the inhibition of adenosine
deaminase (ADA) with EHNA had little effect on EPSP amplitude at immature PF-
PC synapses (figure 5.7). The activity of ADA is not considered to be a major
regulator of extracellular adenosine tone in mature cerebellar slices (Wall, Atterbury
et al. 2007). Similarly, in rat hippocampal slices the inhibition of neuronal activity
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observed with application of adenosine is greatly reduced or not apparent with
application of EHNA to inhibit ADA (Pak, Haas et al. 1994).
Inhibition of ENT1 and ENT2 with NBTI/dipyridamole was used to assess whether
enhanced facilitated diffusion of adenosine from the extracellular space into the
cytoplasm via equalibrative transporters contributes to the low inhibitory A1R tone in
immature slices. Application of NBTI/dipyridamole had no effect on synaptic
transmission at ~50 % of PF-PC synapses and resulted in ~ 32 % reduction in EPSP
amplitude at the remaining synapses (figure 5.8). There was no correlation between
the reduction in EPSP amplitude with NBTI/dipyridamole and the absence of an
inhibitory A1R tone in the immature slices. A similar variability in response to
NBTI/dipyridamole is reported in mature cerebellar slices where EPSP amplitude is
reduced by ~ 47 % in 9 out of 18 slices (Wall, Atterbury et al. 2007).
To examine whether the low inhibitory A1R tone in immature slices is the result of
enhanced intracellular phosphorylation of adenosine by AK, thus preventing
adenosine efflux to the extracellular space (Boison 2006), iodotubericidin was
applied to slices to inhibit AK. Iodotubericidin inhibited EPSP amplitude by ~25 %
in 14 out of 21 slices which is a less reliable effect and significantly smaller than in
mature slices (Wall, Atterbury et al. 2007) and suggests that AK is not particularly
active under basal conditions.
The greater effect of intracellular AK activity in comparison to extracellular
adenosine metabolism by ADA has also been reported in mature cerebellar slices
(Wall, Atterbury et al. 2007) and hippocampal slices (Pak, Haas et al. 1994; Lloyd
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and Fredholm 1995). An important role for AK in the control of extracellular
adenosine is suggested in the rat prepiriform cortex where its inhibition potentiates
the ability of adenosine to suppress bicuculline methiodide-induced seizures (Zhang,
Franklin et al. 1993)
The inhibition resulting from block of the intracellular enzyme adenosine kinase (AK)
with iodotubericidin was not prevented by prior application of NBTI/dipyridamole in
6 out of 10 immature slices (figure 5.13B) suggesting that block of ENT1 and ENT2
does not abolish all transport of adenosine. Similarly, in mature slices effective
block of equilibrative transporters by NBTI/dipyridamole to prevent the efflux of an
increased intracellular adenosine concentration due to inhibition of AK is only
observed in 4 out of 8 slices (Wall, Atterbury et al. 2007). This may be due to
expression of transporters not sensitive to NBTI/dipyridamole at PF-PC synapses
which may be contributing to the low inhibitory A1R tone or a heterogeneous
distribution of ENT1 and ENT2 transporters as ENT2 is only weakly blocked in rats
(Baldwin, Beal et al. 2004). The lack of selective inhibitors prevents the
involvement of the five known concentrative transporter subtypes in the regulation of
adenosine levels from being determined.
During early postnatal development of the mouse hippocampus AK
immunoreactivity is most prominent in neurones with a gradual transition of
expression to newly-formed GFAP-positive astrocytes until around postnatal day 14
and neuronal expression being maintained in only a few areas (Studer, Fedele et al.
2006). If this also occurs in the cerebellum, the expression of AK in neurones may
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reduce intracellular adenosine stores resulting in a decreased release of adenosine to
the extracellular space and a low inhibitory A1R tone.
Overall, the effect of inhibition of ADA, AK and the equilibrative transporters ENT1
and ENT2 had minor and unreliable effects at immature PF-PC synapses and had less
effect on EPSP amplitude reduction than in mature slices (figure 5.14) suggesting
that the low basal inhibitory A1R tone in immature slices is not the result of an
enhanced movement of adenosine between the intracellular and extracellular spaces
under basal conditions.
iv. Active adenosine release may be less efficient in immature slices
Hypoxia and electrical stimulation were used to investigate whether there are
developmental differences in the active release of adenosine in cerebellar slices.
A prolonged release of extracellular adenosine in response to the increased demand
for energy from ATP during pathological events is a well-documented
neuroprotective action of adenosine which is mediated primarily through cellular
pathways triggered by A1R activation (Latini and Pedata 2001). Hypoxia stimulated
the release of adenosine in both immature and mature slices but the release was
delayed and slower at immature PF-PC synapses (figure 5.15, 5.16) suggesting that
the mechanism of adenosine release becomes more sensitive to hypoxia during
development. Synaptic depression during periods of hypoxia induced in rat
hippocampal slices is blocked by an A1R antagonist (Fowler 1989; Gribkoff and
Bauman 1992). These mechanisms inhibit some Ca2+ channels to reduce glutamate
and other neurotransmitter release and hyperpolarise neurones to limit excitotoxic
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damage caused by the entry of Ca2+ (Dunwiddie and Masino 2001). It is possible
that the delayed and slower release of adenosine during hypoxia and low inhibitory
A1R tone in immature slices may make them more sensitive to the effects of hypoxia.
The immature rat brain was originally believed to be more resistant to the damaging
effects of hypoxia compared to the more mature brain. However subsequent research
suggests a non-linear relationship between hypoxic-ischemic brain damage and age.
Brain damage following ischemia or hypoxia appears to be most severe in 1-3 week
old rats followed by those aged 6 months and significantly less severe in 6-9 week
old animals (Yager and Thornhill 1997). The increased vulnerability of the
immature rat brain to the effects of hypoxia compared to the mature brain is
consistent with the findings in this study.
It is unlikely that any inhibitory adenosine tone in the slices is the result of hypoxia
as during experiments the recording chamber was continuously perfused at a rate of 6
ml/min with aCSF bubbled with 95 % O2 and 5 % CO2 using a peristaltic pump. A
suspended grid also ensured that the slices were perfused from above and below and
the tubing had low gas permeability to inhibit induction of hypoxia.
Blockade of A1R with 8-CPT had no effect on the facilitation and depression of
EPSP amplitudes during trains of activity in immature slices suggesting that there is
no adenosine release during trains of stimuli. The facilitation and depression of
EPSP amplitude during trains of activity in immature slices is probably due to the
exhaustion of glutamate stores rather than the active release of adenosine changing
the probability of glutamate release to limit transmitter depletion and maintain
synaptic transmission (Kimura, Saitoh et al. 2003).
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Microelectrode biosensors were not able to measure the release of adenosine during
trains of electrical stimuli in immature slices (figure 5.18) although it has previously
been described that adenosine can be released into the extracellular space of mature
slices in a neuronal activity-dependent manner that is likely to be from parallel fibre
terminals (Wall and Dale 2007). Immature parallel fibre terminals may contain
much smaller pools of releasable adenosine. Alternatively, as granule cell migration
and PF-PC synapse formation is not complete in immature slices at postnatal days 9-
12, the low number of parallel fibre terminals present may result in an undetectable
level of adenosine release during molecular layer stimulation. A different
mechanism of adenosine release may also exist that is not present at this stage in
development.
Blocking action potential adenosine release with TTX has unreliable and small
effects on basal adenosine levels in mature cerebellar slices suggesting that the
activity-dependent release of adenosine is not a major contributor to the inhibitory
A1R tone at postnatal days 21-28 (Wall, Atterbury et al. 2007). The absence of
activity-dependent adenosine release in immature slices is therefore unlikely to be a
major factor in the low or absent basal inhibitory A1R tone.
v. An adenosine tone may be the result of ATP release in cerebellar slices
Damage to cerebellar slices during preparation (and subsequent cell death) may
result in the release of cytoplasmic ATP and conversion to adenosine. This is more
likely to occur in mature slices which survive slicing less well than slices from young
animals. The large population of granule cells could provide a source of ATP if they
slowly die during recordings. ATP could also be released from neurones by
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exocytosis (Edwards, Gibb et al. 1992; Dale 1998) or through the opening of gap
junction hemichannels (Pearson, Dale et al. 2005) and then rapidly converted to
adenosine by ectonucleotidases. Inhibition of PF EPSPs occurs following
application of ATP to mature slices which can be prevented by blockade of A1R with
8-CPT suggesting that the exogenous ATP is rapidly metabolised to adenosine (Wall,
Atterbury et al. 2007). Calcium signals in Bergmann glia triggered by bursts of
parallel fibre activity in cerebellar slices can be blocked with application of the P2
receptor antagonist pyridoxal phosphate-6-azophenyl-2,4-disulfonic acid (PPADS)
suggesting that the release of ATP from parallel fibres may provide a source of
extracellular adenosine (Beierlein and Regehr 2006).
ATP increases the frequency of spontaneous postsynaptic currents (sPSCs) recorded
in Purkinje neurones by activation of P2 receptors. Interestingly, application of the
ecto-ATPase inhibitor ARL67156 from the second postnatal week onwards (Casel,
Brockhaus et al. 2005) also increases sPSC frequency suggesting a tone of
extracellular ATP. However, the direct measurement of ATP in mature cerebellar
slices with microelectrode biosensors did not reveal an ATP signal although this may
be due to rapid breakdown of ATP (Wall, Atterbury et al. 2007). Block of ATP
metabolism had variable effects on the adenosine tone, suggesting that ATP is at
least one of the sources of adenosine in mature slices (Wall, Atterbury et al. 2007).
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6.3.4 Future work
The stimulation of bundles of parallel fibres during extracellular field recordings
does not replicate a physiological situation. It would be interesting to determine
whether the results obtained in this study for the inhibitory A1R tone and adenosine
clearance mechanisms are replicated with patch clamp recordings (from individual
Purkinje cells) with the stimulation of a small number of parallel fibres (using a
patch pipette rather than a bipolar electrode).
The use of microelectrode biosensors in vivo would also allow more physiologically-
relevant recordings and would eliminate any incorrect measurement of adenosine
metabolites due to cell death following slice preparation.
The simultaneous measurement of EPSP amplitude with microelectrode biosensor
measurement has not been used in this study to confirm the effects of blockade of
AK, ADA and equilibrative transporters as was used for mature cerebellar slices
(Wall, Atterbury et al. 2007). The effect of ADA block by EHNA cannot be directly
measured with an ADA biosensor, which also uses the enzyme, but could be
determined with IDO or HYPO biosensors.
Immunohistochemistry could be used to determine whether the expression of AK in
neurones may reduce intracellular adenosine stores resulting in a decreased release of
adenosine to the extracellular space and a low inhibitory A1R tone in immature slices.
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Finally, this study has not determined the contribution of ATP metabolism to the low
inhibitory A1R tone in immature slices. Although a lack of ATP metabolism to
adenosine in the extracellular space is unlikely to contribute to the low or absent
adenosine tone in immature slices this could be confirmed by applying ATP to slices
and measuring the conversion to adenosine with microelectrode biosensors.
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Summary
The first aim of this study was to determine the distribution of A1R at PF-PC
synapses in cerebellar slices at postnatal day 3 prior to PF-PC synapse formation,
postnatal days 8-14 and postnatal days 21-28. Immunohistochemistry suggested that
A1R are widely distributed across Purkinje cell bodies, their dendrites and within the
granule layer of the cerebellum throughout development. The same staining patterns
were also observed prior to PF-PC synapse formation. There was only minor co-
localisation of A1R with glial cell bodies or their processes, eliminating their
involvement in the staining observed. Although these results were replicated using
an alternative protocol, care should be taken in their interpretation as they are partly
contradictory to the expression of A1R described in previous studies.
The widespread expression of A2AR within cerebellar slices which was identical to
that of A1R is contradictory to a number of previous immunohistochemical studies
although a moderate distribution of A2AR has been described in the human
cerebellum. A functional role for A2AR has not previously been described within the
cerebellum.
A further aim of this study was to investigate the pharmacological profile of the
immature rat PF-PC synapse with electrophysiology and microelectrode biosensors.
Application of adenosine resulted in a variable A1R-mediated inhibition at immature
PF-PC synapses. This did not appear to be gender-specific or correlated with age of
rat and the synapses otherwise appeared identical in their properties. This variability
in adenosine-mediated inhibition contrasts with the actions of L-AP4 (mGluR4
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agonist) and baclofen (GABAB receptor agonist) which consistently depress synaptic
transmission. The comparison of log concentration-response curves generated for an
A1R agonist suggested that some A1R may have a lower efficacy at this stage of
development.
Blockade of presynaptic A1R at immature PF-PC synapses suggested that an
inhibitory adenosine tone is low or absent in immature slices and is not the result of a
low A1R expression or developmental differences in A1R efficacy. Inhibition of
adenosine clearance via adenosine deaminase, adenosine kinase and equilibrative
transporters had little effect on synaptic transmission indicating that little adenosine
is moving between the intracellular and extracellular spaces under basal conditions in
immature slices. The control of extracellular adenosine concentration in the
immature cerebellum appears comparable to that in the mature cerebellum and other
brain regions where the activity of adenosine kinase is the major determining factor.
Although adenosine receptors and the mechanisms of adenosine clearance are
present at this stage in development there is very little adenosine release. Active
adenosine release measured by electrophysiology and microelectrode biosensors
could be stimulated with hypoxia in immature slices but this was delayed and slower
in comparison to the release observed in mature slices. In addition adenosine could
not be actively released at immature PF-PC synapses in response to electrical
stimulation in the molecular layer suggesting that the mechanisms of adenosine
release become more efficient with development.
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Control of basal extracellular adenosine concentration
in rat cerebellum
Mark J. Wall, Alison Atterbury and Nicholas Dale
Neuroscience Group, Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK
To re-examine how the basal extracellular concentration of adenosine is regulated in acutely
isolated cerebellar slices we have combined electrophysiological and microelectrode biosensor
measurements. In almost all cases, synaptic transmission was tonically inhibited by adenosine
acting via A1 receptors. By contrast, in most slices, the biosensors did not measure an adenosine
tone but did record a spatially non-uniform extracellular tone of the downstream metabolites
(inosine and hypoxanthine). Most of the extracellular hypoxanthine arose from the metabolism
of inosine by ecto-purine nucleoside phosphorylase (PNP). Adenosine kinase was the major
determinant of adenosine levels, as its inhibition increased both adenosine concentration and
A1 receptor-mediated synaptic inhibition. Breakdown of adenosine by adenosine deaminase
was the major source of the inosine/hypoxanthine tone. However adenosine deaminase played
a minor role in determining the level of adenosine at synapses, suggesting a distal location.
Blockade of adenosine transport (by NBTI/dipyridamole) had inconsistent effects on basal
levels of adenosine and synaptic transmission. Unexpectedly, application of NBTI/dipyridamole
prevented the efflux of adenosine resulting from block of adenosine kinase at only a
subset of synapses. We conclude that there is spatial variation in the functional expression
of NBTI/dipyridamole-sensitive transporters. The increased spatial and temporal resolution of
the purine biosensor measurements has revealed the complexity of the control of adenosine and
purine tone in the cerebellum.
(Resubmitted 9 March 2007; accepted after revision 18 April 2007; first published online 19 April 2007)
Corresponding author M. J. Wall: Neuroscience Group, Department of Biological Sciences, University of Warwick,
Coventry CV4 7AL, UK. Email: mark.wall@warwick.ac.uk
The purine adenosine is an important neuromodulator,
with both excitatory and inhibitory actions within the
CNS. This purine molecule is involved in diverse processes
including locomotion, sleep and respiration, and provides
neuroprotection during hypoxia/ischaemia. Although the
basal extracellular levels of adenosine in the brain are low
(Newman & McIlwain, 1977; Dunwiddie & Diao, 1994),
there is still sufficient to tonically activate high-affinity
A1 receptors and produce synaptic inhibition (Dunwiddie
& Diao, 1994; Takahashi et al. 1995; Dittman & Regehr,
1996). Regulation of the extracellular level of adenosine
in the brain is crucial, since small changes in adenosine
levels will affect the degree of synaptic inhibition, and thus
modulate neural processing.
The extracellular concentration of adenosine will be
determined by the balance of production and elimination.
In many cases, the source and mechanism of adenosine
release are unclear but could occur via ATP metabolism
(released by exocytosis, Edwards et al. 1992; Jo & Schlichter,
1999, or released through gap junction hemi-channels,
Arcuino et al. 2002; Stout et al. 2002; Pearson et al. 2005),
transport from the cell cytoplasm (Craig & White, 1993; Gu
et al. 1995; Sweeney, 1996) or possibly by the exocytosis
of adenosine itself (Wall & Dale, 2007). The actions of
adenosine are terminated by a combination of metabolism
to inosine (by the enzyme adenosine deaminase) and by
translocation into neurons or glia by either equilibrative
transporters such as ENT1 and ENT2 or concentrative
transporters (for review see Noji et al. 2004; Baldwin et al.
2004).
Once internalised, adenosine can be phosphorylated (by
adenosine kinase) to form AMP, thus maintaining low
levels of intracellular adenosine (for review see Boison,
2006). Because the levels of adenosine are determined
by a complex interplay of enzymes and transporters,
several studies have investigated the components
that contribute to determining extracellular adenosine
concentration. In many studies blocking adenosine kinase
has a major effect on adenosine concentration, whereas
blockade of adenosine deaminase has a much smaller effect
(Zhang et al. 1993; Pak et al. 1994; Lloyd & Fredholm,
1995).
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The aim of this study is two-fold: firstly to investigate
whether recently developed biosensors can be used to
determine what controls the basal levels of adenosine in
brain slices. Biosensors have inherently better spatial and
temporal resolution than other methods such as HPLC
or microdialysis, for measuring purine levels. Biosensors
have been successfully used to investigate increases in
adenosine during episodes of ischaemia, hypoxia and
hypercapnia (Dale et al. 2000; Frenguelli et al. 2003,
2007; Dulla et al. 2005) and have been used to measure
adenosine release following electrical stimulation (Wall
& Dale, 2007). However, measurement of the basal tone
of adenosine is more challenging as the concentration
of adenosine will be low and may be more difficult to
detect against a non-uniform background of downstream
adenosine metabolites.
The second aim is to investigate adenosine levels in
the cerebellum, since relatively little is known about
how the extracellular concentration of adenosine is
controlled in this part of the brain. There is growing
evidence that adenosine plays an important role in the
processing of information by cerebellar circuits. Adenosine
is concentrated in the soma and dendrites of cerebellar
Purkinje cells (Braas et al. 1986), and adenosine A1
receptors are expressed within the cerebellum (Rivkees
et al. 1995). The tonic activation of A1 receptors, producing
synaptic inhibition, provides indirect evidence that an
extracellular tone of adenosine is present in cerebellar
slices (Takahashi et al. 1995; Dittman & Regehr, 1996).
The source of this extracellular adenosine is unclear, but in
recent studies, Wall & Dale (2007) have directly measured
adenosine release in the cerebellum and Beierlein & Regehr
(2006) have reported the release of ATP from parallel fibres.
The enzymes required for purine metabolism are present
in the cerebellum: ecto-ATPase (CD39, Wang & Guidotti,
1998), 5′nucleotidase (Schoen et al. 1987) and adenosine
deaminase (Geiger & Nagy, 1986). Nucleoside transporters
are also expressed in the cerebellum (Anderson et al.
1999a,b). However, the relative importance of adenosine
transport, phosphorylation (by adenosine kinase) and
metabolism (by adenosine deaminase) in the regulation
of the adenosine tone remains uncertain. Studies of
synaptic membranes, cultured glia and homogenised brain
tissue suggest that adenosine deaminase activity in the
cerebellum is comparable to or higher than in other brain
regions (Yamada et al. 1998; Wink et al. 2003; Kukulski
et al. 2004). However the physiological relevance of data
from such studies is unclear.
Methods
Preparation of cerebellar slices
Parasagittal or transverse slices of cerebellar vermis
(400 μm) were prepared from male Wistar rats, at post-
natal days 21–28 (P21–28). As described previously (Wall
& Usowicz, 1997) and in accordance with the UK Animals
(Scientific Procedures) Act 1986, male rats were killed by
cervical dislocation and decapitated. The cerebellum was
rapidly removed and slices were cut on a Microm HM 650V
microslicer in cold (2–4◦C) high Mg2+, low Ca2+ aCSF,
composed of (mm): 127 NaCl, 1.9 KCl, 7 MgCl2, 0.5 CaCl2,
1.2 KH2PO4, 26 NaHCO3, 10 d-glucose (pH 7.4 when
bubbled with 95% O2 and 5% CO2, 300 mosmol l−1).
Slices were stored in normal aCSF (1.3 mm MgCl2, 2.4 mm
CaCl2) at room temperature for 1–6 h before recording.
Extracellular recording
An individual slice was transferred to a recording chamber,
submerged in aCSF and perfused at 6 ml min−1 (30–35◦C).
Peristaltic pumps were used to pump aCSF in and out
of the recording chamber, thus ensuring a constant flow
rate. The slice was placed upon a suspended grid to
allow perfusion of the slice from above and below and
thus reduce the likelihood of hypoxia. Furthermore, all
solutions were vigorously bubbled (95% O2/5% CO2)
and all tubing had low gas permeability (Tygon). For
the stimulation of parallel fibres, square voltage pulses
(2–5 V, 200 μs duration) were delivered by an isolated
pulse stimulator (model 2100 AM systems Everett WA,
USA) via a concentric bipolar metal stimulating electrode
(FHC) placed on the surface of the molecular layer in a
transverse slice. The recording electrode (an aCSF-filled
microelectrode) was placed on the same track along which
the parallel fibres travel (‘on-beam’ Yuan & Atchison,
1999). A typical extracellular field potential consisted of an
initial component which persisted in either 10 μm CNQX
or 5 mm kynurenate but was blocked by 1 μm TTX (parallel
fibre volley) followed by a component which could be
blocked by 1 μm TTX and greatly reduced by either 10 μm
CNQX or 5 mm kynurenate. This component is probably
produced by parallel fibre-mediated glutamatergic
excitatory synaptic currents and subsequent action
potentials in Purkinje cells and interneurons (Clark
& Barbour, 1997). Parallel fibre (PF) EPSP amplitude
was estimated from the CNQX-/kynurenate-sensitive
potential, which was measured by subtracting what
remained in CNQX/kynurenate from control potentials.
Confirmation of PF EPSP identity was achieved by
evoking pairs of EPSPs (interval 50 ms) and observing
facilitation (Atluri & Regehr, 1996) and by examining
the pharmacological profile (inhibition by A1, GABAB
and mGlu4R receptor agonists). Pairs of PF EPSPs were
evoked at 0.1 Hz, and the amplitude of the first EPSP was
used as a measure of adenosine A1 receptor activation.
The paired pulse ratio (EPSP2/EPSP1) was used to test for
a presynaptic action on release probability. Extracellular
recordings were made using an ISO-DAM extracellular
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amplifier (WPI), filtered at 1 kHz and digitised online
(10 kHz) with a Digidata 1322A (Axon Instruments)
controlled by 9.2 (Axon pCLAMP).
Purine biosensors
Sensors were obtained from Sarissa Biomedical Ltd
(Coventry UK). In brief, the adenosine sensor consisted
of three entrapped enzymes (adenosine deaminase, AD,
purine nucleoside phosphorylase, PNP and xanthine
oxidase, XO), within a matrix that was deposited around
a 25–50 μm platinum or platinum/iridium (90/10) wire
(Llaudet et al. 2003). The biosensor had an exposed
length of ∼500 μm that was screened with an inner
permselectivity layer to greatly reduce responses to
electro-active interferents (such as 5-HT, noradrenaline,
dopamine and ascorbate). It was then coated with enzymes
to make it capable of detecting purines. Five types of
purine biosensor were used in this study to identify released
substances. Firstly, a screened null sensor, possessing
the deposition matrix but no enzymes, was used to
control for the release of any non-specific electro-active
interferents. Secondly, screened biosensors containing just
XO (only responsive to hypoxanthine, HYPO), PNP and
XO (responsive to inosine and hypoxanthine, INO) and
PNP, XO and AD (responsive to inosine, hypoxanthine and
adenosine, ADO) were used. The difference signal between
these three types of biosensors gave the specific hypo-
xanthine, inosine and adenosine signals. Matching the sizes
and sensitivities of the biosensor types as well as careful
positioning into or above the slice was vital to optimise
the differential recordings. The screened ATP biosensor
(Llaudet et al. 2005) consisted of the entrapped enzymes
glycerol kinase (GK) and glycerol-3-phosphate oxidase
(G3POx). Glycerol 2 mm was included in solutions, as
glycerol is a co-substrate required for ATP detection. A
full description of the properties of the biosensors has
been published. They show a linear response to increasing
concentration of analyte, are fast to respond and have a
10–90% rise time of less than 10 s (Llaudet et al. 2003,
2005).
The biosensors were either carefully inserted (at an angle
of ∼70 deg) either into the molecular layer or positioned
just above the surface of the slice (either at an angle
of ∼70 deg or bent so their longitudinal surface was
parallel to the slice surface). Biosensors were calibrated
with known concentrations (10 μm) of adenosine, inosine,
hypoxanthine and ATP. Calibration was performed before
the slice was present in the perfusion chamber and after
the slice had been removed; this allowed measurement of
any reduction in sensitivity during the experiment.
To quantify the concentrations of adenosine, inosine
and hypoxanthine, it was assumed that the concentrations
of these purines were homogenous in the slice and
thus the calibrated signals can be subtracted from
one another. The HYPO sensor will only detect
hypoxanthine and thus this signal can be subtracted
from the signal on the INO sensor to give the inosine
signal. The signal from the INO sensor (comprising
inosine and hypoxanthine) can be subtracted from the
signal on the ADO sensor to give the specific adenosine
signal. For example, assuming identical sensitivity for
the ADO, INO and HYPO sensors and that 10 μm
of each analyte (adenosine, inosine or hypoxanthine)
produces 3000 pA. Clearly the ADO sensor will produce
a current of 3000 pA in response to 10 μm adenosine,
10 μM inosine or 10 μm hypoxanthine, whereas the
HYPO sensor will only respond to hypoxanthine. If
upon exposure to tissue, the HYPO sensor produces a
current of 300 pA, then the hypoxanthine concentration
in the tissue is (300 pA/3000 pA × 10 μm) = 1 μm. If
The INO sensor produces a current of 700 pA, then
subtracting the current due to hypoxanthine (300 pA)
leaves 400 pA which is the current due to inosine
detection. Thus the inosine concentration in the tissue
is (400 pA/3000 pA × 10 μm) = 1.3 μm. The signal from
the INO sensor can then be subtracted (in a similar way)
from the ADO sensor to give the specific adenosine signal.
In reality, because the sensitivity of sensors to inosine
and hypoxanthine will differ slightly, this has to be taken
into account during subtraction by appropriate weighting.
Note that this differential subtraction procedure only gives
valid results if the metabolites are distributed in a uniform
identical manner. If this is not the case, for example there
are concentration ‘hotspots’, it will be virtually impossible
to place the different sensors at identical relative locations
with respect to the hotspots. Hence the signals will not be
equivalent from the different sensors. Thus the detection
of a purine tone will be accurate but its subdivision into
concentrations of adenosine, inosine and hypoxanthine
may be less so. Sensor signals were acquired at 1 kHz with
a Digidata 1322A or a MiniDigi (Axon) using Pclamp 9.2
or Axoscope 9.2 (Axon). All values are mean ± SEM.
Drugs
All drugs were made up as 10–100 mm stock solutions,
stored frozen and then thawed and diluted with aCSF
on the day of use. Iodotubercidin, pyridoxal phosphate-
6-azo(benzene-2,4-disulfonic acid) tetrasodium salt
(PPADs), suramin, Evans Blue, α,β-methylene-ADP,
adenosine, inosine, hypoxanthine, 6-[(4-nitrobenzyl)
thiol]-9-β-d-ribofuranosylpurine (NBTI) 8-cyclopentyl-
theophylline (8CPT) and dipyridamole were purchased
from Sigma. Erythro-9-(2-hydroxy-3-nonyl) adenine
(EHNA),6-cyano-7-nitroquinoxaline-2,3-dione(CNQX),
ARL67156 and d(−)-2-amino-5-phosphonopentanoic
acid (AP5) were purchased from Tocris-Cookson. ATP
was purchased from Roche.
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Figure 1. Endogenous adenosine inhibits parallel fibre to
Purkinje cell synaptic transmission
A, average of 50 pairs (interval 50 ms) of parallel fibre–Purkinje cell
(PF) EPSPs illustrating paired pulse facilitation (greater amplitude of
second EPSP compared to first). PF EPSPs were averaged by aligning on
the stimulus artefact. B, the A1 receptor antagonist 8CPT (1 μM)
increased PF EPSP amplitude (31%) demonstrating tonic activation of
A1 receptors. PF EPSPs were blocked by CNQX (10 μM), confirming
their production through glutamate receptor activation. Graph plots
the amplitude of individual PF EPSPs against time. C, The antagonist
8CPT (1 μM) decreased the paired pulse ratio, confirming a presynaptic
site of action. Graph plots the paired pulse ratio against time for the
PF EPSPs in B. The line is the mean paired pulse ratio for five EPSPs.
D, adenosine (100 μM) reversibly decreased PF EPSP amplitude (48%).
Graph plots the amplitude of individual PF EPSPs against time.
E, adenosine produced a marked increase in the paired pulse ratio,
indicating a presynaptic site of action. Graph plots the paired pulse
ratio against time for the PF EPSPs in D. The line is the mean paired
pulse ratio for three EPSPs. F, graph summarising the actions of
purines on PF EPSP amplitude (n = 5–12).
Results
Parallel fibre EPSPs are tonically inhibited by
adenosine in the majority of slices
Previous studies have shown that A1 adenosine receptors
on parallel fibre–Purkinje cell synapses tonically inhibit
synaptic transmission, suggesting the presence of an
extracellular adenosine tone (Kocsis et al. 1984; Takahashi
et al. 1995; Dittman & Regehr, 1996). To confirm the
presence of extracellular adenosine in our cerebellar slices,
we have studied parallel fibre–Purkinje cell excitatory post-
synaptic potentials (PF EPSPs). The identity of PF EPSPs
was confirmed by the presence of paired pulse facilitation
(PPF, with a 50 ms interval the paired pulse ratio was
1.3 ± 0.01, n = 20, Fig. 1A) and the sensitivity of PF EPSPs
to the glutamate receptor antagonists CNQX (10 μM) or
kynurenic acid (5 mm, Fig. 1B).
We confirmed previous reports (Takahashi et al. 1995;
Dittman & Regehr, 1996) that inhibitory A1 receptors on
parallel fibre–Purkinje cell synapses are tonically activated
in slices, as application of A1 receptor antagonists enhanced
PF EPSP amplitude (1 μm 8CPT or 200 μM theophylline
46.1 ± 8.6% increase) and significantly reduced the paired
pulse ratio (from 1.3 ± 0.04 to 1.2 ± 0.03, Fig. 1B and
C) in 17 out of 19 slices. In two slices, the antagonists
had no effect on PF EPSP amplitude. The continual
activation of A1 receptors is probably a consequence of
the presence of endogenous adenosine, since application
of adenosine (100 μm) reduced PF EPSP amplitude by
60.5 ± 4.8% and increased the paired pulse ratio from
1.3 ± 0.06 to 1.6 ± 0.08, (n = 12, Fig. 1D and E). As
the applied adenosine could be metabolised to inosine
and hypoxanthine, the activity of these metabolites on
synaptic transmission was assessed. As expected, neither
inosine nor hypoxanthine (100 μm) had any significant
effect on either the PF EPSP amplitude or the paired
pulse ratio (n = 5, Fig. 1F). ATP (100 μm) also reduced
EPSP amplitude (50 ± 6.5%). Since this inhibition was
blocked by A1 receptor antagonists (n = 6), ATP must be
metabolised to adenosine. Our results confirm previous
reports that there is a tone of extracellular adenosine in
the cerebellum which inhibits synaptic transmission and
is present in the majority (∼90%) of slices.
Biosensors detect adenosine metabolites but not
adenosine in most cerebellar slices
We have used microelectrode biosensors to directly
measure the concentration of extracellular adenosine
present in cerebellar slices. The use of different sensors
allows the detection of ATP (a possible source of
adenosine), adenosine and the adenosine metabolites
(inosine and hypoxanthine). A null sensor was also
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present to control for any non-specific electro-active
interferents. To verify our findings we used two different
methods. Firstly, we measured the current produced
when purine biosensors were moved close to the slice
surface (Fig. 2A). This method has the advantage that it is
non-invasive and thus any purines detected do not result
from biosensor-mediated tissue damage. Movement of
null sensors (with no enzyme cascade, n = 10) close to the
slice surface produced either no current or a small negative
current; thus any electro-interferents released from the
slice are not detected by the biosensors. The signal on
ATP biosensors (n = 10) was no different from that on
null sensors (Fig. 2A), and thus the level of ATP at the slice
surface is below the limits of detection by the biosensors
(∼60 nm). In contrast, large currents were measured when
ADO, INO and HYPO biosensors were moved close to the
Figure 2. Adenosine metabolites, but not
adenosine, can be measured in the extracellular
space of cerebellar slices
A, example of biosensor traces from an experiment to
measure the concentration of purines at the slice
surface. Superimposed traces from ADO, INO, HYPO
and ATP sensors. After the biosensors were moved close
to the slice surface there was a rapid increase in the
baseline current of ∼300–500 pA on the ADO, INO and
HYPO sensors. Moving the ATP biosensor close to the
slice produced a small drop in the baseline current.
B, the traces from A were normalised by calibration and
subtracted to give the amounts of adenosine, inosine
and hypoxanthine detected at the slice surface (see
Methods). C, graph plots the mean concentration of
purines measured at the surface of 12 cerebellar slices.
Currents were scaled by sensor calibration and then
subtracted (as in B). D, examples of experiments where
biosensors were used to measure the purine
concentration within slices. Biosensors were carefully
pushed into slices, left in position for ∼30 min and then
withdrawn. The top panel shows the response following
removal of an ATP sensor from a slice. There is a small
sustained increase in current (similar to that observed on
null sensors) and thus no ATP was detected. In contrast
when an inosine (INO) sensor was removed there was a
sustained fall in current as a result of terminating purine
detection (bottom panel). The transient upward
deflections (arrows) are presumably due to cell damage
and the release and resultant metabolism of ATP.
E, graph plotting the mean concentration of purines
measured in the extracellular space of 16 cerebellar
slices. Currents were scaled by sensor calibration and
then subtracted (see Methods).
slice surface (Fig. 2A). After calibration and subtraction
(Fig. 2B), to determine the specific analyte concentration
(see Methods), adenosine was only detected in a single slice
(1 out of 12 slices at 1.5 μm), whereas hypoxanthine was
detected in all slices (0.8 ± 0.2 μm, 12 out of 12 slices) and
inosine was detected in 50% of slices (0.5 ± 0.1 μm, in 6
slices, Fig. 2B).
The second method measured the extracellular
concentration of purines within the cerebellum, by
carefully inserting purine biosensors into the slice. After
30 min biosensors were removed from the tissue and
the resultant deflection in baseline current was used as
a measure of purine concentration within the slice. If
extracellular purines are present, removal of the biosensor
from the slice should result in a rapid fall in baseline, as the
purines will no longer be measured. This method avoids
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the detection of purine release due to tissue damage during
sensor insertion. Removal of null sensors produced either
no current deflection or a small positive current deflection.
The response of ATP biosensors was no different from null
sensors (32–34◦C n = 20 slices, room temperature n = 10
slices, Fig. 2D), and thus no ATP tone could be detected
within the tissue. However clear falls in baseline current
were observed following the removal of ADO, INO and
HYPO biosensors from slices (n = 6 slices, Fig. 2D). After
calibration and subtraction, hypoxanthine was detected
in 81% of the slices (1.8 ± 0.3 μm, n = 13 slices), inosine
was detected in 50% of the slices (2.5 ± 1.1 μm, n = 8
slices) and adenosine was detected in only 12.5% of
the slices (1.2 ± 0.5 μm, n = 2 slices Fig. 2E). Thus both
methods of purine measurement gave similar results: no
ATP was detected, an adenosine tone was occasionally
Figure 3. Exogenous ATP is metabolised by cerebellar slices
A, example traces from adenosine (ADO), null, inosine (INO) and
hypoxanthine (HYPO) biosensors placed on the surface of a cerebellar
slice. Following application of 100 μM ATP, currents were produced on
all the sensors except the null. B, the traces from A, calibrated and
subtracted illustrating the metabolism of ATP to adenosine, inosine,
and hypoxanthine. C, graph plots the mean concentration of ATP
metabolites measured at the surface of slices (n = 6) and within slices
(n = 7) following application of 100 μM ATP.
present and most slices exhibited a tone for inosine and or
hypoxanthine.
The inability to reliably detect adenosine with the
biosensors contrasts with electrophysiological studies on
synaptic transmission that demonstrate an extracellular
adenosine tone in 90% of cases. Adenosine could be
metabolised to inosine and hypoxanthine before it reaches
the sensors, and may thus be present only in the restricted
space around parallel fibre synapses. However it is very
unlikely that the sensors will not sample from this
compartment, as the synapses are present at a high density
in the molecular layer.
A more likely explanation for this discrepancy is that
the subtraction procedure used to measure adenosine
is inaccurate. This could arise from a non-uniform
distribution of the analytes adenosine, inosine and
hypoxanthine, which would reduce the accuracy of the
subtraction procedure (see Methods) In many cases,
subtraction of the calibrated INO sensor signals implied a
negative concentration of adenosine (clearly impossible),
strongly indicating non-uniform concentrations of
inosine and hypoxanthine. Our data suggest considerable
variation in the levels of inosine (0–0.6 μm) and
hypoxanthine (range 0.1–3 μm) between slices. If this
reflects hotspots of release/production, depending on
enzyme location relative to sensor position, then the
differential measurement procedure will not give accurate
concentrations of adenosine and inosine.
Exogenous ATP and adenosine are metabolised
through to hypoxanthine
To test whether: (1) adenosine can be metabolised to
inosine and hypoxanthine (to give the observed purine
tone), (2) adenosine can be detected in cerebellar slices, and
(3) there are hotspots of extracellular purine metabolism,
exogenous ATP was applied to slices and the real-time
production of metabolites was measured using ADO,
INO and HYPO biosensors. As before, this experiment
was carried out in two ways: firstly non-invasively with
sensors placed close to the slice surface, and secondly with
the biosensors placed within the slice. The inflow was
changed from control saline to 100 μm ATP for 5 min.
The exact duration of the ATP application is not known
(as the 5 min includes the time taken for the ATP to
reach the bath and exchange with the bath solution).
However, because the flow rate is constant, the applications
will be reproducible. Application of ATP rapidly resulted
in the detection of 3.8 ± 1 μm adenosine, 0.3 ± 0.2 μm
inosine and 0.14 ± 0.03 μm hypoxanthine at the slice
surface (n = 6, Fig. 3). Similar results were found when
the biosensors were placed within the slice (2.5 ± 0.6 μm
adenosine, 0.5 ± 0.3 μm inosine and 0.3 ± 0.1 μm hypo-
xanthine, n = 7, Fig. 3C). In all slices, after subtraction,
C© 2007 The Authors. Journal compilation C© 2007 The Physiological Society
J Physiol 582.1 Cerebellar control of purines 143
there was a positive amount of adenosine demonstrating
that the subtraction procedure was successful. This
confirms that biosensors can be used to measure adenosine
in cerebellar slices.
To test that the inosine arose from the metabolism
of adenosine and that hypoxanthine arose from inosine
breakdown, adenosine and inosine were applied to slices.
Following a 1 min application of 100 μm adenosine,
3.2 ± 0.7 μm inosine and 0.3 ± 0.06 μm hypoxanthine
were detected (n = 5) and 100 μm inosine produced
0.7 ± 0.1 μm hypoxanthine (n = 5). These results
demonstrate that cerebellar slices contain the enzymes that
rapidly break down adenosine to hypoxanthine (adenosine
deaminase and purine nucleoside phosphorylase). Thus
it is feasible for the inosine/hypoxanthine tone to arise
from the breakdown of endogenous adenosine. The
breakdown of ATP to adenosine suggests that the
extracellular metabolism of ATP could be a potential
source of adenosine.
There was considerable variation in the relative
quantities of the metabolites detected following ATP
application. At the surface of the slice, the proportion
of ATP metabolites (relative proportions of adenosine,
inosine and hypoxanthine) ranged from 25% to 91%
for adenosine, (mean 84 ± 7%), inosine accounted for
0–60% (mean 11 ± 6%) and hypoxanthine accounted for
0–14% (mean 5 ± 1%). Similar results were observed
with biosensors placed within slices. This suggests that
the distribution of metabolising enzymes within slices is
not uniform and that the positioning of the biosensors
relative to the enzymes may dictate the proportions of
metabolites detected. This strengthens the argument that
the inability to detect basal levels of adenosine using
biosensors results from a non-homogenous distribution
of inosine/hypoxanthine in the cerebellum.
Extracellular purine nucleoside phosphorylase (PNP)
is present in the cerebellum
The conversion of inosine to hypoxanthine is catalysed
by purine nucleoside phosphorylase (PNP) which is an
important enzyme in the salvage of nucleotide bases
(Bzowska et al. 2000). Although PNP is considered an
intracellular enzyme it has been described in rat CSF (Silva
et al. 2004). The production of hypoxanthine following
ATP, adenosine or inosine application suggests that an
extracellular form of PNP is expressed in the cerebellum.
To confirm the extracellular expression of PNP, we used
a specific inhibitor of PNP, immucullin H (Horenstein
& Schramm, 1993). Immucullin H (200 nm) caused a
66 ± 3% reduction in the production of hypoxanthine
(following changing the inflow from control saline to
100 μm inosine for 2.5 min) as measured by a HYPO
biosensor laid on the surface of the slice (n = 3, Fig. 4A).
Immucullin H had no effect on the responsiveness of the
HYPO sensor to hypoxanthine, and HYPO sensors could
not detect inosine (Fig. 4B)
What determines the extracellular concentration
of adenosine in the cerebellum?
Adenosine kinase. Adenosine kinase is a key intra-
cellular enzyme that phosphorylates adenosine to form
AMP and thus maintains low levels of intracellular
adenosine helping to prevent efflux via equilibrative
transporters (for review see Boison, 2006). To
assess whether adenosine kinase is important in the
cerebellum, we blocked the enzyme adenosine kinase
with iodotubercidin and measured the effects on synaptic
transmission and the extracellular concentration of
adenosine. Application of iodotubercidin (1–2 μm)
reliably inhibited PF EPSPs (9 out of 10 slices, 51 ± 2%,
Fig. 5A) and increased the paired pulse ratio (from
1.58 ± 0.06 to 1.86 ± 0.02) indicating a presynaptic
action. The effects of iodotubercidin were reversed
by 8CPT (1 μm) and the mean increase in PF EPSP
amplitude was much larger (168 ± 21%) than in
control (46.1%) indicating increased A1 receptor
Figure 4. Extracellular purine nucleoside phosphorylase (PNP)
metabolises inosine to hypoxanthine in cerebellar slices
A, record from a HYPO biosensor placed on the surface of a cerebellar
slice (the sensor was bent so that it was laid parallel to the slice
surface, increasing the sensitivity of purine detection). Application of
100 μM inosine (bar) produced a large current on the sensor due to
rapid conversion of inosine to hypoxanthine. Application of the PNP
inhibitor, immucillin H (200 nM), markedly reduced the conversion of
inosine to hypoxanthine. Following wash there was recovery in the
conversion of inosine to hypoxanthine. B, the same sensor as A, with
no slice present. The sensor responds to hypoxanthine but does not
respond to inosine.
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Figure 5. Inhibition of adenosine kinase increases the
extracellular concentration of adenosine
A, the adenosine kinase inhibitor iodotubercidin (1 μM) caused a
reduction in PF EPSP amplitude (∼50%) which was reversed by the A1
receptor antagonist 8CPT (1 μM). At the end of the experiment, PF
EPSPs were blocked by kynurenate (5 mM). Graph plots the amplitude
of individual PF EPSPs against time. Inset, iodotubercidin (1 μM) caused
an increase in the paired pulse ratio, confirming presynaptic inhibition
due to adenosine efflux. Graph plots the paired pulse ratio against
time for the PF EPSPs in A. The average paired pulse ratio for five EPSPs
is plotted. B, trace from an ADO and INO sensor placed within the
same slice as A. Application of iodotubercidin (1 μM) produced a
current on the ADO sensor with little effect on the INO sensor. After
calibration there was a net increase in the extracellular adenosine
activation. Iodotubercidin was without effect in only
one slice (although EPSP amplitude was increased by
8CPT, suggesting the presence of an adenosine tone).
Simultaneous biosensor measurements reliably detected
an increased level of purines following iodotubercidin
application (8 out of 10 slices, Fig. 5B). After subtraction,
the concentration of adenosine was increased by
0.68 ± 0.1 μm and inosine was increased by 0.37 ± 0.2 μm.
The consistent increase in adenosine suggests that
adenosine kinase is an important and global mechanism
for determining the extracellular concentration of purines
in cerebellar slices. This also demonstrates that our method
of measuring adenosine is reliable and that the variable
results obtained with other manipulations of adenosine
concentration must be due to biological not technical
mechanisms.
To investigate whether the equilibrative transporters
mediate the increase in adenosine tone following block
of adenosine kinase, we applied NBTI/dipyridamole (to
block ENT1/ENT2) prior to application of iodotubercidin
(to inhibit adenosine kinase). NBTI and dipyridamole
have been used to block ENT1 and ENT2 in a number
of studies (Dunwiddie & Diao, 1994; Frenguelli et al.
2007). In four out of eight slices, the inhibitory actions
of iodotubercidin were almost completely occluded by
the prior application of NBTI/dipyridamole (Fig. 5C). At
these synapses the equilibrative transport of adenosine
was abolished and thus the increase in intracellular
adenosine concentration (as a result of adenosine kinase
inhibition) did not result in adenosine efflux. In the
remaining four slices, NBTI/dipyridamole did not occlude
the actions of iodotubercidin (Fig. 5D). Presumably in
these slices, the equilibrative transport of adenosine
was not effectively blocked and thus the increase in
intracellular adenosine concentration (as a result of
adenosine kinase inhibition) still resulted in an efflux
of adenosine. These results suggest heterogeneous
expression of synaptic adenosine transporters with
different proportions of NBTI-/dipyridamole-sensitive
transporters expressed at different synapses.
concentration of ∼0.5 μM. C, the equilibrative transport inhibitors
NBTI (5 μM) and dipyridamole (10 μM) inhibited PF EPSP amplitude and
occluded the effects of iodotubercidin. Although iodotubericidin
(2 μM) had no effect on PF EPSP amplitude (in the presence of
NBTI/dipyridamole), the adenosine receptors were not saturated as
application of adenosine (100 μM) produced increased inhibition. The
modulation of PF EPSPs was reversed by block of A1 receptors (1 μM
8CPT), and EPSPs were blocked by kynurenate (5 mM) at the end of
the experiment. D, NBTI (5 μM) and dipyridamole (10 μM) caused a
small inhibition of PF EPSP amplitude but did not occlude the effects of
iodotubercidin. Application of 2 μM iodotubericidin (in the presence of
NBTI/dipyridamole) markedly inhibited EPSP amplitude. The
modulation of PF EPSPs was reversed by block of A1 receptors (1 μM
8CPT), and EPSPs were blocked by 5 mM kynurenate at the end of the
experiment.
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Equilibrative transporters. We further tested the role
of equilibrative transporters (ENT1 and ENT2) in the
control of the adenosine tone. Adenosine can be removed
from the extracellular space by transport into neurons
and glia. Long applications (30 min) of NBTI (5 μm)
and dipyridamole (10 μm) had variable effects on PF
EPSP amplitude and biosensor measurements (n = 18
slices). Results could be divided into three categories: in
nine slices, PF EPSP amplitude was decreased (47 ± 8%)
with an increase in PPF (from 1.6 ± 0.1 to 1.9 ± 0.1)
and a large increase in EPSP amplitude following 8CPT
(1 μm) application (180 ± 20% vs. 46.1 ± 8.6%, Fig. 6A),
indicating increased A1 receptor activation. However
there was no shift in the baseline current measured by
purine biosensors, suggesting no change in the bulk
concentration of purines within the slice (Fig. 6B). In one
additional slice, as well as reducing PF EPSP amplitude,
the block of adenosine uptake also increased the purine
(inosine/hypoxanthine) concentration measured by the
biosensor (Fig. 6C). In the final eight slices, blocking
adenosine transport had little or no effect on either
PF EPSP amplitude (decrease 3 ± 6%, PPF 1.56 ± 0.1
vs. 1.5 ± 0.1) or biosensor baseline current. However
application of 8CPT (1 μm) still increased EPSP amplitude
by 55 ± 17% (vs. 46.1 ± 8.6% in control) suggesting
that a baseline level of adenosine was present in these
synapses (Fig. 6D). These highly variable data do not reflect
technical deficiencies of measurement, as iodotubercidin
reliably evokes changes in adenosine tone. Rather
they probably reflect that NBTI-/dipyridamole-sensitive
transporters determine the concentration of purines at
only a subset of parallel fibre to Purkinje cell synapses.
Adenosine deaminase. As well as being an intracellular
enzyme, adenosine deaminase can convert extracellular
adenosine to inosine. As our biosensor measurements
routinely detect an extracellular inosine and hypoxanthine
tone, we have investigated the contribution of adenosine
deaminase to this tone by means of simultaneous biosensor
and PF EPSP recordings in the presence of EHNA, a
selective blocker of adenosine deaminase (Agarwal, 1982).
Although the increase in adenosine concentration
cannot be measured directly (biosensor detection of
adenosine uses adenosine deaminase), the effects of EHNA
can be monitored via changes in PF EPSP amplitude and
by changes in inosine/hypoxanthine concentration. EHNA
(20 μm) is effective at inhibiting adenosine deaminase as it
blocks the adenosine deaminase present on the adenosine
biosensor, with no effect on the detection of inosine and
hypoxanthine (Wall & Dale, 2007). Application of EHNA
had only minor effects on PF EPSPs: the mean PF EPSP
amplitude was slightly reduced (11 ± 5%) and the paired
pulse ratio was increased (from 1.4 ± 0.07 to 1.6 ± 0.07,
n = 7, Fig. 7A and B). Furthermore, application of 1 μm
8CPT (in the presence of EHNA) produced a significantly
Figure 6. Blocking equilibrative transport has heterogeneous
effects
A, application of ATP (100 μM) caused a reversible inhibition of PF
EPSP amplitude. Block of equilibrative transport with 5 μM NBTI and
10 μM dipyridamole caused a reduction in PF EPSP amplitude, which
was reversed by block of A1 receptors with 8CPT (1 μM). PF EPSPs
were blocked by CNQX at the end of the experiment. Graph plots the
amplitude of individual PF EPSPs against time. Inset, application of ATP
(∗) and NBTI/dipyridamole caused an increase in the paired pulse ratio,
confirming a presynaptic site of action. Graph plots the paired pulse
ratio against time for the PF EPSPs in A. The average paired pulse ratio
for five EPSPs is plotted. B, trace from an ADO biosensor present in the
same slice as A. Application of 100 μM ATP caused an increase in
adenosine concentration (as a result of metabolism), but 5 μM
NBTI/10 μM dipyridamole had no effect. C, trace from an ADO
biosensor in a different slice. Application of 5 μM NBTI/10 μM
dipyridamole produced a current on the sensor, suggesting an increase
in the concentration of purines in the bulk of the slice. D, application
of ATP (100 μM) caused a reduction in PF EPSP amplitude, but 5 μM
NBTI/10 μM dipyridamole had no effect. There was also no effect on
the paired pulse ratio (not illustrated). There is an adenosine tone, as
block of A1 receptors with 8CPT (1 μM) increased PF EPSP amplitude.
PF EPSPs were blocked by CNQX (10 μM) at the end of the experiment.
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larger increase in PF EPSP amplitude than in control
(84 ± 19% vs. 46.1 ± 8.6%), demonstrating greater A1
receptor activation. Simultaneous biosensor recordings
revealed a fall in the extracellular levels of inosine
Figure 7. The metabolism of adenosine contributes to the
extracellular inosine/hypoxanthine tone but has little effect on
synaptic transmission
A, the adenosine deaminase inhibitor EHNA (20 μM) caused a
reduction in EPSP amplitude (∼17%), which was reversed by block of
A1 receptors with 8CPT (1 μM). EPSPs were blocked at the end of the
experiment with 5 mM kynurenate. Graph plots the amplitude of
individual PF EPSPs against time. B, EHNA caused an increase in the
paired pulse ratio whereas 8CPT reduced the ratio, confirming a
presynaptic site of action. Graph plots the paired pulse ratio against
time for the PF EPSPs in A. The average paired pulse ratio for five EPSPs
is plotted. C, trace from an INO sensor placed within the same slice as
A. Application of EHNA caused a fall in the concentration of the
adenosine metabolites inosine/hypoxanthine.
and hypoxanthine, which was coincident with the effect
on PF EPSP amplitude (Fig. 7C) There was a fall in
hypoxanthine concentration of 1.2 ± 0.7 μm (7 out of 7
slices) and a fall in inosine concentration of 0.3 ± 0.2 μm (4
out of 7 slices). As the basal concentration of hypoxanthine
in the slices is 1.8 μm, then at least 66% of the hypo-
xanthine arises from the metabolism of adenosine. The
remaining hypoxanthine could arise from other sources
such as inosine monophosphate. Although ecto-adenosine
deaminase does contribute to the inosine/hypoxanthine
tone, it does not appear to be the major regulator of the
adenosine tone.
Endogenous sources of extracellular adenosine
We have recently demonstrated that action potential-
dependent adenosine release occurs in response to short
trains of electrical stimuli in the molecular layer (Wall
& Dale, 2007). If this adenosine were to be metabolised
to inosine/hypoxanthine then it could contribute to the
extracellular purine tone. We therefore stimulated in the
molecular layer and recorded the release of adenosine
(with an ADO sensor) and measured any breakdown of
the released adenosine to hypoxanthine (with a HYPO
sensor). Following stimulation there was a rapid release
of adenosine (as previously described, Wall & Dale, 2007)
measured on the ADO sensor, followed by a much slower
build-up of hypoxanthine detected by the HYPO sensor
(n = 6, Fig. 8A). If the entire ADO sensor signal was due
to adenosine, then 360 ± 100 nm adenosine was released,
which was metabolised to 45 ± 58 nm hypoxanthine. Both
the adenosine and hypoxanthine signals were blocked
following addition of TTX to block action potentials
(1 μm, n = 3). If the action potential-dependent release of
adenosine occurs spontaneously, then it could contribute
to the inosine/hypoxanthine tone measured in slices.
Blocking action potential adenosine release with TTX
(1 μm) produced a small fall (∼15 pA) in the baseline
current of the ADO biosensor in three out of ten slices,
suggesting that activity-dependent adenosine is only a
minor contributor to the purine tone in the slice. However
in vivo this source of adenosine may be more important,
as there is much greater parallel fibre activity.
We next tested whether release of ATP is the source
of endogenous adenosine (and the inosine/hypoxanthine
tone). Under control conditions we could not measure any
extracellular ATP (in or above the slice), suggesting either
that little ATP is released or that it is rapidly metabolised.
We thus inhibited the metabolism of ATP with ARL67156
(100 μm), an inhibitor of ecto-ATPase (Crack et al.
1995). Following ARL67156 application, there was still no
difference between ATP and null sensors at either room
temperature (n = 15) or 33–35◦C (n = 20). Similar results
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Figure 8. What is the source of endogenous adenosine?
A, superimposed traces from ADO and HYPO biosensors placed
parallel to the molecular layer surface. Following stimulation (5 V,
20 Hz, 10 s) in the molecular layer, adenosine is released and a
proportion is metabolised to hypoxanthine. The traces are normalised
were found with other ecto-ATPase inhibitors: PPADS
(10–100 μm), suramin (100 μm), dipyridamole (10 μm,
Connolly & Duley, 2000) and Evans Blue (100 μm). We
have previously shown that the agents ARL67156 and
Evans Blue are effective inhibitors of ATP breakdown by
cerebellar slices (Wall & Dale, 2007).
An alternative approach to directly observing the
release of ATP is to inhibit the conversion of ATP
to adenosine and thus measure a fall in adenosine
concentration (measured as an increase in PF EPSP
amplitude and by a fall in inosine/hypoxanthine levels).
The ecto-5′-nucelotidase inhibitor α,β-methylene-ADP
was used to reduce the conversion of AMP to adenosine
(effective in the cerebellum, Wall & Dale, 2007). To
increase the likelihood of reducing the conversion of
ATP to adenosine, α,β-methylene-ADP (100 μm) was
applied in combination with ARL67156 (100 μm). In the
majority of slices (n = 8) there was no effect on either
PF EPSP amplitude or biosensor current (Fig. 8B and
C). In four slices there was a small reversible decrease
in inosine/hypoxanthine levels, as detected by a fall in
the baseline current measured by biosensors (mean fall
in current 49 ± 35 pA, Fig. 8E). In three out of the four
slices this was accompanied by a small increase in PF
EPSP amplitude (mean increase 8.6 ± 5.8%, Fig. 8D).
Upon wash there was a transient increase in adenosine
concentration, presumably as accumulated ADP and
AMP are rapidly broken down to adenosine by the now
uninhibited enzymes. This was measured by biosensors as a
current increase of 56 ± 23 pA and by a transient reduction
in PF EPSP amplitude of 36.6 ± 11% (Fig. 8D and E). We
therefore find that metabolism of ATP may contribute to
the production of adenosine in some slices, but that in
many slices this does not appear to be the source of the
purine tone.
by the biosensor calibration, assuming that all ADO biosensor signal
results from adenosine detection. B, application of
α,β-methylene-ADP (100 μM) and ARL67156 (100 μM), to reduce
conversion of ATP to adenosine, had no effect on PF EPSP amplitude.
However, application of 8CPT (1 μM) increased PF EPSP amplitude,
demonstrating that synaptic A1 receptors were activated by
endogenous adenosine. Graph plots the amplitude of individual PF
EPSPs against time. C, trace from ADO biosensor positioned in the
same slice as A. Application of 100 μM α,β-methylene-ADP and
ARL67156 had no effect on the baseline current. D, application of
α,β-methylene-ADP (100 μM) and ARL67156 (100 μM) increased PF
EPSP amplitude. Upon wash there was a transient reduction in PF EPSP
amplitude below control levels. E, trace from ADO biosensor
positioned in the same slice as D. Addition of α,β-methylene-ADP and
ARL67156 caused a reduction in the baseline current (reduction in the
conversion of ATP to adenosine, coincident with increase in PF EPSP
amplitude). Upon wash there was a transient increase in the level of
adenosine, which coincided with the inhibition of PF EPSP amplitude.
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Discussion
Many studies have demonstrated the presence of an
adenosine tone in the CNS (including the cerebellum,
Takahashi et al. 1995; Dittman & Regehr, 1996). We
have confirmed this by examining synaptic transmission.
Nevertheless, direct measurements with biosensors failed
to reliably detect an extracellular adenosine tone in the
cerebellum. Instead we demonstrated the presence of an
extracellular inosine and hypoxanthine tone that arises
(at least in part) from the breakdown of adenosine.
The conversion of adenosine to hypoxanthine requires
the extracellular expression of adenosine deaminase and
purine nucleoside phosphorylase (PNP). The inhibition of
the conversion of inosine to hypoxanthine by the specific
PNP inhibitior immucullin-H confirms the extracellular
expression of PNP. This is unexpected since PNP is
usually considered an intracellular enzyme (Bzowska et al.
2000). Interestingly, astrocytes cultured from neonatal
cerebellum also metabolise exogenous ATP to hypo-
xanthine (Wink et al. 2003), suggesting that the adenosine
metabolising enzymes could be expressed by glia. The
rationale for the conversion of adenosine to inosine seems
obvious: the conversion of active (adenosine) to inactive
(inosine) molecules. Although inosine is often considered
inert, its metabolism to hypoxanthine suggests that it
may be functionally active and plays some role in the
cerebellum. There is growing support for inosine being
active as it appears to play a role in the immune system
and may be neuroprotective (Hasko et al. 2004).
Inability to directly detect endogenous adenosine
with biosensors
In common with findings in other studies (Takahashi et al.
1995; Dittman & Regehr, 1996), parallel fibre–Purkinje
cell synaptic transmission is tonically inhibited by endo-
genous adenosine in cerebellar slices. However we
have been unable to directly measure this extracellular
adenosine using biosensors. A similar finding has been
reported in the hippocampus where an adenosine tone
was not detectable in three out of four slices, although
tonic adenosine-mediated synaptic inhibition was present
(Frenguelli et al. 2007). It is unlikely that the
levels of adenosine are below the levels of detection,
as pharmacological experiments have estimated that
200–400 nm adenosine is present in the extracellular space
of the brain (Dunwiddie & Diao, 1994). This concentration
of adenosine would give a current on an ADO biosensor
of 60–120 pA, which in normal conditions would easily be
detected. There are two possibilities which would explain
this inability to detect adenosine: firstly, adenosine is
metabolised to inosine/hypoxanthine before it reaches the
sensor. It could be argued that the sensor is further from
the adenosine release sites than the A1 receptors and thus
breakdown in or around the synapses occurs before any
purines reach the biosensor. However the large density
of parallel fibre synapses in the molecular layer makes it
unlikely that the sensor does not sample from the synaptic
compartment. Furthermore, blockade of extracellular
breakdown (with EHNA) had little effect on synaptic
inhibition, suggesting that it is not the major mechanism
of removing adenosine. Dilution of adenosine before
detection was also unlikely, as biosensors were inserted
through the slice and the sensing area of the biosensors
was in intimate contact with the tissue. Secondly, it is more
likely that a non-homogenous distribution of inosine and
hypoxanthine in the extracellular space prevented reliable
measurement of adenosine for technical reasons. If the
levels of inosine/hypoxanthine are not equivalent for each
sensor (ADO, INO and HYPO), then upon subtraction
an inaccurate adenosine concentration will be measured.
A failure of subtraction will result in either an over-
estimate or underestimate of the adenosine concentration.
Subtraction of the calibrated inosine and hypoxanthine
signals gave either a negative adenosine signal or a large
adenosine signal (1–2 μm). The presence of a non-uniform
distribution of inosine and hypoxanthine is supported
by the observations that (1) there is a large variation in
the amount of inosine and hypoxanthine measured in
different slices, and (2) movement of sensors to different
parts of the slice detected differing amounts of inosine
and hypoxanthine following ATP application (M.J. Wall
and N. Dale, unpublished observations). A heterogeneous
distribution of inosine/hypoxanthine could stem from the
distribution of adenosine-metabolising enzymes. If the
enzymes are clustered (rather than spread uniformly),
then the positioning of the sensors relative to the enzymes
will determine the amounts of inosine and hypoxanthine
detected. Future work is required to test directly for the
clustering of enzymes. Despite these limitations we reliably
observed a purine tone. Furthermore, when we used
iodotubercidin (to block adenosine kinase) there was a
global increase in the adenosine tone, which was reliably
detected by the biosensors.
Control of purine levels in cerebellum compared
to other brain regions
The levels of adenosine in the cerebellum are controlled
by the balance between the rates of production and
elimination. The tone of inosine and hypoxanthine arises
(at least in part) from adenosine metabolism. What is
the source of this adenosine? The two major possibilities
are production via extracellular ATP breakdown (for
review see Zimmermann, 2000) or direct release (either
by transport or by exocytosis). Although we have used
several different methods to distinguish between these
possibilities, the major source of adenosine remains
uncertain. It has not been possible to directly measure
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ATP in cerebellar slices with biosensors (limit of detection
∼60 nm), and reducing ATP breakdown (with ecto-ATPase
inhibitors) did not reveal an ATP signal. Thus either the
ATP tone described by Brockhaus et al. (2004) (detected
indirectly by its effect on the spontaneous activity of
inhibitory interneurons) must be too small to detect by
our methods, or the breakdown of ATP is very rapid
and not prevented by the inhibitors. However, slowing
the conversion of ATP to adenosine did reduce the
concentration of adenosine metabolites in some slices.
However, the reduction was small (15%) and the effect
on EPSP amplitude was minor (10% increase vs. 46%
inhibition). Thus the contribution of ATP metabolism
to the purine tone appears minor. This contrasts with
the hippocampus, where metabolism of ATP is a major
contributor to the purine tone (Frenguelli et al. 2007;
Pascual et al. 2005).
We have recently described the release of adenosine in
response to focal electrical stimulation of the molecular
layer, a process which is both Ca2+ and TTX sensitive
(Wall & Dale, 2007). Blocking any spontaneous release of
action potential-dependent adenosine release with TTX
had only a small effect on the inosine/hypoxanthine tone.
However, in vivo, the activity of parallel fibres is much
greater and thus this source of adenosine may be much
more important.
Elimination of adenosine occurs by a combination
of two processes: metabolism (by adenosine deaminase)
to inactive metabolites and transport into neurons
and glia followed by phosphorylation to AMP (by
adenosine kinase). Using pharmacological agents, we have
investigated which of these components is more important
in determining extracellular adenosine levels in the
cerebellum. Changes in adenosine levels were assessed by
comparing synaptic inhibition with direct measurement of
purines via biosensors. Blocking adenosine deaminase had
minor effects on parallel fibre–Purkinje cell synaptic trans-
mission (∼10% reduction), but did reduce the levels of
extracellular inosine and hypoxanthine (∼50%) measured
by biosensors. The small effect of EHNA on synaptic
transmission suggests that extracellular metabolism is
not the major mechanism controlling synaptic adenosine
concentration, and adenosine deaminase maybe located
outside the synapses. Similar small effects of EHNA
on synaptic transmission in the hippocampus have also
been observed (Dunwiddie & Diao, 1994; Pak et al.
1994). The effect of EHNA on the inosine/hypoxanthine
tone demonstrates that around half of the tone arises
from adenosine metabolism (the rest may arise from
other sources such as inosine monophosphate). As the
tone of inosine/hypoxanthine is ∼1–2 μm, the adenosine
concentration would be expected to increase by 0.5–1 μm,
which should markedly increase synaptic inhibition. The
small effect of EHNA on synaptic transmission suggests
that any increase in adenosine is presumably diminished
by greater equilibrative transport into neurons and glia
around synapses.
In contrast to the minor effects of blocking metabolism,
inhibition of adenosine kinase produced a marked
decrease (∼50%) in PF EPSP amplitude in the majority
of slices, accompanied by a simultaneous increase
in adenosine concentration detected by biosensors.
The agreement of biosensor measurements with the
increase in synaptic inhibition suggests that blocking
adenosine kinase produces a global increase in adenosine
concentration. Presumably blockade of adenosine kinase
causes an increase in the intracellular concentration
of adenosine and a resultant efflux of adenosine via
equilibrative transporters (see Boison, 2006). The greater
importance of adenosine kinase activity compared to
extracellular adenosine metabolism has been observed in
other brain regions (Zhang et al. 1993; Pak et al. 1994;
Lloyd & Fredholm, 1995).
The role of equilibrative transport in determining
adenosine concentration was assessed by blocking ENT1
and ENT2. In ∼50% of parallel fibre–Purkinje cell
synapses, synaptic transmission was markedly inhibited
(∼45%) as a result of the build-up of adenosine following
the inhibition of adenosine transport. However (apart
from one slice), no increase in adenosine concentration
could be measured by biosensors. The effects of blocking
equilibrative transport were very inconsistent (compared
to blocking adenosine kinase). We can exclude any
technical difficulties in measuring an adenosine increase,
as adenosine was reliably detected following adenosine
kinase inhibition. Also, after removing the biosensors
from the tissue there was very little reduction in
sensitivity. Thus the biosensors retain their ability to detect
adenosine throughout the experiment. Furthermore,
similar biosensors could reliably detect an increase in
adenosine in hippocampal slices following application
of NBTI/dipyridamole (Frenguelli et al. 2007). The
most likely explanation is that equilibrative transport
in the cerebellum is not always effectively blocked by
application of NBTI/dipyridamole. This is supported
by the observation that we cannot always occlude
the effects of iodotubercidin by prior application
of NBTI/dipyridamole. Heterogeneous expression of
ENT1 and ENT2 could lead to variation in the
actions of NBTI/dipyridamole. Although rat ENT1 is
effectively blocked by NBTI, rat ENT2 is only weakly
blocked by NBTI and dipyridamole (Baldwin et al.
2004).Thus variable expression of ENT2 at parallel
fibre synapses, could plausibly account for the observed
effects of NBTI/dipyridamole. Alternatively, differential
phosphorylation of ENT1 and or ENT2 at different
synapses could change the proportion of transport
via ENT1 or ENT2 (Stolk et al. 2005). It is also
possible that there is heterogeneous expression of another
transporter (other than ENT1 and ENT2) that is
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insensitive to NBTI/dipyridamole. The variation in effect
of NBTI/dipyridamole between different slices suggests
that any rise in adenosine concentration is localised and
does not spread between all synapses. This is supported by
the observation that an increase in purine concentration
(following block of equilibrative transport) could only be
measured by biosensors in one slice. Although antibody
staining has revealed diffuse expression of the transporters
in the molecular layer, granule cell layer and Purkinje cell
bodies (Anderson et al. 1999a,b), the density of ENT1 and
ENT2 relative to each other and to individual synapses is
currently unclear.
In conclusion, we have demonstrated that a
combination of biosensor measurements and electro-
physiology can be used to determine how the basal
extracellular levels of adenosine are regulated. Using these
methods, we have documented an inosine/hypoxanthine
tone (undetectable by electrophysiology alone) that has a
heterogeneous distribution (which would not be observed
with either HPLC or microdialysis). The control of
extracellular adenosine concentration in the cerebellum
appears comparable to that in other brain regions where
the activity of adenosine kinase is the major determining
factor. However the variable effects of blocking adenosine
transport (on both synaptic inhibition and biosensor
measurements) suggest that the transporters display
an unexpected non-uniform distribution relative to
synapses.
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Adenosine signalling at immature parallel fibre–Purkinje
cell synapses in rat cerebellum
Alison Atterbury and Mark J. Wall
Neuroscience Group, Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK
The purine adenosine is an extracellular signalling molecule involved in a large number of
physiological and pathological conditions throughout the mammalian brain. However
little is known about how adenosine release and its subsequent clearance change during
brain development. We have combined electrophysiology and microelectrode biosensor
measurements to investigate the properties of adenosine signalling at early stages of cerebellar
development, when parallel fibre–Purkinje cell synapses have recently been formed (postnatal
days 9–12). At this stage of development, we could detect little or no inhibitory A1 receptor tone
in basal conditions and during trains of stimuli. Addition of pharmacological agents, to inhibit
adenosine clearance, hadonlyminor effects on synaptic transmission suggesting thatunderbasal
conditions, the concentration of adenosinemoving in and out of the extracellular space is small.
Active adenosine release was stimulated with hypoxia and trains of electrical stimuli. Although
hypoxia released significant concentrations of adenosine, the release was delayed and slow. No
adenosine release could be detected following electrical stimulation in the molecular layer. In
conclusion, at this stage of development, although adenosine receptors and the mechanisms of
adenosine clearance are present there is very little adenosine release.
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Abbreviations AD, adenosine deaminase; ADO biosensor, adenosine biosensor/INO inosine biosensor; CPA,
N 6-cyclopentyladenosine; 8-CPT, 8-cyclopentyltheophylline; EHNA, erythro-9-(2-hydroxy-3-nonyl)adenine; NBTI,
S-(4-nitrobenzyl)-6-thioinosine; PF, parallel fibre; PNP, purine nucleoside phosphorylase; XO, xanthine oxidase.
The purine adenosine is involved in many diverse CNS
processes including sleep, locomotion and respiration and
provides neuroprotection during hypoxia and ischaemia.
(for review see Boison, 2007). The mechanism of how
adenosine is released into the extracellular space is still,
in many cases, unclear (for review see Wall & Dale,
2008) but could occur by extracellular ATP metabolism
(ATP released by exocytosis, Edwards et al. 1992; Dale,
1998; or through gap junction hemi channels, Pearson
et al. 2005), adenosine transport from the cell cytoplasm
(Craig & White, 1993; Sweeney, 1996) or possibly by
the exocytosis of adenosine itself (Wall & Dale, 2007).
Once released, the actions of adenosine are terminated
by a combination of extracellular metabolism to inosine
(by the enzyme adenosine deaminase) and transport
into neuronal or glial cytoplasm by equilibrative trans-
porters such as ENT1 and ENT2 or concentrative trans-
porters (for review see Noji et al. 2004; Baldwin et al.
2004). Once internalised adenosine is phosphorylated (by
adenosine kinase) to form AMP, maintaining low levels
of intracellular adenosine (for review see Boison, 2007).
Because the levels of adenosine are determined by the
interplay of enzymes and transporters, a number of studies
have investigated which components play a major role
in determining extracellular adenosine concentration. In
many studies blocking adenosine kinase has a major
effect on adenosine concentration where extracellular
metabolism (via adenosine deaminase) appears less
important (Pak et al. 1994; Lloyd & Fredholm, 1995; Wall
et al. 2007).
Although adenosine release probably occurs in most
brain areas, relatively little is known about how adenosine
release, receptor signalling and clearance change during
brain development. At the calyx of Held in mice, A1
receptor expression declines during the second postnatal
week (Kimura et al. 2003). In the hippocampus, there
is a developmental increase in the A1 receptor tone at
CA1 synapses, with no change in receptor properties
(Psarropoulou et al.1990).There is also a shift of adenosine
kinase expression fromneurones toastrocytes (Studer et al.
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2006). Adenosine appears amore potent anticonvulsant in
hippocampal slices from adult rats compared to immature
rats (Descombes et al. 1998). This is supported by the
observation that pair pulse facilitation shows greater
enhancement in young adult slices (P28–35) compared
to juvenile slices (P15–21) even though the amount of
synaptic depression was similar (Dumas & Foster, 1998).
Thus the aim of this study is to combine biosensor
measurements and electrophysiology to investigate the
properties of adenosine signalling at a period early in
cerebellar development, soon after synapse formation.
The glutamatergic parallel fibre–Purkinje cell synapse is
formed around postnatal day 5 in the rat (Altman, 1972)
and we have investigated the properties of adenosine
signalling between postnatal days 9 and 12 (the earliest
period when extracellular field parallel fibre–Purkinje cell
EPSPs can reliably be measured). Previous studies have
shown that adenosine A1 receptors are present at the
synapses at postnatal days 10–15 (Takahashi et al. 1995),
with A1 receptors expressed in the cerebellum before
birth (Weaver, 1996). In previous studies (from P21–28)
rats we have shown that there is a tone of extracellular
adenosine which tonically inhibits parallel fibre–Purkinje
cell synapses. The concentration of this adenosine is
controlled, in the main, by the level of adenosine kinase
activity (Wall et al. 2007). The source of this extracellular
adenosine is currently unclear but it does not appear
to arise from action potential-dependent release (Wall &
Dale, 2007).
Methods
Preparation of cerebellar slices
Transverse slices of cerebellar vermis (400 μm) were
prepared from male Wistar rats, at postnatal days 9–28
(P9–28). As described previously (Wall et al. 2007) and in
accordance with the UK Animals (Scientific Procedures)
Act 1986, male rats were killed by cervical dislocation
and decapitated. The cerebellumwas rapidly removed and
slices were cut on a Microm HM 650V microslicer in cold
(2–4◦C) highMg2+, low Ca2+ artificial cerebrospinal fluid
(aCSF; composed of, mM: 127 NaCl, 1.9 KCl, 7–8 MgCl2,
0.5 CaCl2, 1.2 KH2PO4, 26NaHCO3, 10 D-glucose (pH 7.4
when bubbled with 95% O2–5% CO2, 300mosmol l−1).
Slices were stored in normal aCSF (1.3 mMMgCl2, 2.4 mM
CaCl2) at room temperature for 1–6 h before recording.
Extracellular recording
An individual slicewas transferred to a recording chamber,
submerged inaCSFandperfusedat 6ml min−1 (30–32◦C).
The slice was placed upon a suspended grid to allow
perfusion from above and below, and this reduce the
likelihood of hypoxia. Furthermore, all solutions were
vigorously bubbled (95% O2–5% CO2) and all tubing
had low gas permeability (Tygon). For the stimulation
of parallel fibres, square voltage pulses (2–5 V, 200μs
duration) were delivered by an isolated pulse stimulator
(model 2100, AM systems, Everett, WA, USA) via a
concentric bipolar metal stimulating electrode (FHC
Inc., Bowdoin, ME, USA) placed on the surface of the
molecular layer. The recording electrode (an aCSF filled
microelectrode) was placed on the same track along which
the parallel fibres travel (‘on-beam’, Yuan & Atchison,
1999). A typical extracellular field potential consisted of a
presynaptic fibre volley followed by a component which
could be blocked by 1μM TTX and greatly reduced by
5mM kynurenate. This component is probably produced
by parallel fibre mediated glutamatergic excitatory
synaptic currents in Purkinje cells and interneurones
(Clark & Barbour, 1997). Parallel fibre EPSP amplitude
was estimated from the kynurenate sensitive potential,
which was measured by subtracting what remained in
kynurenate from control potentials. Confirmation of PF
EPSP identity was achieved by evoking pairs of EPSPs
(interval 50ms) and observing facilitation (20–30%), and
by examining the pharmacological profile (inhibition by
A1, GABAB or mGlu4R receptor agonists). Extracellular
recordings were made using an ISO-DAM extracellular
amplifier (WPI, Sarasota, FL, USA), filtered at 1 kHz and
digitised on-line (10 kHz) with a Micro 1401-2 (Mark 2)
interface controlled by Spike software (v. 6.1) (Cambridge
Electronic Design, Cambridge, UK).
Purine biosensors
Biosensors were obtained from Sarissa Biomedical Ltd
(Coventry, UK). In brief the biosensors consisted of
entrapped enzymes (adenosine deaminase, AD; purine
nucleoside phosphorylase, PNP; and xanthine oxidase,
XO) within a matrix that was deposited around a Pt or
Pt/Ir (90/10) wire etched to∼50μm (Llaudet et al. 2003).
The biosensor had an exposed length of ∼500μm that
was coated with enzymes and thus capable of detecting
purines. Biosensors were screened, which greatly reduced
the responses to electro-active interferents (such as 5-HT,
noradrenaline, dopamine and ascorbate). Three types
of purine biosensor were used in this study to identify
the released substances. Firstly, a screened null sensor,
possessing thematrix but no enzymes, was used to control
for the release of any non-specific electro-active inter-
ferents. Secondly, screened biosensors containing PNP
and XO (responsive to inosine and hypoxanthine) and
NP, XO and AD ((INO) responsive to inosine, hypo-
xanthine and adenosine (ADO))were used. The difference
signal between these two types of biosensors gave the
specific adenosine and adenosine metabolite (inosine and
C© 2009 The Authors. Journal compilation C© 2009 The Physiological Society
) at University of Warwick on August 20, 2010jp.physoc.orgDownloaded from J Physiol (
J Physiol 587.18 Development of adenosine signalling 4499
hypoxanthine) signals. A full description of the properties
of the biosensors has already been published but they show
a linear response to increasing concentration of analyte,
are fast to respond, and have a rise time of less than 10 s
(Llaudet et al. 2003).
The biosensors were positioned just above the surface
of the molecular layer. Biosensors were bent so their
longitudinal surface was parallel to the slice surface,
thus increasing the detection area (Wall & Dale, 2007).
Biosensors were calibrated with known concentrations
(10μM) of adenosine and inosine. The screening of
biosensors was checked by applying 10μM of 5-HT.
Calibration was performed before the slice was present
in the perfusion chamber and after the slice had been
removed; this allowed measurement of any reduction in
sensitivity during the experiment. Biosensor signals were
acquired at 1 kHz with a Micro 1401-2 (Mark 2) interface
using Spike (v. 6.1) software.
Drugs and substances
All drugs were made up as 10–100mM stock
solutions, stored frozen and then thawed and
diluted with aCSF on the day of use. Adenosine,
inosine, S-(4-nitrobenzyl)-6-thioinosine (NBTI),
8-cyclopentyltheophylline (8-CPT), and dipyridamole
were purchased from Sigma. Iodotubercidin was
purchased from Sigma and Molekula (Fine Chemicals,
Gillingham,Dorset, UK). Erythro-9-(2-hydroxy-3-nonyl)
adenine (EHNA) was purchased from Tocris-Cookson
(Bristol, UK). Kynurenic acid and CNQX were purchased
fromAscent Scientific (Bristol, UK). Hypoxia was induced
by changing the inflow from oxygenated aCSF to aCSF
bubbled with N2 (95%)–CO2 (5%).
Results
The tonic inhibition of parallel fibre–Purkinje cell
synapse by endogenous adenosine is greatly reduced
or absent in slices from P9–12 rats
Previous studies have shown that A1 adenosine receptors
at parallel fibre–Purkinje cell synapses tonically inhibit
synaptic transmission, suggesting the continual presence
of extracellular adenosine (Takahashi et al. 1995; Wall
et al. 2007). We have investigated whether such tonic A1
receptor-mediated inhibition is present at a developmental
period soon after the formation of parallel fibre–Purkinje
cell synapses (postnatal days 9–12). Application of the
A1 receptor antagonist 8-CPT (1–2μM) had no effect
on the amplitude of PF EPSPs or the paired pulse ratio
in 9 out of 20 slices (45%, Fig. 1A and B). In the
remaining 11 slices, 8-CPT increased PF EPSP amplitude
by 13.4± 2.6%. Overall the block of A1 receptors only
increased EPSP amplitude by 7.4± 5.6% (n = 20), which
is significantly less (P < 0.001) than that observed in
interleaved experiments on slices from P21–28 rats
(45.6± 7% increase, 8 slices Fig. 1B and see Wall et al.
2007). There was no correlation between the age of rat
(between P9 and 12) and the presence or absence of an
adenosine receptor tone.
A reduced adenosine A1 receptor tone, early in
development, could result from low receptor expression
or the expression of low affinity A1 receptors. This was
tested by applying adenosine (100μM) to inhibit PF EPSPs
(n = 54 slices) and then following wash, applying 8-CPT
(1–2μM) to measure the A1 receptor tone. There were
some synapses where adenosine (100μM) had little or
no effect on synaptic transmission. These synapses were
not investigated further as presumably they would have
no A1 receptor tone. In the remaining synapses (where
100μMadenosine produced at least a 50% reduction in PF
EPSP amplitude), adenosine produced the same reduction
in PF EPSP amplitude whether or not an inhibitory
adenosine receptor tonewas present (no tone, 70.5± 5.4%
vs. 68.5± 4.7% with mean tone of 14.3± 2.8%; Fig. 1A
and C). The inhibition produced by adenosine (100μM)
was not different from that observed in slices from
P21–28 rats (61.5± 2.1%, n = 47 slices; and see Wall
et al. 2007). There was also no significant change in the
adenosine-mediated increase in paired pulse facilitation
between young (increased from1.38± 0.02 to 1.85± 0.04,
n= 54) and adult slices (increased from 1.45± 0.02 to
1.92± 0.06, n = 47). To check the properties of the
A1 receptors more carefully, dose–response curves were
constructed for the non-hydrolysable A1 receptor agonist
N 6-cyclopentyladenosine (CPA). The curves constructed
fromP9–12 and P21–28 could be superimposed (Fig. 1D).
Thus the lack of adenosine tone at immature synapses
does not appear to result from changes in A1 receptor
properties or expression. In all experiments, the sensitivity
of synapses was first tested (with 100μM adenosine) and
synapses were rejected if adenosine did not produce at
least a 50% reduction in EPSP amplitude.
The presence or absence of tonic A1 receptor
activation has marked effects on trains of activity
Numerous studies have demonstrated that presynaptic
inhibition has important effects on trains of activity,
with a reduction in initial transmitter release allowing
synaptic transmission to persist for longer during a train of
stimuli (for example see Kreitzer & Regehr, 2000; Kimura
et al. 2003; Wong et al. 2006). We have investigated what
effect the adenosine tone has on trains of EPSPs (100
EPSPs, 20 Hz) in young and mature slices. During trains
of stimuli, transmission in slices from P9–12 rats was
first facilitated and then depressed (Fig. 2A). PF EPSP
amplitude was increased to amaximumof 157± 10.9%of
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the first EPSP amplitude (n = 6) at around the 10th EPSP
and then decreased to an amplitude less than the first EPSP
by around the 70th EPSP. Blocking of A1 receptors (with
2μM 8-CPT) had no significant effect on the amplitude
of PF EPSPs during the train (Fig. 2A). This was expected
since there is little or no tonic activation of A1 receptors,
but it also suggests that there is little or no adenosine
release during the train (see Wall & Dale, 2007). Addition
of (100μM) adenosine produced a marked change in
the trains of PF EPSPs, with significantly (P < 0.01)
greater facilitation (maximum 215± 27%) and the EPSP
amplitude remaining elevated above the amplitude of the
first EPSP for the duration of the train (Fig. 2A).
Trains of EPSPs were also evoked at parallel
fibre–Purkinje cell synapses in slices from P21–28 rats
where there is a much larger inhibitory A1 receptor tone
(Fig. 2B). Like immature synapses, PF EPSP amplitude
was facilitated (146± 8.1%) and then depressed, although
this depression happened much earlier in the train
(EPSP amplitude less than first EPSP amplitude by
around the 30th EPSP, Fig. 2B). Addition of adenosine
(100μM) caused a marked increase in the degree
Figure 1. Little or no tonic activation of presynaptic A1 receptors at immature parallel fibre to Purkinje
cell synapses
A, plot of the amplitude of individual parallel fibre (PF) EPSPs (field) against time in a slice from a P10 rat. Although
application of adenosine (100 μM) produced a decrease in EPSP amplitude of ∼55%, block of A1 receptors with
8-CPT (2 μM) had no effect on EPSP amplitude. Addition of adenosine (100 μM) in the presence of 8-CPT had no
effect on EPSP amplitude showing A1 receptors were blocked. Synaptic transmission was blocked at the end of the
experiment with 5 mM kynurenate (Kyn). Inset, superimposed average EPSPs from A in control, adenosine (100 μM)
and 8-CPT (2 μM). B, summary of the effects of 8-CPT on the amplitude of PF EPSPs recorded from 20 slices from
P9–12 rats and 8 slices from P21–28 rats. C, plot of the reduction in PF EPSP amplitude following application of
adenosine (100 μM) against the increase in PF EPSP amplitude following block of A1 receptors with 8-CPT (2 μM).
Adenosine was applied first, then washed and then 8-CPT was applied (as in A). D, concentration–response curves
constructed for the reduction in PF EPSP amplitude by the A1 receptor agonist CPA in P9–12 (n = 5) and P21–28
(n = 4) slices.
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of facilitation (255± 32%), which was maintained at
∼200% throughout the train (Fig. 2B). Addition of
8-CPT (1–2μM) caused a small but significant (P < 0.05)
reduction in the degree of facilitation (from 146± 8.1%
to 129± 32%) followed by almost complete depression
of transmission (11% of first EPSP amplitude) of EPSP
amplitude and then recovery (to ∼50% of the first EPSP,
Fig. 2B). The actions of 8-CPT appeared larger later in the
train suggesting that adenosine release occurred during
the train (see Wall & Dale, 2007).
There is a low concentration of extracellular
adenosine metabolites in immature slices
In a previous study (Wall et al. 2007), although A1
receptors were tonically activated in cerebellar slices
from P21–28 rats, biosensors placed in or above the
slices could not detect adenosine but instead detected the
adenosine metabolites inosine and hypoxanthine. It can
be predicted that the concentration of these metabolites
would be reduced in immature slices since there is little
or no A1 receptor tone. The extracellular purine tone
was measured by moving purine (ADO and INO) and
null sensors close to the slice surface. Sensors were bent
so they were parallel to the slice surface, thus increasing
the amount of sensing surface in close proximity to
the slice (this will increase the measured purine tone
compared to Wall et al. (2007), where the sensors were
not bent). The advantage of this experiment is that
the slice is not damaged by sensor insertion and no
resultant purine release occurs (see Wall et al. 2007). As
predicted, there was only a small increase in baseline
current when ADO or INO sensors were moved close to
the slice surface (mean change in current: 43.4± 4.1 pA,
ADO sensors; 61.7± 18 pA, INO sensors; n =
15 slices; Fig. 3A). There was little or no change in
baseline current when a null sensor was moved close to or
away from the slice surface (Fig. 3A). After correcting for
calibration, there was no significant difference between
the current measured on the ADO and INO sensors, and
thus the current is not produced by adenosine but is
produced by the metabolites (inosine and hypoxanthine,
see Wall et al. 2007). If we assume that all of the purine
detected is inosine then the net concentration of inosine
measured on the surface of the slice was 0.25± 0.03μM
(n= 15 slices, Fig. 3B). Interleaved experiments with
slices from P21–28 rats showed an almost 5-fold larger
increase in current when purine sensors were moved close
to the slice surface (224.3± 35.9 pA, Fig. 3A, n = 8 slices,
equivalent to 1.6± 0.3μM inosine also see Wall et al.
2007). The low extracellular concentration of adenosine
metabolites suggests that the lack of adenosine A1
receptor activation does not result from the metabolism
of significant concentrations of extracellular adenosine
(Fig. 3B).
Interrupting adenosine clearance has only small
effects on the inhibitory A1 receptor tone
The lack of adenosine tone could stem from either
the rapid removal of adenosine or reduced extracellular
production. Adenosine is removed from the extracellular
space by a combination of extracellular metabolism
(adenosine deaminase) and uptake (equilibrative and
Figure 2. An A1 receptor tone has marked effects on trains of
activity
A, plot of normalised EPSP amplitude (relative to the first EPSP
amplitude) against stimulus number in control, 100 μM adenosine and
2 μM 8-CPT for 6 parallel fibre–Purkinje cell synapses in slices from
P9–12 rats. B, plot of normalised EPSP amplitude (relative to the first
EPSP amplitude) against stimulus number in control, 100 μM
adenosine and 2 μM 8-CPT for 5 parallel fibre–Purkinje cell synapses in
slices from P24–28 rats. Stimulus frequency was 20 Hz.
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concentrative transporters) followed by intracellular
conversion to adenosine monophosphate by adenosine
kinase. We have used pharmacological agents to reduce
adenosine clearance and thus investigated the rate of basal
adenosine production.
Adenosine metabolism. To investigate the role of
metabolism, PF EPSPs recordings were made in the
presence of EHNA. EHNA blocks the enzyme adenosine
deaminase (Agarwal, 1982) and thus should produce
extracellular adenosine accumulation and inhibition of
PF EPSPs. Application of EHNA (20μM) had little effect
on PF EPSPS; the amplitude (1.2± 1.6% reduction, 5
slices, range 0 to 12%, Fig. 4A) and the paired pulse ratio
(1.33± 0.3 vs. 1.34± 0.3) were not significantly changed.
Figure 3. The concentration of extracellular adenosine
metabolites is reduced in immature slices
A, example biosensor traces from experiments to measure the
concentration of purines at the surface of slices from P23 and P9 rats
(interleaved experiments). After the inosine (INO) biosensor was
moved close to the slice surface there was a rapid increase in the
baseline current of ∼350 pA (P23) and ∼100 pA (P9). Movement of
the null sensor to the surface of the slice had no effect in P23 or P9
slices (P23 illustrated). B, plot of the mean concentration of inosine
measured close to the slice surface (from 15 slices from P9–12 rats and
8 slices from P21–28 rats). The concentration of inosine was
determined following calibration of the biosensor and assumes all the
current arises from inosine.
Thus as suggested by the biosensor results, there appears
to be little ongoing adenosine metabolism.
Equilibrative transporters. We have investigated the roles
of the equilibrative transporters (ENT1 and ENT2) using
the inhibiters NBTI and dipyridamole (Dunwiddie &
Diao, 1994; Frenguelli et al. 2007). Application of 10μM
dipyridamole and 5μM NBTI for prolonged periods
(30min) produced a mean reduction in EPSP amplitude
of 16.9± 3.5% (31 slices). In 15 out of the 31 slices
NBTI/dipyridamole had no effect on EPSP amplitude
(Fig. 5C). In the remaining 16 slices, EPSP amplitude was
Figure 4. Inhibition of extracellular adenosine metabolism and
equilibrative transport has little effect on synaptic transmission
A, although PF EPSPs were markedly reduced by adenosine (100 μM,
∼50%), the adenosine deaminase inhibitor EHNA (20 μM) had no
effect on PF EPSP amplitude. B, block of equilibrative transport with
5 μM NBTI and 10 μM dipyridamole caused a small reduction (∼15%)
in PF EPSP amplitude, which was reversed by blocking A1 receptors
with 8-CPT (1.5 μM). Addition of adenosine (100 μM) at the beginning
of the experiment reduced EPSP amplitude by ∼55%. The graphs in A
and B plot the amplitude of individual PF EPSPs against time. PF EPSPs
were blocked at the end of the experiment with 5 mM kynurenate
(kyn).
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Figure 5. Inhibition of adenosine kinase has minor effects on
synaptic transmission
A, the block of adenosine kinase with iodotubercidin (2 μM) produced
a small reduction in PF EPSP amplitude (∼20%). Block of adenosine
deaminase (EHNA 20 μM) did not increase the block, which was
reversed by blocking A1 receptors with 8-CPT (1.5 μM). B, following
addition of iodotubercidin (2 μM), block of extracellular adenosine
metabolism (EHNA 20 μM) produced a marked increase in the
inhibition of PF EPSP amplitude. The block was reversed by addition of
8-CPT (2 μM). C, pre-incubation with 5 μM NBTI and 10 μM
reduced by 32.7± 4% (Fig. 4B) with an increase in paired
pulse ratio from 1.4± 0.05 to 1.6± 0.08. This inhibition
was reversed by blocking A1 receptors with 8-CPT (2μM).
There was no correlation between the reduction in
EPSP amplitude produced by NBTI/dipyridamole and
the presence or absence of an A1 receptor tone. These
results are similar to those observed atmature slices, where
the actions of NBTI/dipyridamole were heterogeneous,
although the mean inhibition was higher (∼50%; Wall
et al. 2007).
It is possible that any increase in extracellular adenosine
concentration, following the block of equilibrative trans-
port, is rapidly reduced by metabolism. Thus the
adenosine deaminase inhibitor EHNA (20μM) was
applied in the presence of NBTI/dipyridamole (after
20–30min pre-incubation). In six cells, pre-incubation
with NBTI/dipyridamole had no effect on EPSP
amplitude and nor did the addition of EHNA. In three
cells, NBTI/dipyridamole decreased EPSP amplitude by
30± 0.5%, and addition of EHNA produced a further
decrease in EPSP amplitude of 27± 3%. Thus some of the
adenosine is metabolised by adenosine deaminase.
Adenosine kinase. Once transported into cells, adenosine
is phosphorylated to form AMP by the enzyme adenosine
kinase, thus maintaining low levels of intracellular
adenosine and preventing efflux via equilibrative trans-
porters (for review see Boison, 2006). To assess the
importance of adenosine kinase activity, the adenosine
kinase blocker iodotubercidinwas applied. Iodotubercidin
(2μM) reduced PF EPSP amplitude (25± 3%) and
increased the paired pulse ratio (1.3± 0.1 to 1.47± 0.1) in
14 out of 21 slices (Fig. 5A). The effects of iodotubercidin
were completely reversed by blocking A1 receptors
with 8-CPT (1μM). In the remaining seven slices,
iodotubercidin had no effect on PF EPSP amplitude. The
effects of iodotubercidin were significantly smaller than
those observed in interleaved adult slices (68% inhibition,
n= 3) and in published data (Wall et al. 2007).
To check if the elevated concentration of extracellular
adenosine, produced by blocking adenosine kinase, is
metabolised, we co-applied EHNA with iodotubercidin.
The co-application of EHNA and iodotubercidin reduced
PF EPSP amplitude by 50.7± 7.8% (n = 6), which was
significantly (P < 0.05) higher than that observed with
the block of adenosine kinase alone. This increased
reduction in PF EPSP amplitude was reversed by addition
dipyridamole did not occlude the effects of blocking adenosine kinase
(2 μM iodotubercidin). The plots in A, B and C are of individual PF
EPSPs against time with synaptic transmission blocked at the end of
the experiment with kynurenate (kyn, 5 mM).
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of 8-CPT(1μM).Toexamine this inmoredetailwe applied
EHNA (20μM), after first blocking adenosine kinase with
iodotubercidin (2μM). We found the effects of EHNA
mixed, producing little or no effect in three slices (Fig. 5A)
andproducing a largeblock in another four slices (Fig. 5B).
We have tried to occlude the increase in adenosine
tone produced by iodotubercidin by blocking equilibrative
transport. Iodotubercidin would be expected to have no
effect if adenosine translocation is blocked. In six slices,
following application of NBTI/dipyridamole, block of
adenosine kinase with iodotubercidin still reduced EPSP
amplitude by 25.3± 3.5% (Fig. 5C). Thus, as observed
with mature slices (Wall et al. 2007), NBTI/dipyridamole
does not occlude the actions of iodotubercidin. In four
slices, there was little or no adenosine transport as neither
iodotubercidin nor NBTI/dipyridamole had any effect on
synaptic transmission.
Adenosine release is delayed or reduced at immature
parallel fibre–Purkinje cell synapses
Our results demonstrate that there is a low concentration
of extracellular adenosine at parallel fibre–Purkinje cell
synapses in slices fromP9–12 rats. Sinceblocking clearance
had little effect, there is little release of adenosine under
basal conditions. To investigate the active release of
adenosine we have used hypoxia and local electrical
stimulation as release stimuli.
A 10min period of hypoxia reversibly reduced PF EPSP
amplitude, an effect which was reversed by blocking A1
receptors with 8-CPT (1–2μM). At steady state, PF EPSP
amplitude was reduced by 64± 7% and the paired pulse
ratio was increased from 1.25± 0.04 to 1.8± 0.1 (n =
11 slices, Fig. 6A). The reduction in PF EPSP amplitude
can be used to measure the speed of rise in extracellular
adenosine concentration. The inhibition reached steady
state after 5.4± 0.7 min (delay until start of depression
3.7± 0.6 min). The decrease in PF EPSP amplitude was
fully reversed by reoxygenation after 5.3± 0.5 min (n=
8 slices).
As a comparison, hypoxia (10min) was also induced
in P21–28 slices where it induced a marked depression in
PF EPSP amplitude (81.3± 6.6%, n = 5 slices). However,
following 10min of hypoxia, the inhibition was often not
completely reversed by blocking A1 receptors with 8-CPT
(complete reversal was only observed in 2 out of 5 slices).
However, with shorter periods of hypoxia (5min), reversal
of block was observed in 6 out of 8 slices (mean inhibition
73± 5.4%, n = 6 slices). The speed of depression was very
rapid; the time to reach a steady state depression was
2.3± 0.3 min (n = 8 slices), which is double the rate of
inhibition observed in young animals. The delay until the
start of PF EPSP amplitude depression was 1.1± 0.4 min.
To investigate the kinetics of purine release in more
detail we have used purine biosensors. ADO, INO and
null sensors were placed on the surface of the molecular
layer (sensorswere bent to be parallel with the slice surface,
seeWall & Dale 2007). A short period of hypoxia (10min)
produced a large current onADOand INO sensors in both
P9–12 and P21–28 rats (Fig. 6C and D). As no increase
in baseline current was observed on null sensors, the
current was produced by the release of purines (Fig. 6C
inset). Since the currents on ADO and INO sensors were
not different in rise or amplitude (after correction for
calibration), the sensors detected adenosine metabolites
(inosine and hypoxanthine). Assuming that all the
metabolite is inosine, then the maximum concentration
of inosine detected at the surface of the slice (following
hypoxia) was 3.5± 0.4μM for P9–12 slices (n= 8) and
5.5± 0.7μM for P21–28 slices (n = 8). Although hypoxia
appeared to release significantly (P > 0.05) more purines
from older slices, this difference probably stems from
the slower rate of purine release in P9–12 slices. In all
P9–12 slices (n = 8), the sensor current had not reached
steady state after 10min of hypoxia and was still rising
during reoxygenation (Fig. 6C and D). In contrast, the
sensor current reached a plateau after 5.3± 0.5 min in
P21–28 slices (Fig. 6D). The slow release in P9–12 slices
resulted from a greater delay in the start of purine
release combined with a much slower rise in purine
concentration (experiments were interleaved so the bath
inflow and outflow speed were exactly the same in mature
and immature slices). The rising phase of the sensor
current could be fitted with a single exponential to give
a time constant of 9.1± 0.4 min for P9–12 slices and
1.5± 0.3 min for P21–28 slices. In some slices (both adult
and young), following reoxygenation, the rate of purine
release appeared enhanced before it began to fall. Such
a phenomenon has been observed following ischemia
in the hippocampus (termed post-hypoxic purine efflux,
PPE, Frenguelli et al. 2003) and was more apparent if
the biosensor was pushed into the slice (n = 2). After
reoxygenation, the decay of the biosensor current could
be fitted with a single exponential with a time constant of
∼15min for both P9–12 and P21–28 slices.
In P21–28 rats, adenosine can be reliably released by
trains of electrical stimulation in the molecular layer, a
processwhich is both actionpotential andCa2+ dependent
(Fig. 6E; observed in 4 out of 4 slices in interleaved
experiments, and see Wall & Dale (2007)). However it
was not possible to observe such adenosine release (the
response of the ADO sensor was the same as the null
sensor) at immature synapses, even with prolonged high
frequency stimulation (200 stimuli, 20–40 Hz, n = 15
slices, Fig. 6E). To check that it was possible to detect
adenosine release in these slices, the stimulus strength was
increased (above 25 V) to electroporate the cells under the
stimulating electrode (Hamann & Attwell, 1996; Wall &
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Dale, 2007). A large signal was then observed on the ADO
sensor but not on the null sensor (n= 3, not illustrated).
Discussion
There is little or no tonic A1 receptor activation at parallel
fibre–Purkinje cell synapses in slices from P9–12 rats
compared to synapses in slices from P21–28 rats (Wall
et al. 2007). This low level of receptor activation does not
result from either a lack of A1 receptors or the presence of
lowaffinity receptors. Thus during cerebellar development
there is an increase in the level of tonic A1 receptor
activation with no obvious change in receptor properties.
A similar developmental increase in A1 receptor tone
has been reported in the hippocampus (Psarropoulou
et al. 1990) also with no change in receptor properties.
In contrast, at the calyx of Held (in mice) there is a
developmental reduction in both adenosine tone and
receptor number (Kimura et al. 2003). Takahashi et al.
(1995) have report a larger A1 receptor activation in the
cerebellum of postnatal day 10–15 rats (∼24%). However
Figure 6. Hypoxia but not electrical stimulation releases adenosine in immature slices
A, the perfusion of a slice from a P11 rat with aCSF bubbled with N2 (95%)–CO2 (5%) for 10 min (hypoxia)
caused a slow reduction in PF EPSP amplitude (∼45%), which was reversed by block of A1 receptors with 8-CPT
(2 μM). B, in an interleaved experiment (recording from a slice from a P22 rat), the application of aCSF bubbled
with N2–CO2 caused a much more rapid and larger inhibition of PF EPSP amplitude, which again could be reversed
with block of A1 receptors (8-CPT, 2 μM). Note the clear presence of an A1 receptor tone in the slice from the
P22 rat (B). C, example traces from ADO biosensors placed on the surface of slices (molecular layer) from P12 and
P26 rats (interleaved experiments). Perfusion with aCSF bubbled with N2–CO2 for 10 min caused an increase in
extracellular purine concentration for both slices but the rise was much more rapid in the slice from the P26 rat.
Inset, hypoxia causes a small drop in current on the null sensor. D, traces from C expanded to show the difference
in rise-time of biosensor current. E, electrical stimulation (at arrow, 10 s, 20 Hz, 5 V) caused the release of purines
in a slice from a P22 rat but no detectable release in a P10 slice.
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these experiments were carried out at room temperature,
where the clearance of adenosine may be reduced.
Clearly, the presence or absence of an A1 receptor
tone will have marked effects on synaptic transmission.
Addition of exogenous adenosine enhanced facilitation
at both immature and mature synapses during trains
of stimuli. Removal of the A1 receptor tone, at mature
synapses resulted in almost complete synaptic depression.
Developmental changes in other modulators (such as
cannabinoids,Crepel, 2007)will also alter theproperties of
parallel fibre–Purkinje cell synaptic transmission during
trains of activity.
Control of basal adenosine concentration at
immature parallel fibre–Purkinje cell synapses
We have reduced the clearance of extracellular adenosine
at immature parallel fibre–Purkinje cell synapses to
investigate basal adenosine production. The small effect of
blocking adenosine deaminase (withEHNA) suggests little
ongoing extracellular metabolism. Similar small effects of
EHNA have been observed in the hippocampus (Pak et al.
1994; Dunwiddie & Diao, 1994) and in mature cerebellar
slices (Wall et al. 2007).
Adenosine kinase inhibition had minor effects on
synaptic transmission (∼25% inhibition). Blockade of
adenosine kinase causes an increase in the intracellular
concentration of free adenosine and thus a resultant efflux
of adenosine via equilibrative transporters (see Boison,
2006 for review). This is supported by the observation
that blocking extracellular metabolism (with EHNA) can
produce a reduction in PF EPSP amplitude following
adenosine kinase inhibition. This also demonstrates that
EHNA can reduce extracellular adenosine metabolism.
The greater importance of adenosine kinase activity
compared to extracellular metabolism has been observed
in other brain regions (Pak et al. 1994; Lloyd & Fredholm,
1995) and in mature cerebellar slices (Wall et al. 2007).
The role of equilibrative transport was assessed
by blocking ENT1 and ENT2. The effects on
synaptic transmission were mixed with ∼50% of synapses
inhibited (∼30%). Surprisingly, there was no correlation
between the presence of an adenosine tone in control
and the actions of NBTI/dipyridamole. As with mature
slices, the application of NBTI/dipyridamole was unable
to occlude the effects of adenosine kinase inhibition. Thus
NBTI/dipyridamole was unable to block all adenosine
transport. Such effects have also been observed at mature
synapses (Wall et al. 2007) and may result from either
expression of a transporter which is not blocked by
NBTI/dipyridamole or high expression of ENT2, which
is only weakly blocked in rat (Baldwin et al. 2004).
The blockade of adenosine breakdown, uptake and
intracellular conversion to AMP all had relatively minor
effects at immature synapses. The effects were also
heterogeneous with synaptic transmission not effected
at a large proportion of synapses. Thus the extracellular
production of adenosine, under basal conditions, is low at
immature synapses.
The active release of adenosine
We used hypoxia and electrical stimulation to actively
release adenosine and investigate whether there are
pools of releasable adenosine. Hypoxia produced robust
adenosine release and marked PF EPSP inhibition at
both immature andmature synapses. Biosensor recordings
suggest that similar concentrations of adenosine are
released but release is slower and delayed at immature
synapses. At mature slices, adenosine release is very
sensitive to hypoxia as the synaptic depression (and
therefore adenosine release) starts almost as soon as the
hypoxic aCSF reaches the bath. It seems unlikely that the
increased extracellular concentration of adenosine present
inmature synapses stems from the slices being continually
hypoxic as the slices were perfused (from above and
below) by highly oxygenated aCSF at a fast perfusion rate
(6 ml min−1) via gas tight tubing. Thus this mechanism of
adenosine release appears to become sensitive to hypoxia
during development.
It was not possible to measure adenosine release in
response to electrical stimuli in P9–12 slices, which
contrasts with the reliable release in slices from older rats
(Wall & Dale, 2007). It is possible that this mechanism
of adenosine release is not present at this developmental
stage or perhaps the number of adenosine release sites
is so small that the concentration of adenosine released
is below the levels of detection (∼30 nM). As parallel
fibre activity is required for adenosine release (Wall &
Dale, 2007), the smaller number of parallel fibre synapses
present in the immature molecular layer may produce
undetectable adenosine release. However the contribution
of action potential-dependent adenosine release to
the basal extracellular adenosine tone is small at mature
synapses, as TTX had only a very minor effect on the tone
(Wall et al. 2007). Thus the lack of this form of adenosine
release cannot explain the developmental difference in
basal adenosine receptor activation.
In conclusion, the extracellular concentration of
adenosine is low at immature parallel fibre–Purkinje
cell synapses and interference with adenosine clearance
suggests that little adenosine is being cycled between intra-
and extracellular compartments under basal conditions.
Reduced release in response to electrical stimulation
and slowed release in response to hypoxia suggest that
the mechanisms of adenosine release become more
efficient with development. It is possible that changes in
adenosine kinase expression could account for the change
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in the amount of releasable adenosine (and thus lack of
adenosine tone). Studer et al. (2006) showed that early in
development, hippocampal adenosine kinase expression
is mainly in neurones and shifts to glia during the second
postnatal week. Adenosine kinase expression in neurones
could account for the lack of intracellular adenosine
stores and the reduced extracellular release. It would be
interesting to use immunohistochemistry to confirm
cerebellar adenosine kinase expression.
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